An investigation into the role of mesoaccumbal GABAA receptor α2 subunit in mediating cocaine-facilitated conditioned behaviours using the RNA interference system by Sindarto, Marsha Moniaga
   
 
A University of Sussex PhD thesis 
Available online via Sussex Research Online: 
http://sro.sussex.ac.uk/   
This thesis is protected by copyright which belongs to the author.   
This thesis cannot be reproduced or quoted extensively from without first 
obtaining permission in writing from the Author   
The content must not be changed in any way or sold commercially in any 
format or medium without the formal permission of the Author   
When referring to this work, full bibliographic details including the 
author, title, awarding institution and date of the thesis must be given 
Please visit Sussex Research Online for more information and further details   
An investigation into the role of mesoaccumbal GABAA 
receptor α2 subunit in mediating cocaine-facilitated 
conditioned behaviours using the RNA interference 
system 
 
 
 
 
 
 
Marsha Moniaga Sindarto 
DPhil in Psychology 
University of Sussex 
July 2018 
  
 
 
 
 
 
 
 
 
 
 
 
 
I hereby declare that this thesis has not been and will not be submitted in 
whole or in part to another University for the reward of any other degree. 
 
 
Signature ……………………………… 
  
 
 
University of Sussex 
Marsha Moniaga Sindarto 
 
An investigation into the role of mesoaccumbal GABAA receptor 
α2 subunit in mediating cocaine-facilitated conditioned 
behaviours using the RNA interference system 
 
α2 subunit-containing GABAA receptors (α2-GABAARs) are 
abundantly expressed in the nucleus accumbens (NAc), a region thought to 
be important in mediating cocaine’s reinforcing properties. This thesis 
develops viral-based RNAi tools in efforts to investigate the functional role 
of mesoaccumbal α2-GABAARs in mediating cocaine’s ability to facilitate 
conditioned behaviours (i.e. behavioural sensitisation and conditioned 
reinforcement). 
RNA interference (RNAi)-mediated knockdown of the α2 subunit 
expression in the NAc core neither affected appetitive Pavlovian learning 
nor instrumental learning maintained by the conditioned reinforcer, but 
blocked cocaine facilitation of conditioned reinforcement. This behavioural 
phenotype was also observed upon α2 knockdown specifically in NAc core 
dopamine D2 receptor (D2R)-containing neurons, whereas α2 knockdown in 
mesoaccumbal D1R-containing neurons reduced the level of discriminated 
approach during Pavlovian learning. Further, α2 knockdown in the NAc 
core or shell did not block cocaine-induced sensitisation as previously 
observed in the constitutive knockouts (Dixon et al., 2010), but the latter 
increased acute locomotor responses to cocaine.  
Data presented within this thesis indicate that GABAergic signalling 
via α2-GABAARs within the NAc is involved in some of the motivation-
enhancing properties of cocaine, most likely via interactions with the 
dopaminergic system. 
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Chapter 1 
Introduction 
 
1.1. Overview 
Drug addiction is now recognised as a neuropsychiatric disorder and 
its consequences on both physical and mental health continue to place a 
heavy burden on the public health system. According to the World Drug 
Report (2017), the market for cocaine continues to expand in recent years, 
reflected by increases in coca bush cultivation and seizures, raising further 
concerns pertaining to growing cocaine use worldwide. In the UK, deaths 
involving cocaine in 2012-2016 have been reported to reach an all-time high 
(Office for National Statistics, 2016). Whilst various interventions have been 
put in place to manage and restore social and economic impacts associated 
with drug misuse, there remains a lack of effective and accessible 
treatments to tackle drug misuse problems. Further research is therefore 
needed to better understand the biological and behavioural aetiology of drug 
addiction, in the continuing effort to provide effective treatments.  
4 
 
1.2. Genetic basis of addiction: Focusing on GABRA2 
polymorphism 
Human studies of addictive disorders converge on the relevance of 
genetic heritability in the development of drug addiction (Kendler, 
Karkowski, Neale, & Prescott, 2000; Kendler, Karkowski, & Prescott, 1999; 
Verhulst, Neale, & Kendler, 2014). Computations of the weighted mean 
heritability for addictions from large twin studies further revealed that 
while heritability is lowest for hallucinogenic drugs (0.39), it is highest for 
cocaine (0.72) (Goldman, Oroszi, & Ducci, 2005). Among a plethora of genes 
linked to cocaine addiction to date, polymorphic variations of GABRA2, 
encoding the α2 subunit of the Gamma-Aminobutyric acid A receptors 
(GABAARs), have recently been associated with cocaine addiction, 
particularly in individuals with a history of childhood trauma (Dixon et al., 
2010; Enoch et al., 2010). There also exists a large body evidence linking 
GABRA2 variation to individual susceptibility to heroin (Enoch et al., 2010), 
alcohol (Edenberg et al., 2004; Li et al., 2014; also reviewed in Stephens, 
King, Lambert, Belelli, & Duka, 2017), as well as polydrug (Agrawal et al., 
2006; Matthews, Hoffman, Zezza, Stiffler, & Hill, 2007) abuse. 
Maladaptive actions that characterise the addiction phenotype often 
stem from unbalanced neural interactions within circuits implicated in goal-
directed behaviours (Volkow, Wang, Tomasi, & Baler, 2013). GABA is the 
major inhibitory neurotransmitter in the mammalian central nervous 
system (CNS), and therefore plays an integral role in regulating the 
dynamics of neural activity and excitability. It exerts its inhibitory and in 
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minor cases, excitatory, role by acting via ionotropic GABAA receptors 
(GABAARs) (Bracci & Panzeri, 2006; Farrant & Nusser, 2005; Obata, Oide, 
& Tanaka, 1978). The α2 subunit-harbouring GABAARs (α2-GABAARs), in 
particular, are densely expressed in a region by which cocaine and other 
drugs of abuse exert their reinforcing properties, i.e. the nucleus accumbens 
(NAc), as well as in other loci implicated in motivational processes and 
incentive learning, such as the prefrontal cortex, amygdala, and the 
hippocampus (Cardinal, Parkinson, Hall, & Everitt, 2002; Hörtnagl et al., 
2013; Pirker, Schwarzer, Wieselthaler, Sieghart, & Sperk, 2000; Tracy, 
Jarrard, & Davidson, 2001). 
In this thesis, we sought to explore the role of α2-GABAARs, 
specifically in the NAc, in mediating cocaine-induced dopamine-dependent 
behaviours. This introduction will begin by describing the NAc architecture 
and circuitry, GABAAR properties, and the role of the GABAergic system in 
mediating cocaine-induced responses. Finally, this chapter will also 
introduce RNA interference (RNAi) as a strategy to study the functional 
importance of α2-GABAARs in a site- and/or pathway-specific manner.  
1.3. The Nucleus Accumbens (NAc) 
Goal-directed action largely depends on our ability to accurately 
integrate and assess the value of the anticipated incentives with the effort-
related costs (Salamone, Correa, Farrar, & Mingote, 2007; Salamone & 
Correa, 2012). One of the most investigated systems, implicated in the 
expression of motivated actions, is the basal ganglia (BG) circuitry, which 
comprise a set of subcortical structures, forming looped circuits with the 
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thalamus and cortex (Hollerman, Tremblay, & Schultz, 2000; Lanciego, 
Luquin, & Obeso, 2012). 
The striatum serves as the main input nucleus to the basal ganglia. 
Anatomically, the striatal region can be partitioned into dorsal and ventral 
territories, and it is the ventral portion of the striatum (i.e. the nucleus 
accumbens, NAc), which forms the prime focus of this thesis.  The NAc 
receives highly converging inputs from cortical and subcortical structures 
and projects to motor areas to govern behavioural output (Voorn, 
Vanderschuren, Groenewegen, Robbins, & Pennartz, 2004). The net output 
projections from the NAc are also influenced or fine-tuned by the intra-
accumbal microcircuitry, consisting of collateral projections between 
neighbouring NAc neurons, as well as regulation by local GABAergic and 
cholinergic interneurons (Tepper, Wilson, & Koós, 2008; discussed further 
below). 
1.3.1. The NAc architecture 
The NAc is a part of the ventral striatum (VS), originally coined by 
Heimer (Heimer, Switzer, & Van Hoesen, 1982). The NAc can be further 
segregated into two subterritories on the basis of cellular morphology, 
projection patterns, neurochemistry, and biological functions, i.e. NAc shell 
and core (Heimer, Zahm, Churchill, Kalivas, & Wohltmann, 1991; Voorn et 
al., 2004). Based on anatomical landmarks, the core region lies directly 
beneath and continuous with the dorsal striatum (DS) and surrounds the 
anterior commissure (aca), whereas the shell subdivision surrounds the core 
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medially, laterally, and ventrally. Given that the core-shell division can be 
most easily distinguished in a more caudal part of the NAc, the rostral part 
of the NAc is now referred to as the rostral pole (Zahm & Brog, 1992).  
The GABA-releasing medium spiny neurons (MSNs) make up the 
majority (~95%) of the striatal neuronal cell population (Matamales et al., 
2009; Ouimet, Langley-Gullion, & Greengard, 1998) and the remaining ~5% 
of striatal neurons comprise several classes of interneurons, i.e. 
parvalbumin (PV)-expressing fast-spiking GABAergic interneurons (FSIs), 
neuropeptide Y (NPY)/ nitric oxide synthase (NOS)/ somatostatin (SOM)-
expressing GABAergic interneurons, calretinin (CR)-expressing GABAergic 
interneurons, and cholinergic interneurons (CINs) (Tepper & Bolam, 2004). 
1.3.2. Cell populations 
1.3.2.1. Medium Spiny Neurons 
The GABAergic MSNs exhibit a characteristic hyperpolarised resting 
membrane potential (RMP) of approximately ~-80 mV. This is known as the 
‘down state’, due to a strong inward rectification mediated by high amounts 
of inwardly rectifying Kir2 K+ channels (Gertler, Chan, & Surmeier, 2008; 
Mermelstein, Song, Tkatch, Yan, & Surmeier, 1998; Wilson & Kawaguchi, 
1996; Wilson, 1993). A barrage of highly convergent glutamatergic inputs, 
impinging onto the dendritic spines of MSNs, depolarise the neurons, 
thereby overwhelming and promoting the closure of the dendritic Kir2 K+ 
channels and inactivation of the neighbouring Kv4 (A-type) K+ channels. 
These events lead to increased input impedance of the MSN dendrites, 
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yielding an ‘up’ state as the somatic membrane potential approaches the 
spike threshold. It is at this state that MSNs fire (Day, Wokosin, Plotkin, 
Tian, & Surmeier, 2008; Surmeier, Carrillo-Reid, & Bargas, 2011; Wilson, 
1993).  
Based on their neuropeptide expression, electrophysiological 
properties and projection patterns, the striatal MSNs can be further 
classified into two main categories. Namely, the D1-MSNs are enriched with 
Dopamine D1-receptors (D1Rs), substance P and dynorphin, whereas the 
D2-MSNs selectively express Dopamine D2-receptors (D2Rs) and 
enkephalin (Gerfen et al., 1990; Surmeier, Song, & Yan, 1996). Also note at 
least 6% of MSNs in the mouse striatum co-express D1Rs and D2Rs 
(Perreault, Hasbi, O’Dowd, & George, 2011).  
Morphologically, the dendrites of the D1- and D2-MSNs contain a 
similarly high number of spines, though the latter were found to possess 
more, resulting in a greater number of synaptic contacts onto these neurons 
(Gertler et al., 2008). Electrophysiological evidence further suggests that the 
dendrites of the D2-MSNs are more excitable than those of the D1 
counterparts (Day et al., 2008). Nevertheless, unlike projections originating 
from the DS, recent evidence suggests that the canonical ‘striatal-like’ 
segregated projection pattern does not apply to efferents from the mouse 
NAc (further discussed in Section 1.3.3.4 below) (Kupchik et al., 2015; 
Smith, Bevan, Shink, & Bolam, 1998). 
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1.3.2.2. GABAergic interneurons 
Approximately 3-4% of striatal neurons are aspiny GABAergic 
interneurons (Tepper, Tecuapetla, Koós, & Ibáñez-Sandoval, 2010). They 
were first characterised by [3H] GABA uptake combined with Golgi staining 
and were found to accumulate [3H] GABA to a significantly greater extent 
than the MSNs (Bolam, Clarke, Smith, & Somogyi, 1983). Later findings 
further identified three types of GABAergic interneurons on the basis of 
their calcium-binding proteins. These neurons either express PV, CR, or 
NPY-NOS-SOM, representing 0.7%, 0.5%, or 0.6% of the total striatal 
neuron population in the rat, respectively (Rymar, Sasseville, Luk, & 
Sadikot, 2004). 
1.3.2.2.1. Fast-spiking interneurons (FSIs) 
The PV-immunoreactive (PV+) interneurons exhibit a fast-spiking 
electrophysiological profile and are, thus, commonly referred to as fast-
spiking interneurons (FSIs). This subpopulation of striatal interneurons was 
first documented in the Gerfen, Baimbridge, & Miller (1985) study. PV+ 
FSIs can further be classified into two subtypes based on the firing 
characteristics – i.e. exhibiting continuous firing (maintained by continuous 
current injection) vs. “stuttering” response. The latter denotes a brief series 
of action potentials separated by silent periods of variable interval, which 
have been detected specifically in the rodent NAc (Stefano Taverna, 
Canciani, & Pennartz, 2007), though such a phenotype was found to be less 
frequent in mice (Freiman, Anton, Monyer, Urbanski, & Szabo, 2006). 
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Nevertheless, it remains tentative whether these aforementioned firing 
properties reflect different states of the same FSIs or are indicative of 
distinct FSI subpopulations.  
Neurochemically, FSIs express high amounts of the main synthetic 
enzyme for GABA, i.e. glutamate decarboxylase (GAD), specifically the 
GAD67 isoform (i.e. GABA-synthesising enzyme) (Kita, Kosaka, & 
Heizmann, 1990; Lenz, Perney, Qin, Robbins, & Chesselet, 1994). FSIs 
make GABAA receptor-mediated synapses primarily onto the somatic 
membrane of both D1- and D2-MSN subtypes (Bennett & Bolam, 1994; Kita 
et al., 1990), and have been demonstrated to make connections with other 
FSIs, but not with other classes of interneurons (Gittis, Nelson, Thwin, 
Palop, & Kreitzer, 2010). Specifically, paired recordings showed that FSI-
MSN synapses exhibit effective temporal summation, low failure rates 
(<1%), and, importantly, spiking of the FSIs is potent enough to delay or 
completely block MSN firing (Koós & Tepper, 1999). The occurrence of such 
powerful inhibition has been linked to an increase in cortical activity, 
indicating descending excitatory afferents from the cortex to the PV+ FSIs 
(i.e. feedforward inhibition) (Mallet, Le Moine, Charpier, & Gonon, 2005).  
1.3.2.2.2. Low-threshold spiking interneurons  
The NPY-NOS-SOM+ interneurons exhibit a low-threshold calcium 
spike (LTS), high input resistance (>600 MΩ), and a more depolarised RMP 
(~-56 mV). Based on these characteristics, this class of interneurons was 
initially termed PLTS interneurons (PLTSIs) due to the LTS and persistent 
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depolarising plateau potentials (Kawaguchi, 1993). Unlike FSIs, PLTSIs 
form synaptic contacts on distal regions of the MSN dendrites and spines, 
avoiding the soma, as well as on cholinergic interneurons (Kubota & 
Kawaguchi, 2000). Intriguingly, the GABAergic inhibitory post-synaptic 
currents (IPSCs) evoked by LTSI and consequently, the synaptic responses 
in target MSNs are relatively weak. These findings cast doubts as to 
whether the main neuroactive substance released by PLTSIs is GABA, 
considering that GAD and GABA expression levels are relatively low in 
PLTSIs (Gittis et al., 2010; Tepper et al., 2010). 
More recently, the original premise that the NPY-NOS-SOM+ 
neurons represent a single subpopulation of interneurons has been 
disputed, as immunolabelling studies identified NOS-SOM+ interneurons 
that did not harbour NPY (Figueredo-Cardenas, Morello, Sancesario, 
Bernardi, & Reiner, 1996) and stereological cell counting experiments 
revealed differences in the numbers of SOM+ and NPY+ neurons (Rymar et 
al., 2004). For example, a class of NPY+ neurogliaform interneurons (NPY-
NGF) has recently been identified and intriguingly, the NPY-NGF 
interneurons were found to mediate powerful inhibition to MSNs (Du et al., 
2017). These neurons exhibit similar electrophysiological characteristics to 
those of the MSNs, i.e. hyperpolarised membrane potential, low input 
resistance, and marked inward rectification (Wilson, 1993). This subclass of 
interneurons forms extremely high probability of synaptic contacts with 
MSNs with no failures observed. They are thought to mediate feedforward 
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inhibition of MSNs, but with slower kinetics relative to that mediated by 
FSIs (Ibáñez-Sandoval et al., 2011). 
1.3.2.2.3. Calretinin-expressing interneurons 
Out of the three classical types of striatal GABAergic interneurons, 
the least is known about the CR+ subtype. Though these neurons represent 
~0.5% of striatal neurons in based on stereological cell counts of 
immunoreactive neurons in the rat striatum (Rymar et al., 2004), the 
activity of these neurons has never been recorded and they have not been 
intracellularly labelled, in part due to the lack of transgenic mice whereby 
CR is tagged with a fluorescent protein (e.g. EGFP-CR+) to enable selective 
investigation of this neuronal subtype (Tepper et al., 2010). As a result, 
current knowledge of these neurons remains in its infancy and is limited to 
their morphological structure based on immunostaining experiments, which 
revealed at least three morphologically different subtypes of CR+ 
interneurons based on their somatic size (Prensa, Giménez-Amaya, & 
Parent, 1998; Rymar et al., 2004; Schlösser, Klausa, Prime, & Ten 
Bruggencate, 1999). 
1.3.2.3. Cholinergic interneurons 
The cholinergic interneurons (CINs) only make up ~1% of striatal 
neurons, but these neurons ramify extensively and provide the main source 
of striatal acetylcholine (ACh) (Bolam, Wainer, & Smith, 1984; Contant, 
Umbriaco, Garcia, Watkins, & Descarries, 1996). The CINs are 
distinguishable from other striatal cells as they have large soma (>15 µm) 
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and display a unique electrophysiological profile, such as a more depolarised 
RMP (~-60 mV), high input resistance (~ 200 MΩ), and exhibit a tonic firing 
rate of 3-10 Hz, therefore classed as tonically active neurons (TANs) 
(Calabresi et al., 1997; Lee, Dixon, Freeman, & Richardson, 1998; Wilson, 
Chang, & Kitai, 1990). Immunohistochemical analyses further indicated 
that the striatum contains the highest density of cholinergic markers, which 
include ACh, choline acetyltransferase (ChAT), as well as 
acetylcholinesterase (AChE), yielding a hypothesis that cholinergic 
signalling may play a crucial role in regulating striatal activity and its 
output (Lim, Kang, & McGehee, 2014). The mesostriatal cholinergic system 
has been previously implicated in cocaine self-administration, reinforcement 
learning, and sensitization. In turn, chronic cocaine exposure has also been 
shown to induce changes in the cholinergic system (reviewed extensively in 
Williams & Adinoff, 2008). 
1.3.3. Afferents to and efferents from the NAc 
The NAc receives dense excitatory afferents from cortical and 
subcortical structures (Brog, Salyapongse, Deutch, & Zahm, 1993; O’Donnell 
& Grace, 1995; Powell & Leman, 1976) and form output projections to 
ventral mesencephalon and the ventral pallidum (VP) (Floresco, Todd, & 
Grace, 2001; Heimer et al., 1991; Kupchik et al., 2015; Xia et al., 2011), 
which subsequently innervate the thalamic regions and ultimately, the 
cortical regions. Collectively, these projections form the cortico-striato-
pallidal-thalamo-cortical loop (Parent & Hazrati, 1995), which has long been 
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implicated in behavioural responses to rewards (Satoshi Ikemoto, Yang, & 
Tan, 2015).  
1.3.3.1. Excitatory afferents 
The primary afferent regions providing glutamatergic inputs to the 
NAc are the distinct, albeit interconnected, subregions within the prefrontal 
cortex (PFC) (see Heidbreder & Groenewegen, 2003 for review), the 
basolateral nucleus of the amygdala (BLA) (Howland, Taepavarapruk, & 
Phillips, 2002), the thalamus (Wright & Groenewegen, 1995) and ventral 
hippocampus (vHC) (Blaha, Yang, Floresco, Barr, & Phillips, 1997; 
Totterdell & Smith, 1989), which also form reciprocal excitatory connections 
with one another (Jackson & Moghaddam, 2001; O’Donnell & Grace, 1995) 
(Figure 1.1). 
Importantly, there are differences between the origin of afferents 
innervating the core versus the shell subcompartments. Namely, the NAc 
shell is densely innervated by the ventral regions of the infralimbic, 
prelimbic, insular cortices, whereas the core primarily receives afferents 
from the dorsal agranular insular, anterior cingulate, and dorsal areas of 
the prelimbic cortices (Brog et al., 1993; Groenewegen, Wright, Beijer, & 
Voorn, 1999). Nevertheless, stimulation of the PFC, which would typically 
be powerful enough to trigger accumbal MSN firing, failed to do so in fornix-
transfected rats. These data further suggest that the hippocampal afferents 
to the NAc, travelling in the fornix, are required to permit PFC inputs to 
elicit neuronal firing in the NAc by switching the neurons to a more 
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depolarised state (“up” state) (O’Donnell & Grace, 1995). Note, however, 
that recordings were performed from neurons in the medial NAc (medial 
core and shell). A recent study by Britt et al. (2012) further showed that 
glutamatergic inputs from vHC stably depolarised NAc neurons particularly 
those located in the medial NAc shell due to greater NMDA-mediated 
inward currents exhibited by the vHC-NAc synapses, thus providing a 
potential mechanism by which hippocampal inputs have a unique ability to 
depolarise MSNs.  
The topographical organisation of inputs from the BLA, on the other 
hand, is more complex. It generates an elaborate ‘rostral to core’ to ‘caudal 
to shell’ topography that also varies according to the patch-matrix divisions 
of the NAc (Wright, Beijer, & Groenewegen, 1996). These amygdalar inputs 
play a key role in monitoring changes in the affective salience of the stimuli 
(Shiflett & Balleine, 2010), as well as in instrumental learning solely 
maintained by a conditioned reinforcer (Burns, Robbins, & Everitt, 1993; 
also reviewed in Everitt et al., 1999). Finally, the NAc also receives 
excitatory thalamic afferents, with inputs to the core arising from 
intermediodorsal and those to the medial shell originating from 
paraventricular nuclei of the thalamus (Berendse & Groenewegen, 1990). 
Glutamatergic afferents from the thalamus have been demonstrated to 
modulate dopaminergic tone in the NAc, which are thought to be involved in 
mediating behavioural processes relating to arousal (Parsons, Li, & Kirouac, 
2007). Further, dopaminergic drugs, e.g. cocaine, have been shown to induce 
alterations in the thalamic-accumbal projections (Neumann et al., 2016). 
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These excitatory inputs typically synapse onto the dendritic shafts and 
spine heads of MSNs (Ligorio, Descarries, & Warren, 2009; Pinto, 
Jankowski, & Sesack, 2003). They also synapse onto the dendrites of local 
interneurons (Meredith & Wouterlood, 1990).  
Taken together, temporally converging cortical inputs can effectively 
depolarise MSNs first by promoting a depolarised ‘up’ state, therefore 
increasing the likelihood of action potential generation (O’Donnell & Grace, 
1995). Intriguingly, adequate and converging glutamatergic inputs in the 
striatal MSNs have the characteristic ability to generate long-lasting 
dendritic plateau potentials. As a result, fewer excitatory inputs (tens) are 
required to transition from the hyperpolarised RMP to this ‘up’ state (~20-
30 mV state transition) and ultimately, to generate action potentials 
(Oikonomou, Singh, Sterjanaj, & Antic, 2014; Plotkin, Day, & Surmeier, 
2011). Given the highly converging information each NAc neuron receives 
from various afferent sources, it is argued that the intra-NAc microcircuitry 
could impose an elaborate gating mechanism allowing information provided 
by certain subsystem(s) to preferentially affect behavioural outputs 
(discussed below). 
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Figure 1.1. A schematic representation of afferents into the accumbal 
medium spiny neurons. The NAc receives excitatory or glutamatergic inputs 
from the ventral hippocampus (vHC), basolateral nucleus of the amygdala 
(BLA), the prefrontal cortex, and the thalamus, whereas GABArgic inputs 
are provided by neighbouring MSNs (lateral inhibition) and the GABA-
expressing interneurons. The majority of cholinergic inputs into the 
accumbal spiny neurons are derived from the local cholinergic interneurons, 
whereas dopaminergic inputs into the NAc primarily originate from the 
VTA dopamine neurons (adapted from Brown et al., 2012; Russo & Nestler, 
2013; Tritsch et al., 2012).  
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1.3.3.2. Modulatory/inhibitory afferents 
Dopaminergic innervation of the NAc, primarily derived from the 
ventral tegmental area (VTA) has, by far, received the most attention given 
its involvement in mediating reinforcement and motivational processes 
(Saunders, Richard, Margolis, & Janak, 2017; Figure 1.1). Dopamine release 
within the NAc can be further dissociated based on the modes of firing, i.e. 
phasic and tonic signalling. The spike-dependent release of dopamine 
triggered by primary or conditioned reward is known as the phasic 
dopamine response. The magnitude of phasic dopamine signals has been 
shown to encode the expected availability or the size of reward (Schultz, 
1998). Dopamine also accumulates in the extracellular space, usually 
evoked via sustained firing of dopamine neurons or glutamate-induced 
presynaptic stimulation of dopamine terminals at a steady-state 
concentration that is too low to activate post-synaptic dopamine receptors 
but is sufficient to stimulate autoreceptors to counteract phasic dopamine 
response. This phenomenon has been termed the tonic dopamine response 
(Floresco, West, Ash, Moore, & Grace, 2003; Grace, 1991; Grace, 2000).  
Importantly, dopamine binding to the G protein-coupled dopamine D1 
or D2 receptors (D1Rs or D2Rs), primarily residing on the MSNs, exert 
excitatory or inhibitory effects on the MSNs via the modulation of voltage-
dependent ion channels and ionotropic receptors on the dendrites (Bertran-
Gonzalez et al., 2008; West & Grace, 2002). It is commonly accepted that 
dopamine’s action at D1Rs activates the Gs/olf family of G-proteins, leading 
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to cyclic AMP (cAMP) production by adenyl cyclase, PKA activation and the 
subsequent phosphorylation of PKA substrates, e.g. DARPP-32 (dopamine- 
and cAMP-regulated phosphoprotein of Mr 32 kDa) and a transcription 
factor, CREB (Greengard, Allen, & Nairn, 1999; Surmeier, Ding, Day, 
Wang, & Shen, 2007), whereas D2R activation inhibits adenylyl cyclase 
activity via Gi/o proteins. This results in the downregulation of cAMP 
production, leading to reduced activation of PKA (Beaulieu & Gainetdinov, 
2011). The D2Rs are expressed both postsynaptically on the dopamine 
target neurons, as well as presynaptically on dopamine neurons (D2 
autoreceptors). The latter regulate dopamine transmission by indirectly 
affecting expression and activity of the tyrosine hydroxylase (Lindgren et 
al., 2001). Phasic bursts of dopamine primarily increase average D1R 
occupancy, whilst having minimal effects on that of D2R (Dreyer, Herrik, 
Berg, & Hounsgaard, 2010). In contrast, slower tonic dopamine release 
predominantly activates the high affinity dopamine D2Rs (Floresco et al., 
2003; Goto & Grace, 2005) 
Intriguingly, recent findings documented in the Tritsch et al. (2012; 
2014) studies provided evidence for the co-release of GABA, alongside 
glutamate and dopamine from the VTA dopaminergic neurons, indicating an 
alternative mechanism by which dopaminergic neurons inhibit striatal 
output.  The lack of GAD expression in these neurons further suggested that 
GABA co-released by VTA dopamine neurons is not synthesised de novo. 
Instead, they rely on GABA reuptake from the extracellular space, given the 
high expression of membrane GABA transporters (mGAT1 and mGAT4) in 
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these neurons. The NAc also receives GABAergic inputs from the VTA 
GABA neurons (primarily innervating the accumbal CINs) (Brown et al., 
2012; Taylor et al., 2014; Van Bockstaele & Pickel, 1995), as well as 
reciprocal connections from the VP (Stefanik, Kupchik, Brown, & Kalivas, 
2013). GABAergic afferents from the forebrain areas have also been 
detected, though current understanding of their functional importance 
remains rudimentary (Brog et al., 1993; Lee, Vogt, Rubenstein, & Sohal, 
2014). Notably, the striatal MSNs also receive GABAergic afferents from 
neighbouring MSNs and the local interneurons, thus forming a highly 
intricate microcircuits, consisting of the feedforward and lateral inhibitory 
systems (further discussed below) (Tepper et al., 2008).  
Moreover, the NAc receives the majority of its cholinergic inputs from 
the local CINs (Rymar et al., 2004; Figure 1.1). Optogenetic activation of the 
accumbal CINs has been demonstrated to increase the frequency of 
GABAAR-mediated post-synaptic currents (Witten et al., 2010) and evoke 
DA release in the NAc via nictonic acetylcholine (ACh) receptor (nAChR)-
mediated increase in the excitability of dopamine terminals (Cachope et al., 
2012), whereas optogenetic inhibition of these neurons was found to 
increase MSN firing rate (Witten et al., 2010). Behaviourally, activity of the 
CINs has been linked to goal-directed actions, reward learning, and 
motivation (Aitta-aho et al., 2017; Ostlund, LeBlanc, Kosheleff, Wassum, & 
Maidment, 2014; Witten et al., 2010). Further, the NAc also receives 
noradrenergic inputs primarily from the nucleus of the solitary tract (NTS) 
and, to a lesser extent, from the locus coeruleus (LC) (Delfs, Zhu, Druhan, & 
21 
 
Aston-Jones, 1998). Activation of noradrenergic α receptor subtypes in the 
NAc has been implicated in enhancement of memory for arousing events 
(Kerfoot & Williams, 2011).  
1.3.3.3. The NAc microcircuitry: Focusing on the feedforward 
and lateral inhibition 
Though most of the neurons in the striatum are GABAergic, most of 
the synapses (~80%) consist of asymmetric glutamatergic synapses 
originating from cortical and thalamic regions (see Wilson, 2007 for review). 
The local striatal GABAergic circuitry, however, plays a central role in 
modulating striatal output by preventing overexcitation of neurons, as 
blockade of GABAARs was found to markedly augment spontaneous firing in 
vivo (Nisenbaum & Berger, 1992). 
The fast inhibitory transmission in the striatum is mediated through 
the action of GABA at the ionotropic GABAA receptors, located on the 
dendritic and perisomatic membranes of the MSNs (Straub et al., 2016). The 
two primary sources of fast inhibition in the striatum are the feedforward 
and lateral inhibition from GABAergic interneurons and axon collaterals of 
MSNs respectively (depicted in Figure 1.1).  
1.3.3.3.1. Feedforward inhibition by striatal interneurons 
The FSIs receive strong excitatory inputs from the cortex, that 
somewhat differs from those innervating the MSNs. Cortical stimuli that 
are insufficient to evoke excitatory responses in the MSNs have been shown 
22 
 
to elicit strong responses (i.e. large scale immediate early gene expression) 
in the FSIs (Parthasarathy & Graybiel, 1997). The primary target of these 
neurons are the proximal dendrites and the somatic membrane of the 
MSNs, both of which are electrotonically favoured locations. In mature rat 
brain slices, FSI-MSN GABAergic transmission was found to evoke a large 
inhibitory post synaptic potential (IPSP) with extremely low failure rates, 
mediated exclusively by GABAARs, strong enough to delay or block neuronal 
firing (Koós & Tepper, 1999; 2002).  
Similarly, another subclass of GABAergic interneurons with 
characteristics somewhat similar to PLTSIs, have been shown to exert 
relatively powerful inhibitory effect on the MSN spike timing and are 
capable of blocking an action potential generation (Koós & Tepper, 1999). 
More recently, another subpopulation of striatal GABAergic interneurons, 
i.e. NPY-NGF neurons, was characterised. The size of synaptic currents 
evoked by these neurons, as well as the reliable nature of the synapse led to 
a premise that these neurons are powerful mediators of feedforward 
inhibition to the MSNs. However, note that the identification of these cells 
was made based on observations in the DS. It is yet to be investigated 
whether these neurons are also involved in the mesoaccumbal feedforward 
circuitry. Akin to the FSIs, these subtypes of GABAergic interneurons also 
respond to cortical stimulation (Ibáñez-Sandoval et al., 2011; Tepper et al., 
2010).  
Nevertheless, despite compelling evidence for the high efficacy of FSI-
mediated perisomatic inhibition (Tepper, Koós, & Wilson, 2004), a study by 
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Du et al. (2017) observed little effect of GABAergic inputs from FSIs on 
dendritic plateau coupled with high frequency of excitatory inputs 
suggesting that likely role of FSIs was to alter the somatic membrane 
potential rather than switching off the plateau potential altogether, 
preventing an action potential generation. Instead, powerful inhibition of 
dendritic plateau potential was observed to be achieved via GABAergic 
IPSC with slower kinetics, perhaps mediated by the NPY-NGF 
interneurons, whilst more subtle inhibitory control appeared to originate 
from connectivity with neighbouring MSNs (discussed below) and PLTSIs.  
Lastly, the MSN dendritic inhibition can take place in the form of 
shunting inhibition, partly mediated by the opening of extrasynaptic 
GABAARs, which not only generate persistent hyperpolarising current, but 
also decrease the membrane resistance (Lee & Maguire, 2014). In summary, 
research to date has reported at least three types of GABAergic 
interneurons which inhibit MSNs in a feedforward manner through 
dendritic and/or the perisomatic targeting of the MSNs. However, precisely 
how each of these GABAergic neurons sculpt MSN activity in awake, 
behaving animals remains mysterious. 
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1.3.3.3.2. Lateral inhibition by MSN axon collaterals 
In addition to extrastriatal output projections, intracellular and 
immunocytochemical labelling studies indicated that the MSNs form 
recurrent collaterals with neighbouring MSNs, i.e. lateral inhibition (Bolam 
et al., 1983; Tunstall, Oorschot, Kean, & Wickens, 2002). These connections 
are unidirectional as no reciprocal connections have been observed (Tunstall 
et al., 2002). Most of these axons synapse onto the distal dendrites or the 
spine shaft of the target MSN, with a very small percentage of axosomatic 
connections (Bolam et al., 1983). This form of inhibition was found to be 
“weak or non-existent” (Jaeger, Kita, & Wilson, 1994) and exhibited high 
failure rate (>38%), indicated by the low inhibitory postsynaptic currents 
and potentials (IPSCs and IPSPs) (Tunstall et al., 2002).  
Notably, MSN-MSN synapses are not randomly distributed. While 
D2-MSNs innervate both D1- and D2-MSNs, D1-MSNs almost exclusively 
form connections with other D1-MSNs (Dobbs et al., 2016; Taverna, Ilijic, & 
Surmeier, 2008). The unitary IPSC amplitudes in D2- to D2-MSN pairs 
were larger compared to those of D1- to D1-MSN pairs, presumably due to 
more GABAARs residing on the D2-MSNs (Taverna et al., 2008). Though the 
functional significance of lateral inhibition is considered to be minimal due 
to the distal synaptic locations and the high failure rate to induce 
IPSP/IPSC, recent optogenetic evidence presented in the Dobbs et al. (2016) 
study suggests that synchronous activation of D2-MSNs in the NAc core 
produced a large IPSP in the majority of neighbouring putative D1-MSNs, 
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which was sufficient to inhibit neuronal excitability and action potential 
generation, thereby restricting output projections.  
1.3.3.4. Efferents from the NAc 
Mounting evidence derived from tracer studies reveals heterogeneity 
in the efferent projection targets of the NAc core and shell subregions. 
Namely, the NAc core predominantly innervates the dorsolateral portion of 
the VP, entopeduncular nucleus, and the substantia nigra pars reticulata 
(SNr), whereas NAc shell primarily projects to ventromedial VP, lateral 
hypothalamus (almost exclusively innervated by the accumbal D1-MSNs), 
substantia innominata, VTA, the amygdala, parabrachial nucleus, the 
substantia nigra pars compacta (SNc), periaqueductal gray, as well as 
pedunculopontine tegmental nucleus (PPTg) (Heimer et al., 1991; Scofield et 
al., 2016; Usuda, Tanaka, & Chiba, 1998; Williams, Crossman, & Slater, 
1977). The rostral pole of the NAc appears to share output projections with 
the core and shell, with the medial part giving rise to shell-like projections 
and the lateral part resembling the core-like innervations (Zahm & Heimer, 
1993). It is noteworthy that projections originating from the core and shell 
form different limbic loops, potentially subserving distinct motivational 
processes (Scofield et al., 2016). 
The striatal D1- and D2-MSNs have been canonically distinguished 
based on their distinct projection profiles (Gerfen & Surmeier, 2011). Thus, 
manipulations of the accumbal D1-MSNs are thought to exclusively affect 
the striatomesencephalic pathway, whereas D2-MSN regulation is relevant 
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to the striatopallidal circuitry (MacAskill, Little, Cassel, & Carter, 2012; 
Yawata, Yamaguchi, Danjo, Hikida, & Nakanishi, 2012), providing a 
mechanistic explanation for the opposing roles of D1- and D2-MSNs in 
mediating reward-related behaviours (for example, see Lobo et al., 2010). 
Nevertheless, an increasing amount of evidence indicates that such a 
segregated projection pattern does not apply to accumbal efferents, 
specifically from the NAc core. Though the ventral mesencephalon is 
exclusively innervated by D1-MSNs (Bocklisch et al., 2013; Kupchik et al., 
2015; Watabe-Uchida, Zhu, Ogawa, Vamanrao, & Uchida, 2012), NAc-VP 
projections were found to contain a mixture of D1- and D2-MSN axons 
(Kupchik et al., 2015; Lu, Ghasemzadeh, & Kalivas, 1998; Smith, Lobo, 
Spencer, & Kalivas, 2013; Zhou, Furuta, & Kaneko, 2003), warranting 
reconsideration of the current understanding pertaining to D1-D2 projection 
selectivity from the NAc (see Figure 1.2).  
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Figure 1.2. Current view on the efferents from the accumbal D1- and D2-
expressing MSNs (adapted from Kupchik & Kalivas, 2017) 
1.3.4. Summary  
The NAc is part of the main input structure of the basal ganglia, 
receiving glutamatergic inputs from various cortical and subcortical 
structures. These excitatory afferents are thought to be critically involved in 
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driving behavioural responses to salient events, whilst dopaminergic and 
GABAergic inputs serve to fine tune these glutamatergic inputs. The NAc, 
then relays this information to the basal ganglia output structures, which 
ultimately govern motor actions. Nevertheless, note that the NAc core and 
shell subdivisions exhibit distinct, but overlapping, patterns of connectivity 
(Zahm, 1999) and thus, are believed to play distinct roles in motivational 
and emotional processes (see Parkinson, Olmstead, Burns, Robbins, & 
Everitt, 1999; Shiflett & Balleine, 2010 for examples). 
1.4. GABAA Receptors 
1.4.1. Receptor structure and subunit composition 
The GABAA receptors (GABAARs) are considered to be the major 
inhibitory neurotransmitter receptors in the mammalian brain and are 
targets for various clinically important drugs (Farrant & Nusser, 2005a; 
Sieghart, 1995; Erwin Sigel & Steinmann, 2012). They belong to the family 
of Cys-loop ligand-gated ion channels, which members also include the 
nAChRs, strychnine-sensitive glycine receptors, and 5-hydroxytryptamine 
type-3 receptors (5-HT3Rs) (Betz, 1990). The binding of GABA to GABAARs 
triggers the opening of the ion channels, thereby increasing membrane 
permeability to chloride and to a lesser extent, bicarbonate ions, mostly 
leading to a hyperpolarising post-synaptic response in adult neurons (Kaila, 
Pasternack, Saarikoski, & Voipio, 1989). This phenomenon is critical for the 
regulation of neural activity by a diverse set of GABA-releasing neurons and 
deficits in the functional expression of GABAARs have been reported to 
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underpin the pathogenesis of various neurological disorders, including 
substance abuse (Edenberg et al., 2004; Enoch et al., 2010; Hines, Davies, 
Moss, & Maguire, 2012; Lieberman, Kranzler, Joshi, Shin, & Covault, 2015; 
Tan, Rudolph, & Lüscher, 2011). 
Structurally, the GABAARs are heteropentamers that are composed of 
five homologous subunits (Figure 1.3A), sharing a common topological 
organisation, i.e. a large extracellular N-terminal domain and four 
transmembrane domains (i.e. TM1-4). TM2 lines the ion channel and a large 
intracellular domain is located between TM3 and TM4, which is the prime 
target for post-translational modifications that can affect receptor function 
or aid in receptor localisation and/or membrane trafficking (Jacob, Moss, & 
Jurd, 2008; Figure 1.3B). Mature GABAAR subunits are approximately 450 
amino acid residues in length and to date, 19 GABAAR subunits categorised 
into eight distinct classes, i.e. α(1–6), β(1–3), γ(1–3), δ, ε, θ, π and ρ(1–3), 
have been cloned and sequenced in the mammalian CNS (Sigel & 
Steinmann, 2012). The subunit diversity is further increased by the 
existence of alternatively spliced variants (Daniel & Ohman, 2009). 
Examples include the short and long forms of the γ2 subunit, i.e. γ2S and 
γ2L respectively, which differ in an eight amino acid stretch within the 
intracellular domain of γ2L variant (Kofuji, Wang, Moss, Huganir, & Burt, 
1991). Though the multiplicity of subunits theoretically permits the 
formation of a plethora of GABAAR subtypes, only a few subtypes have been 
shown to exist, suggesting a highly selective oligomerisation (see Figure 
1.3A). The most likely subunit stoichiometry of GABAAR pentamers in the 
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CNS comprises two α, two β, and one γ subunit, with α1, β2 and γ2 subunits-
containing GABAARs being generally accepted as the most abundant 
subtype, followed by α2β3γ2 and α3β3γ2 subtypes (Connolly, Krishek, 
McDonald, Smart, & Moss, 1996; Klausberger, Fuchs, Mayer, Ehya, & 
Sieghart, 2000; Knight, Stephenson, Tallman, & Ramabahdran, 2000; 
Tretter, Ehya, Fuchs, & Sieghart, 1997). There are also less abundant 
isoforms where γ2 is replaced by γ1, γ3, δ, ε, or π subunits, or θ subunit 
replacing the β subunit, in certain regions and/or cell types (Sieghart & 
Sperk, 2002).   
Importantly, the GABAAR subunit composition dictates the 
biophysical properties of the receptor (i.e. binding and kinetics of the ion 
channels) and thus, the magnitude of response following ligand binding. 
Each subunit has a principal (+) and the complementary (-) side. GABA 
binds to GABAAR within the accessible intersubunit pockets at the two 
β(+)α(−) interfaces, whereas the benzodiazepine (BZ) allosteric modulator of 
GABAARs binding site is located at the α(+)γ(−) interface (Ernst, Brauchart, 
Boresch, & Sieghart, 2003). The δ-containing receptors exhibit the highest 
affinities for GABA, whereas synaptic α3β3γ2 receptor isoform displays the 
lowest affinity for GABA (Böhme, Rabe, & Lüddens, 2004). However, 
replacing the γ2 subunit with a δ dramatically decreases channel 
conductance independent of the α subunit type, indicating that δ subunit-
containing receptors exhibit a relatively low efficacy despite the high 
affinity for GABA (for example, see Zheleznova, Sedelnikova, & Weiss, 
2008). Moreover, amino acid residues that line the BZ binding site play a 
31 
 
pivotal role in determining binding and/or efficacy of drugs acting at this 
site. Namely, the BZ-sensitive GABAAR subtypes (α1, α2, α3 and α5) 
harbour a histidine residue at a conserved location, whereas the BZ-
insensitive ones carry an arginine residue at the corresponding position. 
Replacing the histidine with an arginine, as does eliminating or substituting 
the γ2 subunit, was found to render the BZ-sensitive receptors insensitive to 
BZ without altering sensitivity to GABA (Günther et al., 1995; Rudolph et 
al., 1999; Sieghart & Sperk, 2002). Intrasubunit pockets also contain 
residues, important for binding and/or efficacy of modulatory drugs, 
including volatile anaesthetics (Nishikawa, Jenkins, Paraskevakis, & 
Harrison, 2002). 
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Figure 1.3. (A) The GABAA receptor (GABAAR) is a chloride-permeable 
heteropentameric channel, composed of five subunits from seven subunit 
subcategories (α,β,γ,δ,ε,θ,π). For the majority of GABAARs in the brain, a 
typical subunit stoichiometry of 2α:2β:1γ is commonly observed. (B) The 
receptor subunits consist of four transmembrane domains (TM1-4). The N 
terminus serves as GABA binding site. TM2 lines the pore of the channel, 
while the intracellular domain between TM3 and TM4 serves as a site for 
various protein interactions and post-translational modifications, which can, 
in turn, regulate receptor activity (adapted from Jacob et al., 2008). 
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1.4.2. Cellular and Subcellular localisation of GABAARs 
1.4.2.1. Cellular localisation 
The heterogenous subunit composition dictates not only the 
biophysical and pharmacological properties of the various GABAAR 
subtypes, but also their cellular/subcellular localisation. 
Immunohistochemical and in situ hybridisation studies have led to a 
conclusion that whilst some GABAAR isoforms are broadly expressed 
throughout the CNS (e.g. α1 subunit-containing GABAARs), others show a 
more confined expression (e.g. α6-containing GABAARs) (Fritschy & Mohler, 
1995; Laurie & Wisden, 1992; Sieghart & Sperk, 2002). Also note that 
outside the CNS, GABAARs are expressed in the peripheral and enteric 
nervous system (PNS & ENS) (Akinci & Schofield, 1999; Magnaghi et al., 
2006). 
Intriguingly, the expression of GABAAR α1 and α2 subunits is 
developmentally regulated (Fritschy, Paysan, Enna, & Mohler, 1994). 
Namely, immunofluorescent analyses detected a developmental switch in 
the rat α1 and α2 subunit expression, whereby an increase in the α1 and a 
decrease in the α2 subunit expression were observed. At birth, the onset of 
α1 became evident in most regions during the first postnatal week and 
reached the formation of adult subunit expression pattern by post-natal day 
(PND) 20, except within the striatum and the olfactory bulb granule cell 
layer whereby its expression was found to remain low at every age 
examined. Despite the overall decrease in the α2 subunit expression, 
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immunoreactivity for this subunit remains high in a few regions, including 
the striatum, hippocampus, olfactory bulb, and superficial cortical layers 
(Fritschy et al., 1994). These immunohistochemical data are further 
corroborated by pharmacological data on BZ I (α1βγ) and II (α2/3/5βγ) 
receptors (Candy & Martin, 1979; Lippa, Beer, Sano, Vogel, & Meyerson, 
1981).  
1.4.2.2. Subcellular localisation 
1.4.2.2.1. Postsynaptic GABAARs 
Upon release in the synaptic cleft, GABA rapidly diffuses away from 
its release site, and the fast increase in IPSC followed by a rapid decay 
further indicate that there is a high density of GABAARs located near the 
transmitter release sites, i.e. the postsynaptic sites. These rapid and 
transient GABAergic events are termed phasic inhibition. A key feature of 
the phasic mode of receptor activation is the short duration of high 
(millimolar) concentrations of vesicular GABA to which the receptors are 
exposed, given that the rate at which GABA binds to the postsynaptic 
receptors is relatively slow compared to its clearance rate from the release 
site (Brickley, Cull-Candy, & Farrant, 1999; Farrant & Nusser, 2005; 
Mozrzymas, 2004). In most mature neurons, the activation of postsynaptic 
GABAARs yields IPSPs, thus temporarily moving the membrane potential 
away from the spike threshold required for the generation of an action 
potential (Connors, Malenka, & Silva, 1988). An essential role of phasic 
inhibition, primarily through the action of GABAergic interneurons at 
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GABAARs, is to prevent overexcitation of neurons, which could lead to the 
development of pathological states within the circuitry, and more 
importantly, to regulate input integration and thus, synchronise cellular 
activities (Somogyi & Klausberger, 2005; Whittington & Traub, 2003) 
The α(1-3)β2/3γ2 subunit-containing GABAARs are the predominant 
receptor subtypes that are enriched at the postsynaptic regions, thus 
mediating phasic inhibition (Figure 1.4). However, these subunits can also 
be found at the extrasynaptic sites, due to the dynamic mobility and rapid 
shift of γ2-containing receptors between postsynaptic and extrasynaptic 
compartments (i.e. receptor trafficking) (Jacob et al., 2005; Thomas, 
Mortensen, Hosie, & Smart, 2005). The γ2 subunit, in particular, plays a 
key role in facilitating the clustering of postsynaptic GABAARs through 
interactions with the GABAAR-associated protein, gephyrin (Jacob et al., 
2005). Namely, global deletion of γ2 in mice reduced gephyrin expression 
and disrupted the clustering of α1, α2, and β2/3 subunits, leading to the 
widely held notion that γ2 is indispensable for synaptic enrichment of 
GABAARs (Schweizer et al., 2003). However, more recent data have 
demonstrated synaptic clustering in the absence of γ2, indicating an 
alternative mechanism for synaptic localisation (Kerti-Szigeti, Nusser, & 
Eyre, 2014). Further corroborating this view is the evidence for 
extrasynaptic clustering of α5β3γ2 GABAARs (Brünig, Scotti, Sidler, & 
Fritschy, 2002) and deletion of the α5 subunit eliminated tonic conductance 
in cultured hippocampal neurons (Caraiscos et al., 2004), though there also 
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exists evidence that this receptor subtype is also found at dendritic synapses 
of hippocampal pyramidal cells (Serwanski et al., 2006).  
1.4.2.2.2. Extra/perisynaptic GABAARs 
The α4 and α6 subunits primarily co-assemble with δ subunits in the 
adult brain and these δ-containing receptor complexes are almost 
exclusively localised remotely from the synapses, i.e. at the extrasynaptic 
dendritic and somatic membranes of the cell (Maguire et al., 2014; Nusser, 
Sieghart, & Somogyi, 1998; Wei, Zhang, Peng, Houser, & Mody, 2003; refer 
to Figure 1.4). Low concentrations of GABA escaping from the synaptic cleft 
(within the submicromolar range) can activate these GABAARs, leading to 
repetitive activation of these receptors and, thus, tonic inhibition (Farrant & 
Nusser, 2005b). Common features of extrasynaptic GABAARs include high 
affinity for GABA and little or no receptor desensitisation (Adkins et al., 
2001; Yeung et al., 2003). Tonic activation of GABAARs triggers a persistent 
increase in the cell’s input conductance, thus, reducing the magnitude of 
EPSP, narrowing the spatial and temporal window for synaptic integration 
and, ultimately, affecting cell excitability (Farrant & Nusser, 2005).  
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Figure 1.4. The GABAAR subunit stoichiometry determines its subcellular 
localisation. Receptors harbouring α(1–3) subunits with β and γ subunits are 
primarily localised at the postsynaptic sites, whereas the α5βγ are 
extrasynaptically localised. The α(4,6)βδ-harbouring, benzodiazepine-
insensitive receptors can be found at extrasynaptic compartments (adapted 
from Jacob et al., 2008). 
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1.4.3. Post-translational modification of GABAARs 
Many endogenous processes are known to modulate GABAAR 
expression and function post-translationally. These include palmitoylation, 
phosphorylation and ubiquitination. Following the assembly in the 
endoplasmic reticulum (ER), mature GABAARs are trafficked to the Golgi 
apparatus prior to transport and insertion to the plasma membrane. This 
process requires a number of proteins performing various forms of post-
translational modifications, some of which are discussed below (extensively 
reviewed in Vithlani, Terunuma, & Moss, 2011).   
Firstly, the intracellular loop of the γ2 subunit is subject to 
palmitoylation, i.e. the covalent attachment of the saturated fatty acid 
palmitate to a specific protein, by the thioacyltransferase Golgi-speciﬁc 
DHHC zinc ﬁnger domain protein (GODZ). This process plays a role in the 
accumulation of γ2 subunit-containing GABAAR targeting at postsynaptic 
sites and its inhibitory function (Fang et al., 2006; Keller et al., 2004). In 
support of this notion, RNAi-induced knockdown of GODZ produced a 
marked downregulation in miniature IPSC (mIPSC), due to a decrease in 
postsynaptic GABAARs (Fang et al., 2006). 
Secondly, the GABAAR subunits are subject to phosphorylation by 
several kinases, including cAMP-dependent protein kinase (PKA), 
calcium/phospholipid-dependent protein kinase (PKC), calcium/calmodulin-
dependent kinase II (CaMKII), protein kinase B (PKB) (reviewed in Vithlani 
et al., 2011). The phosphorylation of GABAARs has been implicated in 
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processes relating to channel kinetics, receptor sensitivity to allosteric 
modulators, and interactions between protein, to name a few (Vithlani & 
Moss, 2009). For instance, in vitro studies demonstrated lower GABA-
activated currents upon cAMP-dependent protein kinase (PKA)-induced 
phosphorylation of β1, but an opposite effect was observed upon β3 
phosphorylation (McDonald et al., 1998). 
Finally, the GABAARs may also be targets for modification by 
ubiquitin– i.e. covalent attachment of the 76-residue ubiquitin monomer to 
lysine residues of a given protein, a process known as ubiquitination 
(Vithlani et al., 2011). Whilst the reversible monoubiquitination is more 
involved in triggering endocytosis, polyubiquitination is required for 
transport of proteins from the ER back to the cytosol for degradation by 
proteases (Saliba, Michels, Jacob, Pangalos, & Moss, 2007). 
Polyubiquitination of GABAAR β3 subunits, for example, markedly 
downregulated the number of assembled GABAARs and therefore, the 
amplitude and frequency of mIPSC (Saliba et al., 2007).  
1.4.4. Pharmacological modulation of GABAARs by endogenous 
and exogenous ligands 
The GABAAR has a rich pharmacology as it not only contains 
bindings sites for its primary ligand (GABA), but also for endogenous and 
exogenous allosteric modulators. Prime examples of the endogenous 
modulators include the neurosteroids, synthesised de novo in neuronal and 
glial cells or produced by the metabolism of precursors from the peripheral 
41 
 
steroidogenic organs (Callachan et al., 1987; Lambert, Peters, & Cottrell, 
1987; Lambert, Belelli, Hill-Venning, & Peters, 1995; Lambert, Belelli, 
Peden, Vardy, & Peters, 2003; Tanaka & Sokabe, 2012), whereas synthetic 
neurosteroids (Lambert et al., 1987), typical and atypical benzodiazepines 
(BZs) (Rudolph et al., 1999; Schofield et al., 1987; Watanabe, Shibuya, 
Khatami, & Salafsky, 1986), as well as general anaestehetics, including 
barbiturates (Schumacher & McEwen, 1989), etomidate (Belelli, Lambert, 
Peters, Wafford, & Whiting, 1997), and propofol (Belelli & Lambert, 2005) 
are exogenous modulators.  
Akin to their physiological properties, the pharmacological properties 
of GABAARs are also determined by variations in the receptor subunit 
composition. For instance, neuronal GABAAR subunit composition appears 
to play a role in determining heterogeneity in neurosteroid sensitivity. The 
binding sites for neurosteroids within the GABAARs are positioned within 
the transmembrane domains of α and β subunits (Hosie, Wilkins, & Smart, 
2007). Previous evidence has shown that GABA-evoked responses via 
α1β1ϒ2 and α3β1ϒ2 were enhanced by a low dose of the pregnane steroid, 
3α,5α-THPROG, whereas much higher doses of 3α,5α-THPROG were 
required to induce similar facilitatory influence on GABAergic responses via 
α2-, α4-, α5-, α6-harbouring receptors (Belelli, Casula, Ling, & Lambert, 
2002). Despite the low steroid sensitivity of α4β1ϒ2 GABAARs, the δ-
containing α4-GABAARs were found to be highly steroid sensitive (Belelli, 
2002).   
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One of the most well-researched examples of a GABAAR modulator is 
a group of BZ drugs (and their derivatives). BZ binds to a specific regulatory 
site located at the interface of adjacent α and γ subunits and increases the 
opening frequency of GABA-gated chloride channels by inducing a 
conformational change to the receptor structure, thus increasing the mean 
opening time of the ion channel and, ultimately, the chloride conductance 
(Pritchett et al., 1989; Sigel & Buhr, 1997).  
As outlined in Section 1.4.1, changing the histidine residue at a 
conserved position within the α subunit affects sensitivity to the typical BZ 
(Rudolph et al., 1999), as does substituting γ2 with a δ, ε or π subunit 
(Barnard et al., 1998) or point mutation at the γ2 subunit (M130L) (Buhr & 
Sigel, 1997). Intriguingly, more recent data from mutagenesis experiments 
in Xenopus oocytes reported a non-canonical BZ-GABAAR interaction, 
whereby diazepam was found to bind to β2+/ γ2- site of the GABAAR. The 
functional implication of this interaction remains to be investigated 
(Wongsamitkul et al., 2017).  
Finally, the enhancement of tonic currents has been observed 
following the administration of the δ subunit-specific positive allosteric 
modulator, DS2 (4-chloro-N-[2-(2-thienyl)imidazo[1,2-a]pyridine-3-yl 
benzamide) (Jensen et al., 2013)or the GABA analog, THIP (4,5,6,7-
tetrahydroisoxazolo[5,4-c]pyridin-3-ol) (Drasbek & Jensen, 2006; Maguire et 
al., 2014). The latter is a full or ‘super’ agonist at the extrasynaptic α4β3δ 
receptors (exceeding the maximum response to GABA), but it also serves as 
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a partial agonist at the synaptic α4β3γ2 receptors (Mortensen, Ebert, 
Wafford, & Smart, 2010).  
Lastly, a few examples of GABAAR inhibitors include picrotoxin, 
bicuculline, and gabazine. Picrotoxin and bicuculline are known to be 
negative allosteric modulators as both of these agents block GABA-activated 
chloride influx at an alternative (allosteric) site, which does not overlap with 
the GABA-binding site. Gabazine, however, acts as a true competitive 
antagonist of GABAARs (reviewed in Olsen, 2018; Stephens et al., 2017). In 
addition, certain atypical BZs negatively modulate some GABAAR subtypes 
in an allosteric fashion, whilst acting as positive allosteric modulators when 
bound to α4- and α6-containing receptors (Stephens et al., 2017; Walker & 
Semyanov, 2008). 
1.4.5. Summary 
The heteropentameric GABAARs are considered to be the major 
inhibitory neurotransmitter receptors in the brain. As discussed above, the 
subunit composition confers not only the cellular and subcellular 
localisation of these receptors, but also their physiological and 
pharmacological properties. In specific, postsynaptic GABAARs (most 
commonly harbouring α1, α2, and α3) mediate phasic inhibition, whereas 
those located extrasynaptically, i.e. α4-, α5-, and α6-containing receptors, 
are involved in mediating tonic inhibition (Farrant & Nusser, 2005; Sigel & 
Steinmann, 2012).  
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1.5. Psychostimulants and the GABAergic system 
Though the neurobiological mechanisms underpinning 
psychostimulant high and its acute effects have been relatively well-
characterised, a critical question remains as to how the brain adapts to 
repeated drug exposure, rendering individuals increasingly susceptible to 
addiction. Whilst the complete answers do not yet exist, research to date has 
shed light on a variety of short- and intermediate-term changes within the 
brain, some of which may give rise to further effects that persist for longer 
periods and may be irreversible (Nestler, 2005). 
1.5.1. Neurobiological effects of cocaine: Initial and intermediate-
term effects 
Central to mediating reinforcing properties of psychostimulant drugs 
is their ability to elevate dopaminergic activity within the NAc (Abi-
Dargham, Kegeles, Martinez, Innis, & Laruelle, 2003; Volkow, Fowler, & 
Wang, 1999). Psychostimulant drugs evoke dopamine buildup in the 
extracellular space within the NAc by increasing dopamine release (e.g. 
amphetamine-type stimulants and cocaine), thus delaying dopamine 
reuptake from the synaptic cleft and prolonging dopamine action 
(Fleckenstein, Volz, Riddle, Gibb, & Hanson, 2007) and/or by acting as a 
competitive inhibitor of the dopamine transporter (e.g. amphetamine, 
cocaine, and methylphenidate) (Fleckenstein et al., 2007; Kuczenski & 
Segal, 1997; Venton et al., 2006). In this thesis, I particularly focus on the 
effects of acute and repeated cocaine exposure. 
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Though cocaine also inhibits the reuptake of other neuromodulators, 
i.e. serotonin and norepinephrine, its effect on dopaminergic system has 
long been thought to be most important (Nestler, 2005; Uhl, Hall, & Sora, 
2002). An increase in dopamine transients in the NAc triggers a 
sophisticated mechanism of feedback inhibition whereby dopamine D2 
autoreceptors on the dopamine cell bodies within the midbrain, as well as on 
the terminals within the NAc are activated to inhibit continuous firing and 
ultimately, dopamine release. Despite this elaborate feedback regulatory 
system, the increase in extracellular dopamine detected following cocaine 
exposure raises a further speculation that there exists an alternative 
mechanism by which cocaine overcomes this (Ford, 2014; Venton et al., 
2006). 
Several reports point towards the possibility that cocaine may also 
influence the release of dopamine (Lee, Balu, Davidson, & Ellinwood, 2001; 
Shore, 1976; Stamford, Kruk, & Millar, 1989). Early work indicated that 
80% of dopamine is unavailable for release (i.e. stored in the reserve pool) 
(Javoy & Glowinski, 1971; Korf, Grasdijk, & Westerink, 1976) and the 
segregation of vesicles into a reserve pool away from the site of exocytosis 
requires synapsins, interacting with the synaptic vesicles (Greengard, 
Valtorta, Czernik, & Benfenati, 1993). More recent data however 
demonstrated that cocaine (Venton et al., 2006) can, in fact, regulate 
dopamine release via the mobilisation of the reserve pool of dopaminergic 
vesicles. In specific, cocaine’s ability to enhance dopamine release evoked by 
electrical stimulation was markedly attenuated in mice devoid of three 
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synapsin genes, encoding Synapsin I, II, and III (i.e. triple knockouts; TKO), 
suggesting that this process is synapsin-dependent, though the mechanism 
by which cocaine interacts with synapsins remains elusive. Cocaine-induced 
enhancement in dopamine release was particularly evident when the 
contribution of releasable pool was compromised by inhibiting its synthesis, 
further indicating that cocaine acts on a pool of dopamine that is not readily 
releasable and this process is independent of the rate of dopamine synthesis 
(Venton et al., 2006).  
Alternatively, previous studies have also implicated the cholinergic 
system in cocaine-enhanced dopamine transients, given previous 
observations of cocaine-evoked increases in the firing rate of CINs (Witten 
et al., 2010) and that antagonism at acetylcholine receptors and optogenetic 
inhibition of CINs consistently reduced dopamine levels and blocked cocaine 
conditioning in a CPP paradigm respectively (Witten et al., 2010; Yorgason, 
Zeppenfeld, & Williams, 2017; also refer to Williams & Adinoff, 2008 for a 
thorough review), collectively implicating the significance of CIN activity in 
influencing cocaine-induced effects. Nevertheless, increasing CIN activity 
did not reliably increase dopamine transients and there exists evidence for 
the absence of cocaine-induced effects on CIN activity (Yorgason et al., 
2017). 
The memory of intense pleasure associated with cocaine use is 
encoded in the “memory centres” of the brain (i.e. the amygdala and the 
hippocampus) (Volkow, Fowler, & Wang, 2003). Additionally, the activity of 
frontal cortex serves as ‘cognitive control’, regulating the activity of the 
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limbic regions implicated in drug abuse (Goldstein & Volkow, 2011) and 
serving to suppress drug-taking urges in non-addicted individuals (Nestler, 
2005; Volkow et al., 2003). Dysfunction of the prefrontal cortex is commonly 
observed in addicted individuals, providing a biological basis for the low 
tendency of addicted individuals to prevail over drug-taking urges, leading 
to uncontrollable drug use (Goldstein & Volkow, 2011). Though some of the 
cocaine’s addictive properties are attributable to its ability to elevate 
extracellular dopamine concentration within the NAc (Everitt & Robbins, 
2013; Kalivas & Stewart, 1991; Kiyatkin, 1994), it should be noted that 
cocaine also has other pharmacological actions in the central and peripheral 
nervous system. To name a few, it acts as a local anaesthetic and blocks 
voltage-gated sodium, calcium, and calcium-activated potassium channels 
(Crumb & Clarkson, 1990; Premkumar, 2005; Ruetsch, Böni, & Borgeat, 
2001).   
Repeated exposure to cocaine yields a host of neuroadaptations, 
particularly within the NAc. Alterations in gene expression are particularly 
intriguing as they tend to be long-lasting and are likely to contribute to the 
transition to addiction (Nestler, 2005). One of the well-studied examples is 
the long-lasting effects of cocaine on ΔFosB expression. Cocaine increases 
the production of ΔFosB and once created, it lasts for 6-8 weeks. Cocaine 
abuse would therefore trigger the accumulation of ΔFosB, which has been 
linked to increased drug sensitivity, self-administration and a greater 
motivational drive for cocaine in rodents (McClung et al., 2004; Nestler, 
2001). Conversely, blocking the activity of ΔFosB produced the opposite 
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effects, i.e. blunted responses to the drug effects (Nestler, 2001). Longer 
persistence of cocaine use has been reported long-term alterations to the 
physical structure of neurons particularly within the NAc and thus, 
connectivity between neurons (Nestler, 2001; Shen et al., 2009). The drug-
induced morphological plasticity, partly triggered by changes in gene 
expression, may have lifelong persistence and have been linked to the 
expression of addiction related behaviours (Li, Acerbo, & Robinson, 2004; 
Russo et al., 2010). 
1.5.2. Cocaine reinforcement  
Dopamine release is stimulated by encountering novel, biologically 
salient stimuli, such as rewards. However, such responses dissipate once a 
reward becomes fully predicted. Instead, dopamine neurons respond to the 
presentation of the reward-predicting stimuli, thereby allowing them to gain 
motivational significance (i.e. Reward Prediction Error (RPE) theory, 
(Schultz, Dayan, & Montague, 1997). Nonetheless, note that cocaine-induced 
increases in dopamine transients remain unabated with every encounter, 
due to its action at DATs (Nestler, 2005). It is, thus, not surprising that 
cocaine, in particular, has been demonstrated to generate stronger 
conditioned reinforcers than food reward (Tunstall & Kearns, 2016). 
Intriguingly, growing evidence shows that cocaine is a weaker 
reinforcer compared to food when animals were given a choice (Cantin et al., 
2010; Lenoir, Serre, Cantin, & Ahmed, 2007; Tunstall & Kearns, 2016). 
Similarly, behavioural economic studies also revealed that when cocaine 
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users were presented with a choice between cocaine and a small non-drug 
reward (small token or food), they consistently chose the latter (Foltin & 
Fischman, 1994; Higgins, Roll, & Bickel, 1996). A more recent study further 
demonstrated that cocaine addicted individuals assigned the highest 
subjective valence to drug rewards when asked to recall the ‘under drug 
influence’ or cue-related situations (otherwise, food > drug) (Goldstein et al., 
2010). These findings collectively suggest that the primary reinforcing 
strength of cocaine alone is not sufficient to explain its ability to cause 
addiction. Corroborating this argument is the incentive salience theory of 
addiction proposed by Robinson & Berridge (1993), which posits that it is 
the motivating power of the drug-associated stimuli, impelled by the 
physiological states and learned values, that elicits an intense sense of 
“wanting”, without necessarily evoking a sense of liking for that drug. This 
is thought to contribute to the manifestation of cue-driven drug-seeking 
behaviours and the associated intrusive thoughts (i.e. craving), rendering 
individuals susceptible to developing compulsive drug-taking behaviours 
and relapse in abstaining addicts. To date, there is mounting evidence from 
pre-clinical (Grimm, Hope, Wise, & Shaham, 2001; Lee, Milton, & Everitt, 
2006) and clinical (Childress et al., 1999; Garavan et al., 2000) studies 
supporting the notion that cocaine-associated stimuli are potent triggers of 
craving and relapse. Imaging studies further revealed that these are 
paralleled by activation in the limbic regions (i.e. the amygdala and anterior 
cingulate) (Childress et al., 1999), dorsolateral prefrontal cortex (Maas et 
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al., 1998), as well as increased dopaminergic activity in the dorsal striatum 
(Volkow et al., 2006). 
Finally, cocaine also has the ability to energise conditioned 
behaviours, potentially by enhancing the incentive value of the reward-
conditioned stimulus (Chu & Kelley, 1992; Dixon et al., 2010; Robbins, 
1975). There exists compelling evidence that this cocaine effect is dependent 
upon its ability to increase mesoaccumbal dopamine transients (Parkinson 
et al., 1999; Taylor & Robbins, 1986). Such a facilitatory effect of cocaine 
will be discussed further in this thesis.  
1.5.3. Cocaine-induced regulation of GABAAR expression: 
Evidence for Dopamine x GABA interaction 
Cocaine indirectly regulates GABAergic activity through alternate 
neurotransmitter systems, i.e. dopaminergic, serotonergic, and 
noradrenergic systems (e.g. see Bocklisch et al., 2013; Li & Kirby, 2016). 
Previous research has reported changes in GABAAR expression in response 
to cocaine treatments (Chen et al., 2007; Purgianto, Loweth, Miao, 
Milovanovic, & Wolf, 2016). In turn, altering GABAergic activity via 
manipulations (i.e. whole-brain deletion) of the GABAAR subunit expression 
also altered behavioural responses to cocaine (Dixon et al., 2010; 
Macpherson et al., 2016; Maguire et al., 2014) and other drugs of abuse 
(Dixon, Walker, King, & Stephens, 2012; Duka et al., 2015). 
The GABAergic MSNs constitute approximately 95% of the neurons 
in the NAc, the prime locus of cocaine action, with a large proportion of the 
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remainder consisting primarily of GABAergic interneurons (Kawaguchi, 
1993; Tepper & Bolam, 2004). In the NAc, specifically, the GABAAR α4, α2, 
and α1 subunits are expressed on the MSNs and/or interneurons (Boyes & 
Bolam, 2007; Dixon et al., 2010; Maguire et al., 2014; Schwarzer et al., 2001; 
Mitchell et al., 2018). Changes in the expression of GABAAR α2 subunit 
(Chen et al., 2007; Purgianto et al., 2016) have been reported following 
cocaine exposure and during withdrawal. It is, thus, important to consider 
how other transmitter systems interact with GABA to shape MSN activity, 
which ultimately mediates the expression of reward-related behaviours 
(Dixon, Halbout, King, & Stephens, 2014). 
Evidence for dopamine × GABA interaction was first derived from 
receptor binding studies investigating the effect cocaine on BZ 
pharmacology and receptor expression, and vice versa. BZ acts primarily at 
GABAARs (Sigel & Buhr, 1997), though other BZ binding sites have been 
identified, which are beyond the scope of this thesis (Le Fur et al., 1983). 
Using [3H]Ro 15-1788 to label BZ receptors, early work demonstrated that 
chronic cocaine treatments induced a significant increase in BZ receptor 
numbers within the caudate nucleus and the cerebellum, but was decreased 
in the frontal cortex following chronic cocaine (Goeders, 1990;1991). In 
keeping, chronic cocaine also enhanced BZ, i.e. [3H]flunitrazepam, receptor 
binding in the hippocampal and striatal regions of the rat brain, which 
persisted for at least 21 days following the cessation of cocaine treatment 
(Lipton, Olsen, & Ellison, 1995). In chronically cocaine-treated animals, the 
binding of [35S]t-butylbicyclo phosphorothionate ([35S]TBPS), a high affinity 
52 
 
ligand for the picrotoxin site of the GABAARs, was also significantly 
increased in the frontal cortex and hippocampus during withdrawal, 
accompanied by an increase in cortical and hippocampal α1 and β3 mRNA 
expression (Suzuki et al., 2000). The authors further postulated that the 
increase in GABAergic activity particularly in the cortex might contribute to 
the hypofunction of dopamine system in the cortical area observed during 
cocaine withdrawal (Suzuki et al., 2000). Importantly, cocaine-induced 
enhancement of BZ binding was markedly attenuated upon dopamine 
depletion using neurotoxin 6-hydroxydopamine (6-OHDA), suggesting that 
cocaine effect on BZ receptor expression and binding is largely mediated by 
dopamine (Goeders 1990;1991).  
1.5.4. Alpha4-containing GABAARs and cocaine-induced 
responses  
In the striatum of an adult mouse brain, tonic inhibitory current is 
primarily mediated by the α4βδ-harbouring GABAARs (Heiman et al., 2008). 
This is further supported by mounting immunohistochemical and 
electrophysiological evidence for the high expression level of these receptors 
in the accumbal MSNs and interneurons (Hörtnagl et al., 2013; Maguire et 
al., 2014; Pirker, Schwarzer, Wieselthaler, et al., 2000).  
Previous work in our laboratory has demonstrated that mice devoid of 
the Gabra4 gene did not differ from the wild-type counterparts in the 
expression of cocaine-induced conditioned place preference (CPP) or cocaine-
facilitated conditioned reinforcement (CRf). However, α4 knockout specific 
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to the D1R-expressing neurons facilitated CPP, whereas α4 deletion 
specifically in the D2R-expressing neurons abolished cocaine facilitation of 
CPP (Maguire et al., 2014). Further, enhanced activation of α4-GABAARs 
with THIP blocked cocaine enhancement of CPP (Maguire et al., 2014) and 
CRf (Macpherson et al., 2016). Given that these cocaine-induced behavioural 
phenotypes are dependent upon cocaine-induced increases in mesoaccumbal 
dopamine (Cervo & Samanin, 1995; Hnasko, Sotak, & Palmiter, 2007; 
Taylor & Robbins, 1986), it is likely that the cell type-specific deletion of α4 
modulated the action of cocaine by disrupting the functional interactions 
between the dopaminergic and GABAergic subsystems.  
Intriguingly, past research has also yielded evidence for dopamine × 
GABA interaction at the intracellular level. Namely, agonism at, or acute 
activation of dopamine D1 receptors augmented GABAergic tonic 
conductance, thus, dampening the excitatory effect of dopamine acting at 
D1Rs, whereas the blockade of G-protein coupling via the intracellular GDP-
βs prevented the enhanced tonic current (Maguire et al., 2014). By contrast, 
only prolonged, but not acute, activation of D2Rs modestly reduced tonic 
current, thus collectively providing a short-term homeostatic balance in 
neuronal activity within the striatum by preventing overexcitation of the 
neurons (Maguire et al., 2014).   
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1.5.5. Summary  
Studies to date have provided convincing evidence that whilst the 
primary reinforcing properties of cocaine may play an important role in the 
initial episodes of drug use, these properties cannot fully account for the 
transition from repeated use to addiction. Instead, it is widely believed that 
the ability of addictive drugs to heighten Pavlovian and/or instrumental 
responsiveness to drug-associated cues may lead to aberrant drug use, 
despite the adverse consequences (Belin, Jonkman, Dickinson, Robbins, & 
Everitt, 2009; Everitt & Robbins, 2005). Others have also reported cocaine-
induced potentiation of instrumental responding for cues associated with 
other reinforcers (e.g. food) (Dixon et al., 2010; Chu & Kelley, 1992).  
Biologically, this aberrant motivational process is thought to be mediated by 
the drug’s ability to increase mesoaccumbal dopamine concentration 
(Everitt & Robbins, 2005; Taylor & Robbins, 1986). There, however, exists 
evidence that manipulations of GABAergic activity via the α2- or α4-
containing GABAARs alter cocaine’s ability to potentiate conditioned 
behaviours (Dixon et al., 2010; Maguire et al., 2014; Macpherson et al., 
2016), perhaps by modulating dopamine × glutamate interactions, 
particularly in the NAc, that are deemed important in the manifestation of 
cocaine-facilitated motivated actions (Burns, Everitt, Kelley, & Robbins, 
1994). 
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1.6. The role of α2βγ GABAA receptors in cocaine addiction: 
What do we know so far? 
A strong link between GABAAR α2 subunit-encoding gene, GABRA2 
(or Gabra2 in the mouse), polymorphism and alcohol use disorder has been 
well-documented in the literature through the use of various study designs, 
including genome-wide association studies (Bierut et al., 2010), genetic 
linkage studies (Edenberg et al., 2004; Enoch, Schwartz, Albaugh, 
Virkkunen, & Goldman, 2006; Soyka et al., 2008), and haploytpe analyses 
(Covault, Gelernter, Hesselbrock, Nellissery, & Kranzler, 2004). More 
recently, emerging evidence has further implicated GABRA2 polymorphic 
variations in cocaine addiction vulnerability in some populations (Dixon et 
al., 2010; Enoch et al., 2010). To date, the molecular mechanism by which 
GABRA2 variation influences the risk for cocaine addiction is unknown.  
Among the SNPs characterised in the Dixon et al. (2010) study, one 
risk SNP linked to cocaine addiction, rs279871, is in 100% linkage 
disequilibrium with rs279858 (linked to alcohol dependence) (Stephens et 
al., 2017). In a more recent study by Lieberman et al. (2015), lower α2 
mRNA expression was detected in neural cell cultures derived from alcohol 
dependence-associated risk (rs279858*C) allele carrier. The rs279858-
containing GABRA2 haplotype block harbours a functional polymorphism 
that also has a regulatory effect on the expression of all GABAAR subunit 
genes on chr4p12 (i.e. GABRB1, GABRA2, GABRA4, GABRG1) (Lieberman 
et al., 2015). It is, thus, tempting to hypothesise that the level of α2 
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expression in cocaine addiction-associated risk (rs279871*G) allele carriers 
may also be lower than those carrying the protective haplotype (rs894269*T, 
rs2119767*T, rs929128*G) (Dixon et al., 2010; Duka et al., 2015).  
Another GABRA2 SNP, rs11503014, has also been linked to cocaine 
addiction vulnerability in individuals with a history of childhood trauma 
(Enoch et al., 2010). Given the SNP position, within a DNA sequence that is 
similar to exon splicing enhancers: srp55, srp40, sf2, and sc35, it is 
conceivable that polymorphic variations may affect α2 expression via 
alternative splicing (Enoch et al., 2010). Indeed, analyses of GABRA2 
mRNA from the human brain revealed at least four different isoforms of the 
α2 subunit (Tian, Chen, Cross, & Edenberg, 2005).  
Interestingly, whole-brain deletion of Gabra2 in the mouse failed to 
disrupt cocaine self-administration or reinstatement of cocaine seeking 
when compared to the wild-type (WT) counterparts, suggesting that α2-
GABAAR-mediated activity does not play a key role in mediating cocaine 
reward (Dixon et al., 2014). Instead, the α2 knockout mice appeared to be 
insensitive to cocaine, as well as methylphenidate, enhancement of 
conditioned behaviours, i.e. instrumental responding for CRf and locomotor 
sensitisation (Dixon et al., 2010; Duka et al., 2015). Intriguingly, whilst 
deletion of Gabra2 blocked cocaine-induced locomotor sensitisation (Dixon et 
al., 2010), selective activation of mutant α2(H101R)-GABAARs (refer to 
Section 1.4.1) with Ro15-4513 induced sensitising effects (Morris et al., 
2008).  
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Mesoaccumbal dopamine is implicated in these forms of conditioned 
behaviours (Chu & Kelley, 1992; Heidbreder, Thompson, & Shippenberg, 
1996; McCreary & Marsden, 1993; Taylor & Robbins, 1986; Wolterink et al., 
1993)). Supporting this notion, α2(H101R) mice sensitised to Ro 15-4513 
displayed an enhanced stimulant response to cocaine (10 mg/kg), but Ro15-
4513 failed to enhance conditioned activity in cocaine-sensitised α2(H101R) 
mutants. Thus, cocaine’s ability to enhance conditioned activity (i.e. cross-
sensitisation) in α2(H101R) mutants is most likely to depend upon its ability 
to increase accumbal dopamine level (Morris et al., 2008). Moreover, the 
Morris et al. (2008) study further demonstrated the importance of α2-
containing receptors in mediating BZ (midazolam) potentiation of cocaine-
induced hyperactivity.  
Histological examinations, profiling the α2 expression patterns 
throughout the brain, reveal that this subunit is abundant in regions 
implicated in reinforcement learning and motivational processes, including 
the hippocampus, cortex, amygdala and striatal subcompartments (Burns et 
al., 1993; Cardinal et al., 2002; Dixon et al., 2010; Hörtnagl et al., 2013; 
Pirker, Schwarzer, Wieselthaler, et al., 2000; Tracy et al., 2001). A thorough 
understanding of GABAergic signalling via the α2-containing receptors may 
thus provide valuable insights into the development of aberrant behaviours 
linked to addiction. 
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1.7. Behavioural strategies for investigating cocaine-
induced reinforcement 
As delineated above, cocaine exerts reinforcing effects, some of which 
rely on its action on mesolimbic dopamine neurons. Some of these cocaine-
induced effects can be modelled using the locomotor sensitisation and 
conditioned reinforcement paradigms, which are the main focus of this 
thesis (Vanderschuren & Kalivas, 2000; Parkinson, Olmstead, Burns, 
Robbins, & Everitt, 1999). Intriguingly, previous data from our laboratory 
showed that α2 knockout mice failed to display cocaine-induced locomotor 
sensitisation and cocaine facilitation of CRf, leading to a further speculation 
that these cocaine-induced responses may share a similar mechanism 
involving the α2-GABAAR-mediated system, particularly in the NAc. 
1.7.1. Locomotor sensitisation to cocaine 
Repeated exposure to cocaine elicits a progressive increase in a subset 
of responses to the drug, a phenomenon termed sensitisation. Though note 
that while some effects of the drug sensitise, tolerance develops to other 
effects of the drugs, and both sensitisation and tolerance often co-exist 
(Stewart & Badiani, 1993). Drug-induced sensitisation is commonly assayed 
by monitoring increases in motor activity following non-contingent, 
intermittent drug administration and this form of sensitisation has been 
shown to persist for at least a year (Kalivas & Stewart, 1991; Paulson, 
Camp, & Robinson, 1991). However, sensitisation has also been reported to 
occur in a conditioned place preference (CPP) paradigm, whereby increases 
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in the amount of time spent in a cocaine-paired chamber were observed 
(Lett, 1989). Thus, in addition to the motor stimulant effects, the positive 
unconditioned properties of the drug appear to gradually strengthen over 
time. 
It has been argued that many aspects of behavioural sensitisation 
seem to reflect Pavlovian associations between the unconditioned stimulant 
properties of the drug and the context where drug effect is experienced, such 
that the context itself can enhance activity in the absence of the drug (Le 
Merrer & Stephens, 2006; Pert, Post, & Weiss, 1990). Corroborating this 
account is the evidence that a robust sensitisation induced by 
psychostimulants is highly context-specific and can be blocked by a context 
switch (Mattson et al., 2008; Vezina, Giovino, Wise, & Stewart, 1989; Wang 
& Hsiao, 2003). There also exists evidence that context-dependent 
sensitisation can be extinguished following repeated pairings of saline and 
the test environment (Hinson & Poulos, 1981) and that locomotor 
sensitisation to a non-motor-stimulant reward, i.e. food, has been observed 
(Le Merrer & Stephens, 2006). However, given that under some conditions, 
drug-induced sensitisation can still occur in a context-independent manner 
(Partridge & Schenk, 1999), it has been argued that drug-context learning 
may aid, but is not necessary or sufficient for, the development of 
psychostimulant-induced sensitisation. 
The development of drug-induced sensitisation can be examined in 
two temporal domains, i.e. initiation and expression, which are anatomically 
distinct. Initiation denotes acute neural events involved in the induction of 
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sensitisation, whereas expression is defined by the long-term alterations of 
these initial neural events. Only changes that persist for at least two weeks 
after withdrawal from a drug can be deemed significant in the expression of 
sensitisation (Kalivas & Stewart, 1991). The initiation and expression of 
sensitisation are linked to activities within the VTA and NAc respectively, 
as early work demonstrated that repeated microinjections of amphetamine 
into the NAc merely induced hyperactivity, but no sensitising effects, 
whereas injections of amphetamine in the VTA produced the latter (Kalivas 
& Weber, 1988). More recent evidence further demonstrated that both 
initiation and expression of cocaine-induced locomotor sensitisation involved 
accumbal activity (reviewed in Vanderschuren & Kalivas, 2000). 
Nonetheless, it should be noted that even during the so-called initiation 
phase, neural plasticity is already taking place and expressing itself in the 
form of increases in locomotor activity. Thus, for clarity, this thesis 
addressed the initiation phase as the ‘early stage’ or the ‘development’ of 
sensitisation.  
Much of the early work on neuroadaptations underlying sensitisation 
primarily focused on the mesocorticolimbic dopamine transmission (Kalivas 
& Duffy, 1993; Parsons & Justice, 1993; Burger & Martin-Iverson, 1994; 
Sorg, Davidson, Kalivas, & Prasad, 1997; Williams & Steketee, 2005). More 
recent evidence however further suggests the importance of excitatory 
afferents to the VTA and the NAc. Electrical stimulation of excitatory 
projections to the VTA was found to induce sensitisation (Schenk & Snow, 
1994) and drug-induced sensitisation was blocked by glutamate receptor 
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antagonist micro-injected into the VTA (Kalivas & Alesdatter, 1993). 
Similarly, inhibiting or lesioning excitatory transmission in the NAc blocked 
the long-term expression of sensitisation (Karler, Calder, & Brent 
Bedingfield, 1994; Pierce, Reeder, Hicks, Morgan, & Kalivas, 1998; 
Vanderschuren & Kalivas, 2000). Other studies have also implicated the 
hippocampus, laterodorsal tegmentum, amygdala, and the paraventricular 
nucleus of the thalamus (PVN) in the development of sensitisation 
(Degoulet, Rouillon, Rostain, David, & Abraini, 2008; Yong Li et al., 1999; 
Nelson, Wetter, Milovanovic, & Wolf, 2007; Wolf, Dahlin, Hu, Xue, & White, 
1995), most likely by influencing the dopamine system (discussed in 
Steketee & Kalivas, 2011). 
1.7.2. Cocaine-facilitated conditioned reinforcement 
In addition to enhancing locomotor activity, cocaine and other 
psychostimulant agents also have the capacity to enhance the expression of 
a learned instrumental response maintained by conditioned reinforcement 
(CRf) (Beninger, 1983; Cador, Taylor, & Robbins, 1991; Chu & Kelley, 1992; 
Dixon et al., 2010; Robbins, 1978). CRf is a phenomenon whereby a discrete 
arbitrary stimulus (e.g. tone or light stimulus) acquires the capacity to 
reinforce instrumental actions in its own right (i.e. conditioned reinforcer, 
CR) upon Pavlovian association with a primary natural reinforcer 
(unconditioned reinforcer, UR) (Kelleher & Gollub, 1962). The key neural 
circuitry subserving CRf primarily involves BLA-NAc interactions as lesion 
to this region impaired the ability of the CR to support the acquisition of a 
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new instrumental response (Burns, Robbins, & Everitt, 1993; Cador, 
Robbins, & Everitt, 1989).  
Whilst Pavlovian stimulus-reward association provides knowledge of 
reward predictability, it is not motivation in itself (Berridge, 2012; 
Fernando, Urcelay, Mar, Dickinson, & Robbins, 2013). Despite the 
remembered knowledge of stimulus-reward association, the motivating 
power of a CR is generated anew with every encounter and thus, can vary in 
its ability to evoke desire. For example, the same food-associated stimulus 
that elevates the motivation to seek food rewards, or drug-related stimuli 
that could trigger relapse in recovering addicts, might have been 
successfully resisted on previous encounters. There are therefore 
contributing factors that transform this knowledge to motivation and 
ultimately, the expression of goal-directed actions (Berridge, 2012). Of these, 
fluctuations in neurobiological states, including changes in 
mesocorticolimbic dopamine, are considered to be one of the critical 
modulators of motivated behaviours (extensively reviewed in Salamone & 
Correa, 2012). It is thus not surprising that drugs, acting to modulate the 
dopaminergic system, can alter the expression of CR-governed motivated 
behaviours (discussed below).  
The notion that psychostimulant drugs have the capacity to increase 
the efficacy of rewarding stimuli was first proposed by Stein (as cited in 
Robbins, 1975) and as an extension of this hypothesis, Hill (as cited in 
Robbins, 1975) further observed selective enhancement of responding for the 
CR by pipradrol (10 mg/kg), while, in the absence of the CR, pipradrol 
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reduced responses, indicating a true interaction between drug effect and 
CRf. To date, there is compelling evidence that systemic or intra-accumbal 
administration of psychostimulant drugs, including pipradrol, 
amphetamine, methylphenidate, potentiates responding CRf, though 
evidence pertaining to cocaine effect was less consistent in the rat literature 
(Beninger, Hanson, & Phillips, 1981; Cador et al., 1991; Chu & Kelley, 1992; 
Robbins, 1975, 1978; Robbins, Watson, Gaskin, & Ennis, 1983). Studies with 
mice however have consistently observed cocaine’s (10 mg/kg) potentiating 
effects on instrumental responding for CRf (Dixon et al., 2010; Macpherson 
et al., 2016). 
Biologically, a host of pharmacological studies to date, primarily with 
rats, provide empirical support for the notion that the mesoaccumbal 
dopamine action particularly at D1R and D2R subtypes is critical for 
psychostimulant potentiation of CRf (Cador et al., 1991; Chu & Kelley, 1992; 
Ranaldi & Beninger, 1995; Taylor & Robbins, 1984; Wolterink et al., 1993). 
For instance, microinfusion of D1R or D2R agonists (SKF 38393 or 
quinpirole respectively) in the NAc has been shown to facilitate responding 
for CRf, but blockade of either receptor subtype only impaired d-
amphetamine’s CRf-potentiating effect without retarding the reinforcing 
efficacy of the CR (Wolterink et al., 1993). Nevertheless, there also exists 
evidence that co-activation of D1Rs and D2Rs is required for 
psychostimulant enhancement of CRf as agonism at D1Rs (CY 208-243) or 
D2Rs (quinpirole) alone failed to potentiate responding for CRf (Chu & 
Kelley, 1992). In fact, under some conditions, D1R agonist (including SKF 
64 
 
38393) impaired preferential responding for CRf (Beninger & Rolfe, 1995; 
Beninger & Ranaldi, 1992; Collins & France, 2015; Collins & Woods, 2009; 
Ranaldi & Beninger, 1995). Methodological variations, including the routes 
of the drug administration (i.e. systemic vs. localised treatments), are 
thought to underlie the discrepancy in the literature (Beninger & Rolfe, 
1995). The significance of the dopaminergic system was further emphasised 
by findings that intra-accumbal dopamine, but not noradrenaline infusion 
produced increases in responding on the CR-associated lever (Cador et al., 
1991). Likewise, 6-hydroxydopamine-induced dopamine, but not 
noradrenaline, depletion in the ventral, but not dorsal striatum abolished 
the CRf-enhancing properties of intra-NAc d-amphetamine micro-infusion 
(Taylor & Robbins, 1986). Taken together, there is compelling evidence to 
date that cocaine-induced increases in mesoaccumbal dopamine is involved 
in its ability to facilitate the expression of conditioned behaviours, i.e. 
conditioned reinforcement and behavioural sensitisation. 
1.8. RNA interference: A method to study the lack-of-
function phenotype 
Over the past decades, the RNA interference (RNAi) technology has 
revolutionised the way we study genome. It reveals an array of conserved 
pathways in which small (20-30 nucleotide) double-stranded, non-coding 
RNA (dsRNA) molecules associate with the enzymatic machinery of RNAi to 
orchestrate post-transcriptional control over gene expression through 
sequence-specific targeting of the target messenger RNAs (mRNAs) 
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(Elbashir, 2001; Fire et al., 1998). To date, RNAi-induced gene silencing 
remains to be a powerful analytical modality to study gene function in 
various organisms ranging from unicellular parasites to mammalian cells 
(Hannon, 2002).  
1.8.1. A brief history of RNAi discovery 
Prior to the discovery of RNAi by Andrew Fire and Craig Mello (Fire 
et al., 1998), pioneering observations of post-transcriptional gene silencing 
were initially reported in plants, but several years later, this phenomenon 
was also reported in most, if not all, eukaryotes. The first known report of 
this phenomenon was detailed in the Napoli, Lemieux, and Jorgensen (1990) 
study, whereby the overexpression of chalcone synthase (CHS) gene with 
the aim to generate violet petunia flowers instead resulted in white petunia 
flowers. Transcript analyses further revealed that the transgenic flowers 
had 50-fold lower CHS mRNAs than the wildtype counterparts. The 
researchers argued that the introduction of exogenous transgene suppressed 
the endogenous CHS level, which was termed “co-suppression”. Years later, 
a number of studies reported a similar phenomenon occurring in the 
nematode worm, Caenorhabditis elegans. For example, endogenous small 
regulatory RNA, also known as microRNA (miRNA), lin-4 was found to 
negatively regulate the expression of LIN-14 protein via antisense RNA-
RNA interactions with the 3’ untranslated region (UTR) of the lin-14 
transcript (Lee, Feinbaum, & Ambros, 1993). However, a more recent 
attempt to silence par-1 gene in C. elegans by introducing antisense RNA in 
the experimental condition, with the sense RNA as a control condition, 
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yielded an unexpected result. That is, the introduction of sense RNA, which 
could not hybridise with the endogenous target mRNA, induced a silencing 
effect (Guo & Kemphues, 1995). 
In 1998, the work by Fire and colleagues provided an explanation for 
the Guo and Kemphues’s (1995) findings. They postulated that the gene 
silencing trigger was in the form of double-stranded RNA (dsRNA), instead 
of single-stranded RNA (ssRNA). Injection of antisense or sense RNA 
targeting the unc-22  gene in C. elegans produced minimal interference 
activity, requiring a high dose of RNA molecules to induce observable 
effects. In contrast, injection with a mixture of sense and antisense RNA 
produced potent unc-22 silencing activity and further electrophoretic 
analyses revealed that the injected material was mainly double stranded. It 
is thus less likely that the highly efficient silencing activity by sense and 
antisense RNA was triggered by alternative strand interactions.  
Since the discovery of RNAi, several important findings have 
emerged, including: (1) the RNAi is a well conserved mechanism (Bellés, 
2010; Davis et al., 2010; also see studies above), (2) miRNA-induced 
silencing mechanism appears to be widespread. Within the human genome, 
for example, approximately ~2000 miRNA molecules have been identified, 
each serving to orchestrate the expression of proteins involved in various 
vital processes, including cell growth, proliferation, differentiation, as well 
as those involved in disease pathologies (Calin et al., 2004; Chan, 
Krichevsky, & Kosik, 2005; Choi et al., 2011; also reviewed in Ha, 2011). 
Contrary to miRNA, short interfering RNAs (siRNAs) are synthetic effectors 
67 
 
of the RNAi pathway, though some may arise due to viral infections and are 
fully complementary to their targets. The effective siRNA duplexes are ~21-
23 basepairs (bp) in length, containing the mRNA sequence of the target 
gene (sense strand) and its complement (active antisense strand) have been 
extensively used in biomedical research to allow selective suppression of the 
target gene expression (Elbashir et al., 2001). Throughout this thesis, the 
term RNAi will be predominantly used to describe siRNA-based gene 
silencing. 
1.8.2. RNAi in eukaryotes 
In many eukaryotes, RNAi serves primarily as a defence mechanism 
against mobile genetic components, e.g. viruses and transposable elements, 
though the role of RNAi as a natural antiviral response in mammalian cells, 
remains unclear (Cullen, 2006; Yang Li, Lu, Han, Fan, & Ding, 2013; Schütz 
& Sarnow, 2006; Zambon, Vakharia, & Wu, 2006). The key microprocessor 
proteins involved in eukaryotic RNAi are Dicer, an endoribonuclease with a 
helicase domain and a dimer of RNAse III domains, a dsRNA-binding 
protein (dsRBP) such as TAR RNA-binding protein (TRBP), and an 
Argonaute family protein, which is involved in the recognition of the guide 
(or antisense) siRNA strand, target mRNA cleavage, and recruitment of 
other proteins involved in RNAi. It is the existence of multiple paralogues of 
this machinery that creates the diversity of RNAi systems among all major 
eukaryotic lineages (extensively reviewed in Hutvagner & Simard, 2008; 
Wilson & Doudna, 2013). 
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  In principle, RNAi-induced gene silencing involves four major steps, 
(1) mature small-interfering RNA (siRNA) biogenesis; (2) recruitment of 
siRNA antisense or guide strand to the protein complex to form the RNA-
induced silencing complex (RISC); (3) target mRNA recognition and 
cleavage; and (4) target mRNA degradation and ultimately, the inhibition of 
protein synthesis. The siRNA duplexes can either be generated from 
cleavage of long dsRNA precursor (viral RNA) by the RNase III domain of 
Dicer, or exogenously synthesised and introduced into the cells in its mature 
siRNA form (Brummelkamp, Bernards, & Agami, 2002; Ding & Lu, 2011; 
Sui et al., 2002; Xia, Mao, Paulson, & Davidson, 2002). 
 One of the important advances in the RNAi field was the discovery of 
short-hairpin RNA, as a substitute for the use of synthetic siRNAs. The 
main advantage of shRNA over siRNA is that it permits more stable 
silencing of gene expression. It is synthesised in the nucleus upon delivery 
via various methods of transfection or viral-mediated delivery, transported 
and processed into the cytoplasm via the miRNA machinery to yield mature 
siRNA molecules prior to RISC loading (depicted in Figure 1.5). As its name 
suggests, the primary transcript forms a hairpin-like structure with stem 
and loop components. In the nucleus, it is transcribed by RNA Polymerase II 
or III, and further processed by a complex containing RNaseIII enzyme, 
Drosha, and a dsRNA-binding protein, DiGeorge syndrome critical region 
gene 8 (DGCR8), which collectively measure the hairpin and excise the 
stem-loop structure to yield mature shRNAs with a 2 nucleotide (nt) 3’ 
overhang prior to being transported to the cytoplasm by Exportin-5. In the 
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cytoplasm, shRNAs are further processed by Dicer and TRBP where loop 
processing takes place to yield mature double-stranded siRNA. The guide 
strand of mature siRNA is anchored into a specific binding pocket of the 
Argonaute protein by Dicer and further aided by TRBP, whilst the 
passenger strand is rapidly degraded. Collectively, the complex containing 
the siRNA guide strand and the three proteins constituting the basic RNAi 
machinery, i.e. Argonaute, Dicer, and TRBP, form a transient RISC, 
allowing the guide strand to identify the target mRNA through perfect or 
near-perfect complementarity, followed by target mRNA cleavage by the 
endonucleolytically active Argonaute protein and its degradation (Wilson & 
Doudna, 2013; Yi, Doehle, Qin, Macara, & Cullen, 2005). 
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Figure 1.5. A schematic representation of RNAi interference with the short-
hairpin RNA (adapted from de Fougerolles, Vornlocher, Maraganore, & 
Lieberman, 2007; Torrecilla, Rodríguez-Gascón, Solinís, & del Pozo-
Rodríguez, 2014). 
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1.8.3. siRNA vs. shRNA 
Despite extensive similarities in the mechanistic actions of shRNA- 
and siRNA-based silencing, notable differences have been documented, 
pertaining to requirements for sequence composition, duration of 
knockdown and off-target effect profiles (Rao, Vorhies, Senzer, & 
Nemunaitis, 2009; refer to Table 1.1 for comparison).  
Synthetic siRNA can be introduced into the cytoplasm, ready for 
RISC assembly for RNAi function. However, this process has been shown to 
be 10-fold less efficient than shRNA, which assimilates into the miRNA 
pathway. However, it has been shown that increasing the length of siRNA 
with 2nt 3’ overhangs on the antisense strand improves efficacy (Kim et al., 
2005; Sano et al., 2008). Further, whilst tracing experiments revealed high 
degradation and turnover rate of synthetic siRNA (Järve et al., 2007), 
shRNA can be continuously synthesised due to its nuclear localisation, thus 
permitting prolonged knockdown effect (Rao et al., 2009). 
It was originally assumed that the siRNA and shRNA would share 
nearly identical properties given that siRNA duplexes are final products of 
the hairpin-based RNA intermediates. Therefore, sequences that were 
proven optimal with siRNA have often been used for shRNA construction 
(Taxman et al., 2006). Nonetheless, it has been demonstrated that 
functional shRNA products possessed distinctive key features for efficient 
target silencing. For instance, strong preferences for G/C at position 11 and 
A/U at positions 9 and 12 were observed in functional shRNA constructs but 
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these preferences were less pronounced or even reversed in functional 
siRNAs. The observed differences in nucleotide preferences were believed to 
be shRNA-specific features that may not be the priorities in advanced 
siRNA design algorithms (Li, Lin, Khvorova, Fesik, & Shen, 2007).  
1.8.4. RNAi activity in neuronal cells 
1.8.4.1. si/shRNA triggers 
Long dsRNA serves as a potent effector of RNAi in various organisms. 
However, it has been found to induce a robust immune response, i.e. the 
interferon (IFN) response, in mammalian cells as the first defence 
mechanism to limit viral replication. This subsequently leads to a global 
inhibition of protein synthesis and ultimately apoptotic effects, thus 
rendering long dsRNA inefficient as a potential activator of the RNAi 
pathway in mammalian systems (Clemens, 1997). More recent findings 
documented in the Elbashir et al. (2001) and Caplen et al. (2001) studies, 
however, showed that shorter RNA duplexes, i.e. 21-25 mer in length are 
potent and specific effectors of the RNAi machinery, bypassing the dsRNA 
detectors of the innate immune response.  
Mounting evidence to date indicates that RNAi appears to be 
operative in neurons. For example, the introduction of exogenously-
synthesised siRNAs directed against MAP2 and YB-1 transcripts into 
cultured rat primary hippocampal and cortical neurons via cationic lipid-
based method caused efficient suppression of gene expression (Krichevsky & 
Kosik, 2002). Similarly, the success of viral-based mediated shRNA-based 
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RNAi has been reported in mouse and rat neuronal or non-neuronal cells 
within the CNS, targeting various genes in distinct regions (e.g. Heitz et al., 
2014; Hommel, Sears, Georgescu, Simmons, & DiLeone, 2003; Sapru et al., 
2006). 
74 
 
Table 1.1. Differences between siRNA and shRNA. 
  
Table 1.1 
Criterion siRNA shRNA 
Synthesis (Kim et al., 
2005; Sano et al., 
2008) 
Exogenously 
synthesised 
Nuclear expression 
Delivery method 
(Foged, 2012; Vorhies 
& Nemunaitis, 2009; 
Moore et al., 2010) 
Synthetic polymer-
/Lipid-based 
delivery to the 
cytoplasm 
Viral- (in vivo) or 
non-viral delivery 
(in vitro) methods 
to the nucleus 
Duration of 
knockdown (Jarve et 
al., 2007; Rao et al., 
2009) 
Short-term (99% 
degraded after 48 
hours) 
Long-term 
Sequence-specific off-
target effects 
(Rao et al., 2009a) 
Higher than 
shRNA 
Lower than siRNA 
Activation of 
immune/inflammatory 
responses 
(Singh et al., 2011) 
Higher than 
shRNA 
Lower than siRNA 
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1.8.4.2. Off-target effects 
Despite the reported high potency and specificity of RNAi-induced 
gene knockdown, there are a number of impediments to the use of RNAi for 
phenotypic analysis of gene function. Previous studies have identified 
multiple mechanisms through which the delivery of silencing triggers can 
cause effects other than the intended mRNA depletion, termed off-target 
effects. Unintended transcripts with <100% base-pair interactions with the 
siRNA can be targeted for RNAi-mediated knockdown and this is thought to 
occur due to high availability of cytoplasmic siRNA (Alemán, Doench, & 
Sharp, 2007).  
First, off-target phenotypes are commonly observed due to partial 
complementarity between the 5’ region of siRNA and the 3’ UTR hexamers 
of the off-target transcripts, reminiscent of micro RNA (miRNA)- mRNA 
interaction. Given that siRNA and miRNA share the same RNAi machinery, 
the off-target gene suppression could potentially result from siRNA 
functioning as miRNA on unintended targets (Jackson & Linsley, 2010; 
Siolas et al., 2005). Several proposed ways to mitigate off-target effects 
include the introduction of a short overhang on the guide strand, the 
introduction of single/double base mismatches, as well as chemical 
modification of the passenger strand or the guide strand to prevent its 
participation in silencing or to reduce the entry of siRNA constructs into the 
endogenous miRNA-based silencing pathway respectively (Bramsen et al., 
2010; Jacksonet al., 2006; 2006a). 
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Under certain conditions, the delivery of synthetic siRNA or shRNA, 
despite its short length, has been reported to trigger perturbations within 
the cellular environment, independent of the interaction of RNAi construct 
and a transcript – activating a host of immune mediated responses and 
subsequently, a cascade of mRNA decay pathways, ultimately resulting in 
aptoptosis (Bridge, Pebernard, Ducraux, Nicoulaz, & Iggo, 2003). 
Alternately, cellular toxicities have also been specifically associated with 
nucleotide composition of the siRNA. Sequence analyses documented in the 
Fedorov et al. (2006) study revealed that a significant proportion of toxic 
siRNAs contain motifs enriched with AU-rich sequences. AU-rich-elements 
that exist in the 3’ untranslated region (UTR) of transcripts have been 
implicated in transcript stability, and toxic siRNAs reported in this study 
were found to contain AU-rich pentamers, potentially targeting and 
affecting the stability of off-target transcripts.  
The current view posits that shRNA produces less downregulation of 
off-target transcripts than the corresponding siRNA, dosed to achieve 
similar levels of suppressive effect. Such difference has been postulated to 
occur due to mechanistic variations by which siRNA and shRNA enter the 
RNAi pathways (Rao, Senzer, Cleary, & Nemunaitis, 2009). This further 
indicates that off-target effects seen with shRNA may not be observed with 
siRNA with identical targeting sequences and vice versa. For instance, liver-
directed viral-based RNAi induced dose-dependent, albeit not sequence-
specific, lethality in the mouse. It was later found to be due to the 
overexpression of shRNA oversaturating the endogenous miRNA system, 
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particularly the Exportin-5-mediated export to the cytoplasm and the 
downstream Argonaute-2 activity, resulting in toxic effects (Grimm et al., 
2006). The shRNA-mediated off-target dysregulation of endogenous miRNA 
pathway has also been detected in neuronal cells. Namely, both the active 
shRNA construct and the scrambled control yielded neuronal migration 
defect by disrupting endogenous let7 miRNA levels (Baek et al., 2014) in the 
mouse brain and degenerative changes in cell morphology due to shRNA-
induced saturation of miRNA pathway have also been reported in the rat 
brain (van Gestel et al., 2014), masking true effects of specific gene 
expression knockdown. The discrepancies between shRNA- and siRNA-
induced off-target effects should therefore be taken into account when 
designing and optimising RNAi assays.  
Finally, specific delivery vehicles of exogenous RNAi constructs may 
also contribute to the manifestation of these perturbations. For instance, 
adenoviral (AdV) vectors have been found to evoke sustained and strong 
expression of chemokines and cytokines in transduced human cells, i.e. 
HeLa cells (Zaiss et al., 2002). Marked inflammatory responses have also 
been detected in mouse neurons following injection of replication-competent 
or incompetent AdVs (Byrnes, Wood, & Charlton, 1996; Ohmoto et al., 
1999), thus indicating that the pharmacodynamics of small RNA delivery 
system are not only dependent on the structure and chemistry of the 
constructs but also upon the biomaterials used for delivery (Kanasty, 
Whitehead, Vegas, & Anderson, 2012). Adequately addressing these 
concerns is essential for minimising the introduction of confounding 
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artefacts and therefore maximising the potential of RNAi-based 
applications.  
1.8.4.3. Targeted delivery 
A suitable delivery method of dsRNA intermediates into mouse 
neurons largely depends on the experimental setup. In cultured neurons, 
siRNA can be directly introduced into single neurons via lipid-based 
approaches, such as lipofection (Kao, Krichevsky, Kosik, & Tsai, 2004), 
cationic lipid-based transfection (Krichevsky & Kosik, 2002), and lipid 
nanoparticle delivery vehicles (Rungta et al., 2013), whereas plasmid-based 
shRNA can be readily introduced into the nucleus of post-mitotic neurons by 
nucleofection or using viral vectors (for example, see Katsu-Jiménez et al., 
2016; Zeitelhofer et al., 2007).  
For in vivo applications, the use of viral-based delivery vehicles via 
intracranial injection remains a widely popular and the most proficient 
method for delivery of RNAi effectors. Virus-mediated delivery is usually 
based on delivery of shRNA, though note that a few non-viral-based 
approaches, e.g. systemic injection of targeted exosomes or recombinant 
protein fusion have recently been developed to facilitate siRNA delivery to 
the mouse brain (Alvarez-Erviti et al., 2011; Haroon et al., 2016). In terms 
of viral-mediated delivery, the type of viral vector used is primarily 
governed by specific research requirements, i.e. the duration of knockdown, 
cell type, and the safety profile of the viral vector. For instance, adeno-
associated viruses (AAVs) and Lentiviruses (LVs) are favoured if long-term 
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gene knockdown is required. These vectors are also considered relatively 
safe to use and pseudotyping the vectors with different envelope (LV) or 
capsid (AAV) structures improves tissue tropism (Burger et al., 2004; Couto 
& High, 2010; Cronin, Zhang, & Reiser, 2005; Hommel et al., 2003; Stewart 
et al., 2003).  
1.8.5. Summary  
Since its discovery, RNAi continues to be considered as an important 
tool for functional genomics (Agrawal et al., 2003) and is a promising 
therapeutic strategy to suppress the expression of the disease-relate genes 
(Chen & Xie, 2012). Two of the most common RNAi effectors are the 
exogenously synthesised siRNA and its precursor, plasmid-based shRNA 
(Rao et al., 2009). Despite its applicability across various cell lines and the 
advantages associated with RNAi over the traditional deleterious mutation 
strategy (i.e. more spatial and temporal control over gene expression and 
the lack of genetic compensation) (Rossi et al., 2015), there are caveats 
associated with RNAi, such as the off-target effects (Jackson & Linsley, 
2010).  
1.9. Viral-mediated DNA delivery: A focus on recombinant 
adeno-associated viral vectors 
1.9.1. Adeno-associated virus (AAV) and its natural diversity 
The adeno-associated viruses (AAVs) are helper-dependent members 
of the family Parvoviridae, which require helper viruses, such as 
adenoviruses (AdVs) and herpes simplex viruses (HSVs), or DNA damaging 
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agents for a productive infection. These helper functions elicit changes in 
the cellular environment, thereby aiding AAV replication and gene 
expression. In the absence of helper viruses, AAV lies dormant within the 
cell but can be rescued by subsequent infection of the helper virus. Despite 
its prevalence in humans, AAV has not been associated with any human 
disease and is thus widely considered as a non-pathogenic virus (Berns & 
Giraud, 1996; Weitzman & Linden, 2011). 
There are currently more than 100 known serotypes of AAV, 
discovered fortuitously as contaminants from AdV preparations from 
various species (12 human serotypes and more than 100 serotypes from 
nonhuman primates). In specific, AAV serotypes 2,3,5 and 6 were first 
discovered from human cells and the rest were isolated from the nonhuman 
primate origins (Daya & Berns, 2008; Weitzman & Linden, 2011). Though 
the general organisation of the AAV genome is conserved across different 
serotypes, the capsid structure of the numerous serotypes reveals distinct 
surface topologies determining the tissue tropisms. Namely, there are 
serotype-specific variations pertaining to antigenicity, receptor interactions 
and intracellular pathways (Aschauer, Kreuz, Rumpel, Tsao, & 
Cerniauskas, 2013; Zincarelli, Soltys, Rengo, & Rabinowitz, 2008). 
1.9.2. AAV2 structure and biology of infection 
Among all of the known AAV serotypes, AAV type 2 (AAV2) is the 
most extensively studied serotype to date and therefore commonly serves as 
a prototype for the AAV family. The AAV2 genome consists of a single-
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stranded DNA (ssDNA) molecule of approximately 4.7kb in length and at 
both ends of the genome exist the inverted terminal repeats (ITRs). These 
ITR regions form a T-shaped hairpin structure and contain cis-elements 
essential for viral replication and packaging. Within the wild-type AAV2 
genome are the rep and cap genes encoding proteins required for viral 
replication (i.e. Rep40, Rep52, Rep 68 and Rep78) and structural proteins 
that produce the capsid (i.e. VP1, VP2 and VP3) respectively (Srivastava, 
Lusby, & Berns, 1983; Wistuba, Weger, Kern, & Kleinschmidt, 1995). In 
order to produce recombinant AAVs, the rep and cap genes from the AAV 
genome can be replaced by a transgene (4.7-5kb) corresponding to the size of 
wild-type AAV genome and provided in trans during transfection for viral 
assembly (Zolotukhin, 2005).  
The AAV ssDNA is encapsidated within the non-enveloped 
icosahedral capsid architecture of approximately 20nm in diameter. The 
AAV virion consists of VP1, VP2, and VP3 in 1:1:10 ratio. While VP1 and 
VP3 are crucial for viral infectivity, i.e. implicated in virus escape from 
endosomes and receptor usage respectively, VP2 is not crucial for viral 
assembly or infection (Girod et al., 2002; Rabinowitz, Xiao, & Samulski, 
1999). 
Successful AAV infection requires the following key steps: (1) capsid-
receptor interaction, (2) endocytic uptake, (3) release from endosomal 
compartments, (3) entry into the nucleus, (4) capsid uncoating and DNA 
release, (5) second strand synthesis and finally, (6) viral DNA transcription 
(Bartlett, Wilcher, & Samulski, 2000). The heparan sulfate proteoglycan 
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(HSPG) was first discovered to be the preferred docking partner of AAV2 
and the binding region was then mapped to amino acids 585-588 of the viral 
capsid protein (Opie et al., 2003). Within the CNS, AAV2 preferentially 
infect the neurons due to higher HSPG availability on the surface of 
neurons in comparison with non-neuronal cells, e.g. glia (Hsueh et al., 
1998). To corroborate this argument, AAV2 delivery in the brain yielded a 
largely neuronal transduction profile and direct injection of soluble heparin 
into the brain has been shown to improve transduction efficiency of 
intracranially injected AAV2 (Bartlett, Samulski, & McCown, 1998; Nguyen, 
Sanchez-Pernaute, Cunningham, & Bankiewicz, 2001). In addition to 
mediating neurotropic bias of AAV2, binding to the heparan sulfate is 
interestingly associated with the limit of CNS volume effectively targeted by 
AAV vectors (Murlidharan, Samulski, & Asokan, 2014). 
Following cell surface attachment and internalisation into the cell, 
via clathrin-coated vesicles, AAV enters the nucleus of the host cell and 
reveals its genomic content though the trafficking pathway of AAV particles 
from the cell surface to the nucleus is not fully understood. In the CNS, 
paravascular cerebrospinal fluid (CSF) transport and axonal transport are 
the two main systems thought to regulate spread of AAV vector within the 
interstitial space and the intracellular environment correspondingly. Intact 
AAV2 virions are known to exclusively undergo anterograde axonal 
transport where they enter the somatic region of the host neuron, travel 
along the axon and are subsequently released at the projection site. These 
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released virions are then free to transduce neighbouring cells within the 
region (Aschauer et al., 2013; Murlidharan et al., 2014).  
1.9.3. Manufacturing recombinant AAV (rAAV) vectors: The 
helper-free system 
Early methods for rAAV production require auxiliary viruses, e.g. 
adenoviruses, to provide helper functions described above. However, a 
pivotal advancement in the AAV manufacturing field was made through the 
identification and cloning of AdV regions important for AAV replication and 
encapsidation, thus eliminating the use of helper viruses and decreasing the 
risk of contamination during AAV preparation (Matsushita et al., 2004; 
Samulski & Shenk, 1988). The helper-free system utilises the HEK293 cell 
line, transiently transfected with: (i) recombinant vector genome plasmid, 
(ii) rep/cap plasmid and (iii) AdV helper plasmid, allowing viral assembly to 
occur inside the host cells (Xiao, Li, & Samulski, 1998).  
1.9.4. Advantages and disadvantages of using rAAV vectors: 
Technical considerations 
To date, AAV continues to establish its position as one of the most 
popular gene delivery systems in dividing and non-dividing cells for 
numerous reasons. A major advantage of rAAV vectors, and in fact, 
retrovirus-derived vectors (e.g. LV vectors), is the long-term expression of 
the transgene following in vivo gene delivery. While LV vector system aids 
long-term expression of the gene of interest by integrating its genome within 
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the host genome, the rAAV genome primarily forms a stable concatemer 
episomally, lowering the risk of insertional mutagenesis (McCarty, Young, 
& Samulski, 2004; Schnepp, Clark, Klemanski, Pacak, & Johnson, 2003; 
Singer & Verma, 2008). Although rAAV is small in size reflecting its 
restricted packaging capacity, this may provide an advantage over larger 
vectors, such as LVs, with regards to viral spread (see Parr-Brownlie et al., 
2015for review). Thirdly, the non-pathogenic and replication defective 
nature of AAVs ensure the safety of this vector system, reflected by lowered 
biosafety level requirements (Flotte & Carter, 1995; Nayak & Herzog, 2010). 
Nevertheless, there are several impediments associated with AAV 
vector use. For many years, the use of rAAV was limited by the inefficient 
methods of virus production, but this issue has been resolved by a number of 
research groups (discussed above in Section 1.9.3), thus currently leaving 
slow onset of transgene expression and restricted packaging capacity in a 
single vector approach (~4.7kb) as primary obstacles of rAAV use. In 
experimental settings where a fast onset of transgene expression is 
required, the use of self-complementary AAV (scAAV) expression construct, 
where two halves of the single-stranded AAV (ssAAV) genome can form 
intramolecular double strands, may be more desirable given that the 
formation of dsDNA in the ssAAV expression construct is considered to be a 
rate-limiting step for AAV-mediated transgene expression. While this 
approach significantly shortens the onset of transgene expression, it reduces 
the effective genome size to approximately 2.3kb (Ferrari, Samulski, Shenk, 
& Samulski, 1996; Fisher et al., 1996; Raj, Davidoff, & Nathwani, 2011).  
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Furthermore, findings from transduction experiments revealed that 
AAV vectors carrying larger genomes (>5.3kb) transduced cells much less 
efficiently than those carrying WT size genomes. This was postulated to be 
due to preferential degradation of viral particles encapsidating larger 
genomes as the addition of proteasome inhibitor rectified this issue. To 
improve AAV packaging capacity, researchers have also harnessed the 
ability of rAAV genome to link together in strings or doublets (Flotte, 2000). 
A few examples of developed techniques include overlapping two 
independent vectors by homologous recombination, the trans-splicing 
approach where exons can be reconstituted through splicing, the hybrid dual 
vector system (Duan, Yue, Engelhardt, Boss, & Kerem, 2001; Ghosh et al., 
2008; Ghosh & Duan, 2007). 
1.9.5. Summary  
To date, the AAV remain to be one of the most popular vectors of 
choice for DNA/gene delivery in vivo, due to its efficiency both in dividing 
and non-dividing cells (Aschauer et al., 2013; Xiao et al., 1998). Upon 
insertion into the target cells, the AAV genomes form stable concatemers 
episomally, thus minimising the risk of mutagenesis within the host genome 
(Singer & Verma, 2008). Nonetheless, it is noteworthy that different AAV 
serotypes exhibit distinct tissue tropism and specifically, though all 
serotypes have the general ability to transduce all major cell types in the 
brain (i.e. neurons, astrocytes, microglia, and oligodendrocytes), transgene 
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expression was found to vary for specific cell type and serotype combinations 
(Aschauer et al., 2013).   
1.10. Aims and structure of the thesis 
1.10.1. Chapter 2 
Chapter 2 describes the experimental procedures used for this thesis. 
This includes AAV design and production, in vitro and in vivo testing of 
AAV functionality, as well as the behavioural experiments (sensitisation 
and conditioned reinforcement).  
1.10.2. Chapter 3 
Chapter 3 details the design and production of viral vectors, 
harbouring α2-targeting (or non-targeting) shRNA, as tools to study the 
function of α2-GABAARs in the region, as well as in a specific cell type, of 
interest. Given the novelty of the silencing construct used in this thesis, its 
knockdown potency was first characterised in vitro prior to viral assembly 
and subsequently, in vivo testing. Specifically, quantitative real-time PCR 
(qRT-PCR) and immunocyto/histochemistry were performed to analyse the 
silencing potency of the RNAi effectors, both at the mRNA and protein 
levels. These viral tools were then used to characterise the role of 
mesoaccumbal α2-GABAARs in mediating cocaine-facilitated conditioned 
behaviours, detailed in the following chapters.  
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1.10.3. Chapter 4 
Previous research in our laboratory demonstrated that the whole-
brain deletion of Gabra2 blocked cocaine-potentiated conditioned behaviours 
(i.e. locomotor sensitisation and conditioned reinforcement). It was further 
hypothesised that such phenotypes might have been linked to the loss of 
Gabra2 particularly in the nucleus accumbens (NAc) (Dixon et al., 2010). 
This chapter therefore seeks to investigate the effects of α2 knockdown in 
the NAc core and shell (using the RNAi strategy) on cocaine-induced 
locomotor sensitisation and cocaine facilitation of CRf. In the sensitisation 
experiment, mice were given repeated, intermittent cocaine (10mg/kg) over 
10 daily sessions. Conditioned activity (with a sham injection) was 
measured seven days following the final day of sensitisation. The CRf 
experiment was also carried out to probe whether silencing α2 in the NAc 
core/shell would affect the potentiating effect of cocaine (0, 3, 10 and 30 
mg/kg cocaine, Latin-square design) on selective nosepoking for CRf.  
1.10.4. Chapter 5 
Approximately 95% of neurons within the NAc are GABAergic 
medium spiny neurons (MSNs), which could be subdivided into two main 
populations, i.e dopamine D1R- and D2R-expressing MSNs (Matamales et 
al., 2009; Ouimet et al., 1998). This chapter therefore seeks to further probe 
the roles of α2-GABAAR-mediated signalling in D1R- and D2R-expressing 
neurons within the NAc core in mediating cocaine-facilitated conditioned 
reinforcement using the Cre-dependent RNAi strategy.  
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Chapter 2  
 
Materials and Methods 
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2.1. Molecular cloning/subcloning procedures 
2.1.1. Methods for DNA preparation for cloning 
2.1.1.1. Annealing of single-stranded oligonucleotides  
Single-stranded oligonucleotides (ssDNA), comprising the top and 
bottom strands of a DNA fragment, were synthesised commercially by 
Eurofins Genomics (final concentration = 100µM). Each pair of ssDNA was 
annealed by mixing forward and reverse oligonucleotides (100nmoles/ml 
final concentration for each of the oligonucleotides) in 1× annealing buffer 
(10 mM Tris, pH 7.5 - 8.0, 50 mM NaCl, 1 mM EDTA), with a total volume 
of 50µl. Each reaction was set up in a 0.2ml thin-walled PCR tube (Alpha 
Laboratories, LW2340). The reaction was incubated at 95˚C for two minutes 
in a thermal cycler (Bio-Rad T100™) and cooled to 25˚C for 3 hours before 
further use. The dsDNA was then phosphorylated to aid ligation into the 
recipient plasmid (see Section 2.1.3). Note that all oligonucleotides used in 
this thesis were synthesised by Eurofins Genomics.  
2.1.1.2. Polymerase chain reaction (PCR)-based isolation of DNA 
fragment  
To introduce new restriction sites to dsDNA fragments for subcloning 
purposes, PCR-based isolation of DNA fragment was performed. The dsDNA was 
isolated from a plasmid by amplifying the sequence of interest using primers 
containing new restriction sites. Note that all primers used in this thesis were 
synthesised by Eurofins Genomics. 
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Phusion® High-Fidelity DNA Polymerase (New England Biolabs 
(NEB), M0530) was used for all PCR procedures unless stated otherwise. 
PCR reactions were set up in 0.2ml thin-walled PCR tubes in a total volume 
of 50µl. A typical reaction contained 10ng of plasmid DNA, 0.5µM of 
Forward and Reverse primers, 200µM dNTPs, 1× Phusion GC buffer, 3% 
DMSO. The DNA fragment was isolated from the plasmid and amplified by 
PCR with an initial denaturation step at 98°C for 30 seconds, followed by 35 
PCR cycles [98°C for 10 seconds, 45-72°C (depending on the melting 
temperature of the primers) for 30 seconds, and 72°C for 15-30 seconds per 
kb], with a final extension of 72°C for 10 minutes using a thermal cycler. 
The PCR products were electrophoresed on a 1% agarose gel, purified using 
the QIAquick gel extraction kit (Qiagen, 28704) (see Section 2.1.2), and 
phosphorylated as non-phosphorylated primers were used (refer to Section 
2.1.3 below) 
2.1.1.3. Plasmid digestion with restriction enzymes 
To isolate a DNA fragment from a plasmid by restriction digests, 3µg 
plasmid DNA was used. A typical restriction digest reaction (50µl total 
volume), set up in a 0.2ml PCR tube, contained 3µg DNA, 10 units of each 
restriction enzyme (for a double digest reaction, refer to specific experiments 
below), and 1× NEB buffer. The restriction digest reaction was then 
incubated at the recommended temperature (refer to the manufacturer’s 
protocol of the restriction enzyme used for incubation temperature and 
duration). Next, digested DNA fragments were electrophoresed on a 0.5% 
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agarose gel and purified using the QIAquick gel extraction kit as described 
in Section 2.1.2. Also note that the ends of blunt-ended, recipient plasmids 
were dephosphorylated to prevent self-ligation, prior to gel electrophoresis 
and DNA purification steps (see Section 2.1.3). 
2.1.2. Agarose gel electrophoresis and DNA purification 
PCR products or linearised DNA were visualised and purified by 
agarose gel electrophoresis, followed by gel extraction. PCR products were 
electrophoresed on a 1% agarose gel (Fisher Bioreagents, BP160-500), 
whereas restriction digest reactions were electrophoresed on a 0.5% agarose 
gel. Agarose was dissolved in 1× TAE buffer (40 mM Tris, 20 mM acetic 
acid, 1 mM EDTA, pH 8.0) by heating the agarose mixture in the microwave 
until boiling. The solution was then cooled to approximately 55˚C before 
adding Ethidium bromide (0.5 µg/ml final concentration from a 10mg/ml 
stock solution, Sigma-Aldrich, E1510). For estimation of fragment size, a 
100bp (NEB, N0467S) or 1kb ladder (NEB, N0468S) was used. Gel 
electropheoresis was carried out in a horizontal tank containing 1x TAE 
buffer and run at 100V for approximately 30 minutes or until the DNA 
fragments were fully resolved. Gels were imaged using a UV 
transilluminator. 
Next, DNA bands were excised from the gel as 200mg agarose slices 
using a scalpel blade and purified using the QIAquick gel extraction kit 
according to the manufacturer’s instructions. DNA was eluted from the 
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QIAquick spin column with 30µl of TE buffer  (10 mM Tris-HCl, 1 mM 
EDTA, pH 7.5). 
2.1.3. Phosphorylation and dephosphorylation of DNA fragments 
Phosphorylation and/or dephosphorylation of DNA ends were 
performed to aid ligation. DNA duplexes (up to 300 pmol of 5’ termini) were 
phosphorylated by T4 Polynucleotide Kinase (PNK; NEB, M0201), in a 50µl 
reaction (see manufacturer’s protocol). To prevent religation of plasmid 
DNA, dephosphorylation of linearised DNA (1pmol of DNA ends) was 
performed using Calf Intestine Phosphatase (1 unit; NEB, M0290) prior to 
gel electrophoresis and DNA purification (see manufacturer’s instructions).  
2.1.4. Ligation 
DNA fragments were ligated at a 1:3 vector:insert molar ratio (i.e. 
0.02pmol vector and 0.06pmol insert) in a 20µl reaction using T4 DNA 
Ligase (400 units) (NEB, M0202S) according to the manufacturer’s 
instruction. The ligation reaction was incubated overnight (~18 hours) at 
16˚C in a thermal cycler. After incubation, ligase was heat inactivated at 
65˚C for 10 minutes and the ligation mixture was chilled on ice for an hour 
prior to bacterial chemotransformation.  
2.1.5. Bacterial chemotransformation  
Chemically-competent One Shot™ Stbl3™ E. coli (Invitrogen, 
C737303) were used to propagate recombinant plasmids. Cell aliquots were 
gently thawed on ice before use. Next, 5µl of the ligation mix, or ddH2O 
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(negative control), was added to a 50μl vial of cells, followed by incubation 
on ice for 30 minutes. Heat-shock transformation was performed according 
to the manufacturer’s protocol. Next, 100µl of the cell mixture was streaked 
onto LB (Luria Broth) agar plates containing the appropriate antibiotics, i.e 
ampicillin or kanamycin (100µg/ml), and incubated overnight at 37˚C.  
For blue/white colony screening, 100 µl of 20 mg/ml X-gal stock 
(Roche, 03117073001) and 100 µl of 10 mM Isopropyl-β-D-thiogalactoside 
(IPTG; Roche, 010724815001) were spread on to each pre-made LB agar 
plate (containing 100 μg/ml ampicillin). 
2.1.6. Colony PCR 
This step was performed to identify the presence (or absence) of insert 
DNA in the recipient vector, as well as to determine insert size and 
orientation. For this, the Megamix Blue PCR mastermix (Microzone, 
2MMB) with the experiment-specific primer sets were used. Each individual 
colony was isolated with a sterile toothpick and dipped into the reaction 
tube (PCR tube) containing the mastermix and primers. The toothpick was 
removed from the tube and streaked onto an agar plate containing the 
appropriate antibiotics (with X-Gal and IPTG for blue/white screening). The 
plate was then incubated overnight at 37˚C. 
A typical PCR condition for colony PCR consists of an initial 
denaturation step of 95˚C for 15 minutes, followed by 35 PCR cycles (95˚C 
for 30 seconds, 55˚C for 60 seconds, and 72˚C for 45 seconds), with a final 
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extension at 72˚C for 10 minutes. PCR products were then electrophoresed 
on a 1% agarose gel, followed by gel imaging (see Section 2.1.2). 
2.1.7. Miniprep isolation of recombinant plasmids 
The positive clones (i.e. individual colonies) were selected and grown 
for 16 hours in 5ml LB broth containing the appropriate antibiotics (100 
μg/ml ampicillin or kanamycin) at 37˚C in a shaker-incubator (250rpm). 
Plasmids were then isolated from 3 ml of the liquid cultures using the 
QIAprep Spin Miniprep Kit (Qiagen, 27104) according to the manufaturer’s 
instructions. Using a sterile loop, some of the liquid cultures were streaked 
on agar plates containing the appropriate antibiotics and grown overnight 
at 37˚C. The concentration and purity of DNA extracted were measured 
using Nanodrop 2000 Spectrophotometer (Thermo Scientific, ND2000) (refer 
to Section 2.1.9 for sample preparation for DNA sequencing). 
2.1.8. Maxiprep isolation of recombinant plasmids 
The positive clones (i.e. individual colonies) were selected and grown 
for 8 hours in 5ml LB broth containing the appropriate antibiotics at 37˚C in 
a shaker-incubator (250rpm). Next, 250µl of the liquid culture was added to 
100ml of the LB broth containing the appropriate antibiotics for high copy 
plasmids (or 500ml for low copy plasmids), followed by a 16-hour incubation 
at 37˚C in a shaker-incubator (set to 250rpm). Some of the overnight 
bacterial cultures were stored in 15% glycerol at -80˚C (i.e. 500µl liquid 
culture + 500µl 30% glycerol (v/v), mixed by vortexing). 
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Plasmids were isolated from the ~100ml (or ~500ml) liquid cultures 
using the PureLink® HiPure Plasmid Filter Maxiprep Kit (Invitrogen, 
K210017) according to the manufacturer’s protocol. The DNA pellet was 
resuspended in 200µl TE buffer (or in 100µl of TE buffer for the low copy 
plasmids).  
2.1.9. Sample preparation for DNA sequencing 
Sequencing of plasmid DNA was carried out by Eurofins Genomics 
(TubeSeq Service). DNA samples (80 ng/µl sample concentration) and the 
sequencing primers were prepared according to their sample submission 
guideline.  
2.2. Mammalian cell culture 
2.2.1. Maintenance of adherent HEK293 cells 
All cell culture work was performed in a laminar flow hood under 
aseptic conditions. Human embryonic kidney (HEK)293 cells were used for 
in vitro experiments and rAAV production in this thesis. This cell line was 
provided by Dr. Majid Hafezparast as laboratory stock (University of 
Sussex).  HEK293 cells were maintained in growth medium of Dulbecco's 
Modified Eagle Medium (DMEM; Gibco, 11960044), supplemented with 
6mM L-Glutamine (Gibco, 25030081), 10% Fetal Bovine Serum (Gibco, 
26140079), and Penicillin/ Streptomycin (final concentration of 100U/ml/ 
100µg/ml; Gibco, 15140122). These cells were grown in Corning T175 
(175cm2) cell culture flasks (Sigma-Aldrich, CLS431080) at 37˚C with 5% 
CO2, and passaged when cells reached 80-90% confluency.  
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Prior to cell passage, growth medium, 1× Dulbecco’s Phosphate 
Buffered Saline (DPBS; Gibco, 14190250) and Trypsin were pre-warmed at 
37˚C. Firstly, growth medium was removed from the flask and cells were 
washed once with sterile DPBS and 9ml of Trypsin-EDTA (0.25%; Gibco, 
25200056) was added to the cell monolayer, followed by 5-minute incubation 
at 37˚C to promote cell detachment from the flask. Trypsin was deactivated 
by adding the same amount of 10% Fetal Bovine Serum-containing growth 
medium to the flask. The single cell suspension was centrifuged at 300g at 
room temperature (~25˚C) for 5 minutes followed by removal of the 
supernatant and cell pellet resuspension in 10ml of the growth medium. 
Cells were counted using a glass haemocytometer (refer to Section 2.2.3 for 
cell counting). Once counted, cells split into new T175 flasks at a ratio of 
1:10 for maintenance or seeded into 10-cm dishes or multi-well plates for 
subsequent experiments. Cells were then returned to the incubator (37˚C, 
5% CO2). 
2.2.2. Freezing and recovery of HEK293 cells 
For long-term storage, cells were kept in the liquid nitrogen (<150˚C). 
Prior to storage, 80% confluent cells with a low-passage number (i.e. split 
less than 3×) were trypsinised and centrifuged to form a pellet as described 
in Section 2.2.1. Cells were resuspended in growth medium and counted (see 
Section 2.2.3). Each cell suspension was formed with 1 million cells in 1ml of 
growth medium containing 10% dimethyl sulfoxide (DMSO; Sigma-Aldrich, 
M81802) to protect cells from damage at low temperature conditions. The 
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cell suspensions were kept in a Nalgene™ cryovials (Thermo Scientific, 
5000-1012), stored overnight in -80˚C freezer in a Nalgene™ Mr. Frosty cryo 
freezing container (Thermo Scientific, 5100-0001) prior to storage in liquid 
nitrogen. 
To retrieve HEK293 cells that were previously stored in liquid 
nitrogen, cryovials containing HEK293 cells were heated to 37˚C until cells 
were 80% thawed. In the cell culture hood, cells were transferred from the 
cryovial to 10ml of pre-warmed growth medium. The cell suspension was 
then centrifuged at 300 G at room temperature (~25˚C) for 5 minutes. The 
supernatant was removed and the cell pellet was resuspended in fresh 
growth medium before being transferred to a T175 flask. The appropriate 
volume of growth medium was then added to the flask to allow cell growth 
and the flask was kept in the 37˚C incubator (with 5% CO2).  
2.2.3. Viable cell counting with trypan blue 
Cells were counted using the trypan blue staining procedure with a 
glass haemocytometer. Following resuspension of cells with the growth 
medium, 500µl of cell suspension was transferred into a 1.5ml Eppendorf 
tube (Eppendorf, Cat no. 0030120086). From this, 100µl cells were 
transferred to a new 1.5ml tube containing 400µl of 0.4% Trypan Blue 
(0.32% final concentration; Sigma-Aldrich, T8154). Next, 100µl of the cell-
Trypan Blue mix was applied to the haemocytometer by gently filling both 
chambers underneath the coverslip. Using a light microscope (at10x 
magnification), count the number of unstained, live cells in one set of 16 
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squares (Figure 2.1 highlighted in blue). The number of live cells in the 
other three sets of corner squares were also counted. 
 
Figure 2.1.  Haemocytometer grids for cell counting (image retrieved from 
Abcam; https://www.abcam.com/protocols/counting-cells-using-a-
haemocytometer) 
To calculate the number of viable cells per ml, cell counts from the 
four sets of 16 squares were averaged and multiplied by 104. The value was 
then multiplied by 5 to account for the 1 in 5 dilution from the addition of 
Trypan Blue.  
2.2.4. Transfection of HEK293 with Lipofectamine 3000 
Transfection experiments for in vitro assays of pAAV functionality 
were performed using Lipofectamine 3000 (Invitrogen, L3000015) in 24-well 
plates (Sigma-Aldrich, CLS3527) on round glass coverslips (13mm diameter; 
Fisher Scientific, 12392128) according to the manufacturer’s instructions. 
HEK293 cells were seeded the day before so that they were 80% confluent 
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on the day of transfection (approximately 2×105 cells/well). Also note that 
for each well, 1µl of Lipofectamine 3000 was used and cells were incubated 
for 48 hours at 37˚C prior to imaging and/or immunocytochemical analyses. 
Imaging of live cells transfected with fluorescent constructs were performed 
using the epifluorescent Zeiss Axiovert 200 motorized inverted microscope. 
2.2.5. Immunocytochemical staining 
Forty-eight hours post-transfection, cells were washed once with 1ml 
of DPBS (per well), then fixed with 4% paraformaldehyde (PFA; Sigma-
Aldrich, 158127) for 10 minutes. Cells were washed 3× with 1ml of DPBS 
post-fixation. 
Fixed cells were permeabilised in 0.2% Triton X-100 (Sigma-Aldrich, 
T8787) in sterile PBS for 2 minutes with gentle agitation before blocking 
with 5% Bovine Serum Albumin (BSA; Sigma-Aldrich, A9418) in PBS (i.e. 
BSA-PBS) for 30 minutes. Cells were then incubated with the primary 
antibody (diluted in 1% BSA-PBS) at 4˚C overnight (~16 hours).  
On the following day, cells were washed with PBS-TS (PBS, 0.1% 
Tween 20 (Sigma-Aldrich, P2287), 0.02% Sodium Dodecyl Sulfate (SDS; 
Fisher BioReagents, BP166-100)) for 5 minutes (1ml per well) with gentle 
agitation to remove unbound primary antibodies. Cells were incubated with 
the secondary antibody in 1% BSA-PBS for 1 hour at room temperature with 
gentle agitation. Note that this and the subsequent steps were performed in 
the dark given the light-sensitive fluorophores. Following incubation with 
the secondary antibody, cells were washed 3× in PBS-TS for 5 minutes each. 
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The coverslips were then mounted on to 76 × 26mm glass microscopic slides 
(Fisher Scientific, 13192131) with Fluoroshield™ (Sigma-Aldrich, F6182). 
The edges of the coverslips were sealed with nail varnish and slides were 
stored at 4˚C before imaging on the microscope. Slides were imaged using 
the Olympus BX53 epifluorescent microscope (at 10x magnification). Images 
were captured using a QI click camera (Qimaging) attached to the 
microscope, viewed using the iVision software (version 4.0.15, Biovision 
Technologies), and analysed in Fiji.  
2.3. RNAi vector design and preparation 
2.3.1. Design of the shRNA constructs 
Two shRNA sequences, containing Gabra2-targeting siRNA 
constructs (i.e. shα2(A) and shα2(B)) with a non-targeting scrambled control 
sequence were designed in the present research. The shRNA construct used 
in this thesis contained 24-nucleotide (nt) siRNA stem sequences, with a 6-
nt loop structure (5’-CTTCCTGTC-3’) (refer to Table 2.1 for siRNA 
sequences). The siRNAs used in the present research were designed 
according to the Reynolds’ design algorithm (Reynolds et al., 2004) using 
RNAi explorer (www.genelink.com/sirna/siRNAorder.asp). BLAST 
(https://blast.ncbi.nlm.nih.gov/Blast.cgi?PAGE_TYPE=BlastSearch) 
analyses on these sequences were then performed to minimise off-target 
effects (i.e. targeting non-target endogenous genes and/or those within the 
pAAV construct).  
101 
 
To facilitate cloning into the pAAV-EGFP-shRNA vector (kindly 
donated by Ralph DiLeone, Yale University), XbaI and SapI sites were 
added to the shRNA construct (see Figure 2.2). For ligation into the Cre-
dependent pAAV vector, (blunt-end ligation; Figure 2.5), a“T’ base was 
added at the 5’ end of the hairpin sequence to aid transcription by the mU6 
promoter (Ma et al., 2014). 
Table 2.1 
Sequence  Sense (5'-3') Antisense (5'-3') 
shα2(A) GGA GAC AGT ATT ACT 
GAA GTC TTC 
 
GAA GAC TTC AGT AAT 
ACT GTC TCC 
shα2(B) GGA TGA TGG AAC ATT 
GCT ATA TAC 
 
GTA TAT AGC AAT GTT 
CCA TCA TCC 
shScr GGA TGC TAG AAC ATC 
CCT ATA TGC 
 
GCA TAT AGG GAT GTT 
CTA GCA TCC 
Table 2.1. Sense and antisense siRNA sequences of Gabra2-targeting and 
scrambled shRNA constructs. 
2.3.2. Construction of pAAV-EGFP-shRNA 
2.3.2.1. Vector and insert DNA preparation 
The shRNA constructs (Gabra2-targeting constructs and the non-
targeting control) used in this thesis are listed in Table 2.1 and the pAAV-
EGFP-shRNA vector was kindly donated by Ralph DiLeone (Yale 
University).  
Firstly, shRNA oligonucleotides (synthesised by Eurofins Genomics) 
were annealed and subsequently phosphorylated as described in Sections 
2.1.1.1 and 2.1.3. The recipient plasmid was then digested with XbaI (NEB, 
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R0145S) and SapI (NEB, R0569S) enzymes at 37˚C for 1 hour (see Figure 
2.2 for the cloning site; also refer to Section 2.1.1.3) and dephosphorylated 
with CIP (see Section 2.1.3). The digested plasmid was then isolated and 
purified by agarose gel electrophoresis on a 0.5% agarose, followed by gel 
extraction (refer to Section 2.1.2). 
2.3.2.2. Ligation and transformation 
The vector and the shRNA (shα2(A), shα2(B), or shScr) insert were 
ligated according to the protocol described in Section 2.1.4 and the ligated 
products were transformed into Stbl3 cells as outlined in Section 2.1.5. 
2.3.2.3. Miniprep of pAAV-EGFP-shRNA 
Five individual colonies from each shRNA-carrying vector were 
picked and plasmid DNA was extracted from these colonies using the 
miniprep kit (see Section 2.1.7). 
2.3.2.4. Diagnostic restriction digest and sequence verification 
Diagnostic restriction digest with SapI or XbaI was then performed to 
identify the positive clones (refer to Section 2.3.2.1 for digestion condition). 
A successful ligation of the shRNA was marked by the loss of SapI, but not 
XbaI, recognition site (refer to Chapter 3 for results). DNA sequence 
integrity was further determined through DNA sequencing 
shRNA sequencing primers (synthesised by Eurofins Genomics):  
F (5’-3’): CAC AGA CTT GTG GGA GAA GC 
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R (5’-3’): CCC CTG AAC CTG AAA CAT AAA)  
2.3.2.5. Maxiprep of pAAV-EGFP-shRNA 
Plasmids from positive clones were then further amplified and 
extracted from bacterial cells using the maxiprep kit (see Section 2.1.8). 
 
Figure 2.2. shRNA cloning site within pAAV-EGFP-shRNA. 
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2.3.3. Construction of pAAV-EGFP_mCherry(DO_DIO)-shRNA 
This Cre-dependent RNAi vector was constructed using elements 
from two plasmids, i.e. pAAV-Ef1a-DIO-mCherry-WPRE-pA (kindly gifted 
by Bernardo Sabatini, Addgene plasmid #37083) and pSico (a gift from Tyler 
Jacks, Addgene plasmid #11578). 
2.3.3.1. Subcloning EGFP (pSico) to pBluescriptII SK+ 
Firstly, the EGFP construct was isolated from pSico and AscI sites 
were introduced at both ends of the gene through PCR-based DNA isolation 
(refer to Section 2.1.1.2) to facilitate ligation to pAAV-Ef1a-DIO-mCherry-
WPRE-pA.  
For this purpose, 1ng of plasmid DNA template was used, and the 
PCR condition consisted of an initial denaturation step at 98˚C for 30 
seconds, 35 cycles (98˚C for 10 seconds, 68˚C for 30 seconds, and 72˚C for 30 
seconds), with a final extension at 72˚C for 10 minutes.  
Primers, with protective sequences (in red), used to isolate EGFP from pSico 
(in black) and introduce AscI sites (in purple): 
F: TAA TTG GCG CGC CTT AGT GAA CCG TCA GAT CCG 
R: TTA TTA GGC GCG CCT TAT GCG GCC GCT ACT TGT 
The PCR product was then electrophoresed on a 1% agarose gel and 
purified (Section 2.1.2), phosphorylated (Section 2.1.3), and stored 
temporarily at 4˚C. 
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Next, pBluescript II SK+, provided by Dr. Majid Hafezparast as 
laboratory stock (University of Sussex), was digested with EcoRV-HF® 
(NEB, R3195) at 37˚C for 1 hour and dephoshorylated to prevent religation 
of the blunt-ended, digested plasmid (refer to Sections 2.1.2 and 2.1.3). The 
linearised plasmid was then run on a 0.5% agarose gel and further purified 
using the gel extraction kit as described in Section 2.1.2.  
The linearised vector and the EGFP insert were ligated as described 
in Section 2.1.4, followed by bacterial transformation for propagation of 
recombinant plasmids (refer to Section 2.1.5). Transformation with 
pBluescript required blue/white colony screening (see Section 2.1.5  for 
details) due to the presence of lacZ within the vector. Successful ligation of 
the insert into the multiple cloning site (MCS) of pBluescript disrupts the 
lacZ sequence, thus leading to a loss of functional β-galactosidase (colonies 
should appear white). If lacZ remains intact and β-galactosidase is 
produced, hydrolysis of X-Gal to form 5-bromo-4-chloro-indoxyl occurs and 
its dimerization produced an insoluble blue pigment, hence the blue colonies 
(Juers, Matthews, & Huber, 2012).  
Plasmid from white colonies were subsequently extracted from the 
bacterial cells using the miniprep kit (refer to Section 2.1.7) and sequence 
integrity was checked through DNA sequencing using (Section 2.1.9) using 
pBluescript KS (5’- CGA GGT CGA CGG TAT CG -3’) and SK (5’- TCT AGA 
ACT AGT GGA TC -3’) primers. 
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2.3.3.2. Subcloning EGFP into pAAV-Ef1a-DIO-mCherry-
WPRE-pA to produce pAAV-EGFP_mCherry(DO_DIO) 
  The EGFP construct (flanked by AscI sites) was isolated from 
pBluescript by restriction digest with AscI (NEB, R0558S) enzyme 
(incubated at 37˚C for 1 hour). The pAAV-Ef1a-DIO-mCherry-WPRE-pA 
was also digested with AscI (Section 2.1.1.3) to permit EGFP insertion into 
the plasmid, then dephosphorylated (Section 2.1.3) to prevent religation.  
Linearised DNA was, then, electrophoresed on a 1% agarose gel and 
extracted from the gel (Section 2.1.2). The EGFP construct was 
phosphorylated by T4 PNK as previously described in Section 2.1.3. The 
linearised mCherry vector and EGFP insert were ligated as described in 
Section 2.1.4, followed by bacterial transformation (refer to Section 2.1.5). 
Next, colony PCR (Section 2.1.6) was performed to identify colonies 
harbouring the recombinant plasmids, as well as to determine size 
(approximately 1kb) and orientation of EGFP (see Figure 2.3), with the 
following primers (5’-3’ orientation):  
F: CAT TAT ACG AAG TTA TGG CGC G  
R: TAT GCG GCC GCT ACT TGT AC 
A positive clone was selected based on the colony PCR outcome and 
the plasmid DNA was extracted by miniprep for sequencing (Section 2.1.7) 
and by maxiprep for subsequent steps (refer to Section 2.1.8). The EGFP 
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sequence was checked by DNA sequencing (Eurofins Genomics), with the 
following sequencing primers (5’-3’ orientation): 
F: GGT AGC TGG ATT GTA GCT GC 
R: TAA TGC AGA AGA AGA GGA TGG G 
 
Figure 2.3. Insertion of the EGFP (with AscI sites) construct into pAAV-
Ef1a-DIO-mCherry-WPRE-pA. 
2.3.3.3. Substituting CMV-EGFP in pSico with a STOP cassette 
In pSico, the presence of CMV+EGFP served to prevent shRNA 
transcription in the absence of Cre and enable visualisation of Cre-negative, 
transfected cells. For our Cre-dependent RNAi vector, we substituted the 
region spanning CMV promoter and EGFP within pSico with a 82-bp STOP 
cassette (synthesised by Eurofins Genomics). The single-stranded DNA 
molecules were annealed as described in Section 2.1.1.1, followed 
phosphorylation of DNA ends (Section 2.1.3). 
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STOP cassette 
Top strand (5’-3’): AAT TCA ACT TGT TTA TTG CAG CTT ATA ATG GTT 
ACA AAT AAA GCA ATA GCA TCA CAA ATT TCA CAA ATA AAG CAT 
TTT TTG C 
Bottom strand (5’-3’): GGC CGC AAA AAA TGC TTT ATT TGT GAA ATT 
TGT GAT GCT ATT GCT TTA TTT GTA ACC ATT ATA AGC TGC AAT 
AAA CAA GTT G 
Next, pSico was digested with EcoRI (NEB, R0101) and NotI-HF® 
(NEB, R3189) at 37˚C for 1 hour to remove CMV+EGFP (refer to Section 
2.1.1.3), dephosphorylated (Section 2.1.3), electrophoresed on a 0.5% agarose 
gel and purified using the gel extraction kit (Section 2.1.2).  
The STOP cassette and pSico vector were ligated as described in 
Section 2.1.4 and the ligated product was transformed into Stbl3 E.coli cells 
(Section 2.1.5).  
Individual colonies were miniprepped to extract plasmid DNA and 
the cloning of STOP cassette into pSico was checked through DNA 
sequencing (refer to Section 2.1.9 for sample preparation).  
Sequencing primers to check the presence of the STOP cassette and its 
sequence integrity (5’-3’): 
F: AGT TTG GTT AGT ACC GGG CC 
R: TCG TGA AGC GAG CTT ATC GAT A 
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2.3.3.4. Construction of the pAAV-EGFP_mCherry(DO_DIO)-
shRNA template plasmid 
Next, a region spanning the mU6 promoter, the STOP cassette, and 
the shRNA cloning site within pSico (insert DNA) was amplified by PCR 
(refer to Section 2.1.1.2) with the following primers (5’-3’): 
F: AGT TTG GTT AGT ACC GGG CC 
R: TCG TGA AGC GAG CTT ATC GAT A 
The PCR cycle condition for this consisted of an initial denaturation step at 
98˚C for 30 seconds, 35 PCR cycles (98˚C for 10 seconds, 55˚C for 30 seconds, 
and 72˚C for 30 seconds), with a final extension at 72˚C for 10 minutes. PCR 
products were purified by agarose gel electrophoresis on a 1% gel, followed 
by gel extraction (Section 2.1.2), and phosphorylated by T4 PNK (Section 
2.1.3). 
The pAAV-EGFP_mCherry(DO_DIO) vector was then digested with 
EcoRV-HF® (37˚C incubation for 1 hour), dephosphorylated (Section 2.1.3), 
then purified by agarose gel electrophoresis on a 1% gel, followed by gel 
extraction (Section 2.1.2).  
The linearised vector and the insert, containing mU6, STOP cassette, 
and the shRNA cloning site, were ligated and chemically transformed into 
Stbl3 cells as previously described (Sections 2.1.4 and 2.1.5). Colony PCR 
(1832bp product size; Section 2.1.6) was then performed to determine 
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positive clones (i.e. recombinant plasmids with the insert positioned in the 
right orientation) with the following primers (5’-3’): 
F: CGC ACC ATC TTC TTC AAG GAC GAC 
R: TCG TGA AGC GAG CTT ATC GAT A 
Recombinant plasmids (Figure 2.4) were extracted from the bacterial 
cells using the miniprep kit for DNA sequencing and using the maxiprep kit 
for the subsequent steps.  
Primers used for sequence confirmation (5’-3’): 
F: AGT TTG GTT AGT ACC GGG CC 
R: TCG TGA AGC GAG CTT ATC GAT A 
 
Figure 2.4. Construction of pAAV-EGFP_mCherry(DO_DIO)-shRNA 
template vector. A region spanning mU6 promoter, STOP cassette, and the 
shRNA cloning site from the modified pSico (refer to Section 2.3.3.3) was 
subcloned into pAAV-EGFP-mCherry(DO_DIO). 
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2.3.3.5. Construction of pAAV- EGFP_mCherry (DO_DIO)-
shRNA (final plasmid) 
The design of the shRNA (shα2(A) and shScr) used for the Cre-
dependent pAAV is described in Section 2.3.1. The single-stranded shRNA 
oligonucleotides were annealed and phosphorylated as previously outlined 
in Sections 2.1.1.1 and 2.1.3. 
The pAAV-EGFP_mCherry(DO_DIO)-shRNA template plasmid was 
digested with HpaI (NEB, R0105) at 37˚C for 1 hour (refer to Figure 2.5) 
and dephoshphorylated to prevent religation (Sections 2.1.1.3 and 2.1.3). 
The linearised plasmid was purified by agarose gel electrophoresis on a 0.5% 
agarose, followed by gel extraction (see Section 2.1.2). 
The vector and shRNA insert was ligated and chemically transformed 
into Stbl3 cells as previously outlined in Sections 2.1.4 and 2.1.5. Colony 
PCR was then performed to identify recombinant plasmids carrying the 
shRNA insert in the orientation with the following primers (5’-3’): 
F (shRNA-specific primer): AGC CTT GTT TGA AGA CTT CA (for shα2) or 
AGC CTT GTT TAT ATA GGG AT (for shScr) 
R: TCG TGA AGC GAG CTT ATC GAT A 
Recombinant plasmids were extracted from the bacterial cells using 
the miniprep kit for DNA sequencing and using the maxiprep kit for 
subsequent experiments and rAAV production. The following primer pair 
was used to check sequence integrity of the ligated shRNA (5’-3’): 
112 
 
F: AGT TTG GTT AGT ACC GGG CC 
R: TCG TGA AGC GAG CTT ATC GAT A 
 
Figure 2.5. shRNA cloning site within pAAV-EGFP_mCherry(DO_DIO)-
shRNA 
 
2.4. In vitro assays of pAAV functionality and shRNA potency 
2.4.1. Assaying the knockdown potency of Gabra2-targeting 
shRNA constructs 
Prior to the start of the experiment, the amount of pCMV-Gabra2 
(Origene, MR225561) was amplified through bacterial chemotransformation 
113 
 
(grown in kanamycin-containing media) and the plasmid was extracted from 
the cells using the maxiprep kit as described in Sections 2.1.5 and 2.1.8. 
Figure 2.6 illustrates the co-transfection conditions. All experimental 
conditions were set up in triplicates. Each well of cells was co-transfected 
with mouse Gabra2 cDNA-containing plasmid DNA and pAAV-EGFP-
shRNA containing either shα2(A), shα2(B), or the shScr control at a 1:3 ratio 
(125ng Gabra2 cDNA + 375ng shRNA-containing plasmid), or sterile ddH2O 
(negative control) using Lipofectamine 3000 as described in Section 2.2.4. 
Next, cells were fixed in 4% PFA and immunofluorescent analyses of EGFP 
expression to probe for transfection efficiency and mouse α2 expression to 
probe the knockdown efficacy of the shα2 constructs relative to the control 
condition (co-transfection with Gabra2 cDNA and shScr) were performed as 
described in Section 2.2.5. For this purpose, cells were stained with the 
Chicken Anti-GFP (1:2000) and Rabbit Anti-α2 (1:500) primary antibodies. 
Secondary labelling with Donkey Anti-Chicken CFTM 488 (1:500) and Goat 
Anti-Rabbit Alexa Fluor 568 (1:500) was performed (refer to Table 2.2 for 
details). Quantitative assays of fluorescence intensity are described in 
Section 2.12.1 
114 
 
 
Figure 2.6. Co-transfection conditions. HEK293 cells were transfected with 
pCMV-mGabra2-Myc and pAAV-EGFP-shRNA in a 24-well plate setup. 
2.4.2. Assaying the efficacy of the Cre-dependent pAAV-
EGFP_mCherry(DO_DIO)-shRNA 
In this experiment, we assessed the functionality of the Cre-
dependent switch of the fluorescent markers (i.e. EGFP and mCherry) and 
the functionality of the silencing (i.e. shα2(A)) construct. Note that prior to 
the start of the experiment, the amount of pAAV-Ef1a-Cre (kindly gifted by 
Karl Deisseroth, Addgene #55636) was amplified through bacterial 
chemotransformation (grown in ampicillin-containing media) and the 
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plasmid was extracted from the cells using the maxiprep kit as described in 
Sections 2.1.5 and 2.1.8. 
HEK293 cells were seeded in a 24-well plate (on glass coverslips) and 
co-transfected with pAAV-EGFP-mCherry(DO_DIO)-shRNA, harbouring 
shScr or shα2 (214ng), pCMV-gabra2 (71ng), and pAAV-EF1α-iCre (214ng) 
at a 3:1:3 ratio using Lipofectamine 3000 (refer to Section 2.2.4). All 
experimental conditions were set up in triplicates (refer to Figure 2.7 for the 
experimental setup).  
 
Figure 2.7. Co-transfection conditions (for two separate staining 
experiments) to assess the functionality of the RNAi Cre-dependent pAAV.  
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Two separate staining experiments were performed. Firstly, to assess 
whether the fluorescent switch was mediated by Cre recombinase, cells were 
stained with the Rabbit Anti-GFP (1:1000), Chicken Anti-mCherry (1:1000), 
and Mouse Anti-Cre (1:600) primary antibodies. Secondary labelling was 
then performed with Goat Anti-Rabbit Alexa Fluor 488 (1:500), Goat Anti-
Chicken Alexa Fluor 568 (1:500), and Goat Anti-Mouse Alexa Fluor 647 
(1:500) (Section 2.2.5)  
Secondly, to assess the Cre-dependent shα2-induced Gabra2 
knockdown, immunocytochemical staining was performed, whereby cells 
were stained Chicken Anti-mCherry (1:1000) and Rabbit Anti-α2 antibodies 
(1:500), followed by secondary labelling with Goat Anti-Chicken Alexa Fluor 
568 (1:500) and Goat Anti-Rabbit Alexa Fluor 647 (1:500) (refer to Section 
2.2.5). Quantitative measurements of α2 knockdown are described in Section 
2.12.1. 
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Table 2.2 
Primary Antibodies 
Antibody Dilution Source 
 
ICC IHC 
 
Chicken Anti-GFP 1:1000 1:10,000 Abcam 
(RRID:AB_300798) 
Rabbit Anti-α2 1:500 1:1000 Synaptic Systems 
(RRID:AB_2108839) 
Rabbit Anti-GFP 1:1000 1:10,000 Abcam 
(RRID:AB_303395) 
Chicken Anti-
mCherry 
1:1000 1:6000 Abcam 
(RRID:AB_2722769) 
Mouse Anti-Cre 1:600 1:2000 Millipore 
(RRID:AB_2085748) 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2.2. A list of the primary and secondary antibodies used for 
immunocytochemical and immunohistochemical analyses in this thesis.
Secondary Antibodies 
Antibody Dilution Source 
 
ICC IHC 
 
Donkey Anti-Chicken 
CF 488 
 
 
Sigma-Aldrich 
(RRID:AB_2631230) 
Goat Anti-Rabbit AF 
568 
ThermoFisher 
(RRID:AB_143157) 
Goat Anti-Mouse AF 
647 
Abcam (ab150119) 
Goat Anti-Rabbit AF 
488 
Abcam 
(RRID:AB_2630356) 
Goat Anti-Chicken AF 
568 
Abcam (ab175477) 
Goat Anti-Rabbit AF 
647 
Abcam 
(RRID:AB_2714032) 
1:500  
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2.5. Recombinant AAV (rAAV) production  
2.5.1. Plasmid preparation 
The pAAV-RC, containing the viral rep and cap genes, and pHelper, 
carrying the adenovirus E2A, E4, and VA RNA genes, from the AAV Helper-
Free System (Stratagene, 240071) were provided by Dr. Ralph DiLeone 
(Yale University). These plasmids were amplified by bacterial 
chemotransformation and the DNA was extracted using the maxiprep kit 
(Sections 2.1.5 and 2.1.8). The concentration of each of these plasmids and 
the pAAV expression vectors (i.e. pAAV-EGFP-shRNA and pAAV-
EGFP_mCherry(DO_DIO)-shRNA) was adjusted to 1µg/µl in TE buffer (pH 
7.5) prior to rAAV production. 
2.5.2. Preparing the HEK293 cells 
Forty-eight hours before transfection, HEK293 cells were seeded into 
30× 10cm dishes so that they were confluent on the day of transfection (refer 
to Section 2.2 for recovery and maintenance of HEK293 cells). Cells with a 
low passage number (<5) were used for transfection.  
2.5.3. Transfecting HEK293 cells 
For rAAV production, calcium phosphate transfection method was 
used. For each dish, 10µg (10µl) of each plasmid (pHelper, pAAV-RC, and 
pAAV expression vector) was added to a 15ml conical tube. Next, 1ml of 
0.3M CaCl2 (Sigma-Aldrich, 449709) was added to the DNA mixture and 
mixed gently. Then, 1 ml of 2× HEPES-buffered saline [280 mM NaCl 
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(Sigma-Aldrich, S3014), 1.5mM Na2HPO4 (Sigma-Aldrich, 255793), 50mM 
HEPES (Sigma-Aldrich, H3375), pH adjusted to 7.10 with NaOH] was 
added to a second 15ml conical tube. The 1.03ml of DNA-CaCl2 mixture was 
then added to the 2× HBS solution dropwise and the solution was mixed by 
inverting the tube twice. The solution was then immediately applied to the 
dish of HEK293 cells in a dropwise manner while swirling the dish gently. 
The dish was returned to the 37˚C incubator (5% CO2) for 6 hours. Note that 
the precipitate (small grains about the size of bacteria) should be visible 
approximately 1 hour after transfection. Six hours post-transfection, the 
medium was replaced with 10ml of fresh growth medium. The dishes were 
then incubated for 72 hours before harvesting the rAAVs. 
2.5.4. Harvesting rAAVs 
Seventy-two hours post-transfection, the colour of the growth medium 
turned yellow and a large amount of cell death was observed. Growth 
medium and cells were collected from the dishes by scraping the cells off the 
dish using cell scrapers (Thermo Scientific, 179693) and transferred into a 
50ml conical tube. Four dishes were harvested at a time into the same 50ml 
tube for each rAAV and the cells were pelleted by centrifugation at 250g for 
5 minutes at 20˚C. These steps were repeated until cells from all 30 dishes 
were pelleted.  
 Next, the pellet was resuspended in 8ml of lysis buffer (refer to Khan, 
Hirata, & Russell, 2011 for recipe) and subjected to two rounds of freeze-
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thaw cycles in dry ice/ethanol bath and in a 37˚C water bath. The pellet was 
then stored at -80˚C until virus purification.  
2.5.5.  rAAV purification  
The rAAVs in the present research was purified using the Iodixanol 
gradient purification method as described in the Khan et al. (2011) protocol. 
2.5.6. Titering purified rAAV stocks 
The rAAV stocks used in this thesis were purified according to the 
McClure et al. (2011) protocol. However, following cell fixation and prior to 
cell counting, transduced HEK293 cells were stained with the Rabbit Anti-
GFP primary antibody (1:1000), followed by secondary labelling with Goat 
Anti-Rabbit Alexa Fluor 488 (1:500) (refer to Table 2.2 for further details on 
antibody dilutions).  
2.6. Animals 
Dopamine receptor D1- or D2-specific Cre recombinase hemizygous 
mice (strain name; D1-Cre = Tg(Drd1-cre)EY217Gsat; D2-Cre = Tg(Drd2-
cre)ER44Gsat), supplied by Mutant Mouse Regional Resource Centers 
(MMRRC), were maintained at the University of Sussex by breeding D1-Cre 
or D2-Cre mice with wild-type (WT) C57BL/6 obtained from Charles River 
Laboratories. Some of the experimental WT mice used in this thesis were 
obtained from Charles River Laboratories (refer to specific experiments for 
more details on the number of animals used).  
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All mice were 7-8 weeks old at the start of experiments. They were 
housed under a 12-hour light/dark cycle (lights on at 7:00 A.M.), at the 
maintained humidity level of 50±5% and temperature of 21±2˚C. During 
Conditioned Reinforement (CRf) experiments (refer to Chapters 4 and 5), 
mice were food-restricted to 85%-90% ad libitum body weight one week 
before and throughout the behavioural experiment. All experiments were 
carried out in accordance with the United Kingdom (Home Office) Animal 
Act 1986. 
2.7. Genotyping 
2.7.1. DNA extraction 
Mouse ear punches were collected and digested in a 20µl solution 
containing Proteinase K (1mg/ml final concentration, Roche, RPROTK-RO), 
20mM Tris HCl (Sigma-Aldrich, 857645), and 10mM EDTA (Sigma-Aldrich, 
EDS) lysis buffer. Each solution was overlayed with two drops of mineral oil 
(Sigma-Aldrich, M5904), prior to incubation at 55˚C for 2 hours and at 95˚C 
for 15 minutes in a thermocycler. Extracted samples were then diluted in 
100µl RNase-free H2O (Invitrogen, AM9932).  
2.7.2. PCR 
A pair of Cre primers were used to confirm the presence (or absence) 
of Cre (102 bp product) in D1- and D2-Cre mouse lines.  
PCR primers used for Cre detection (5’-3’): 
F: GCG GTC TGG CAG TAA AAC TAT C 
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R: GTG AAA CAG CAT TGC TGT CAC TT 
PCR was performed using the Megamix Blue PCR mastermix (Microzone, 
2MMB) according to the manufacturer’s protocol (with 0.5µl of extracted 
DNA in each reaction). Solutions were overlayed with two drops of mineral 
oil, then incubated at 95˚C for 5 minutes (initial denaturation step), followed 
by 35 PCR cycles (95˚C for 30 seconds, 55˚C for 30 seconds and 72˚C for 1 
minute), and incubation at 72˚C for 10 minutes (final extension step). 
2.7.3. Agarose gel electrophoresis and DNA visualisation 
PCR products were electrophoresed on a 1.5% agarose gel as 
described previously (Section 2.1.2) alongside a 100bp ladder. Gels were 
imaged using the UV transilluminator. 
2.8. Stereotaxic viral injection 
One day before surgery (and for 3 days post-surgery or until no pain 
symptoms present), Metacam (Meloxicam, Boehringer Ingelheim) was 
administered orally in wet mash.  
Prior to the surgical procedure, mice were anaesthetised with a 
gaseous mix at 1L/min flow rate (70% O2, 50% N2O), containing isoflurane 
(Abbott Laboratories). Anaesthesia was induced using 3% isoflurane for 
around 3 minutes and maintained at 1-1.5% to keep the animal at a surgical 
plane. Once anaesthetised, mice were mounted onto the stereotax (Kopf 
Instruments) and stereotaxically infused with 1μl (0.5μl per side) of either 
saline or rAAV vectors expressing shScr or shα2, bilaterally into the NAc 
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core (coordinates AP 1.18; L+/-1.00; DV -4.20), shell (coordinates AP 1.18; 
L+/-0.50; DV -4.50), or into the dorsal striatum (coordinates AP+1.18, L+/- 
1.00, DV -3.30). Viral infusion was carried out using 33-gauge steel infusers 
(Cooper’s needleworks) connected to 5μl Hamilton Gastight syringes via 
polyethylene tubing (Harvard Apparatus) at a rate of 0.2μl per minute for 
five minutes, and infusers were left to settle for additional five minutes. 
Infusers were gently removed and the scalp incision was closed with a non-
absorbable, sterile polypropelene surgical suture (Ethicon, W8871T).  
2.9. In vivo assays of α2 knockdown with the rAAV vectors 
2.9.1. Knockdown of α2 expression with rAAV-EGFP-shα2  
2.9.1.1. Stereotaxic viral injection 
Two groups of mice were used in this experiment, bilaterally injected 
with rAAV-EGFP-shScr (n = 7) or rAAV-EGFP-shα2(A) (referred to as shα2; 
n = 8) into the NAc core (coordinates: AP +1.18, L ±1, DV +4.20 (Paxinos and 
Franklin, 2001). The procedure for stereotaxic viral injection is described in 
Section 2.8. 
2.9.1.2. Immunohistochemical analysis  
Four weeks post-surgery, four animals from each group were deeply 
anaesthetised with 200mg/kg sodium pentobarbital and transcardially 
perfused with ice-cold 1× PBS for 5 minutes, then with 4% PFA (Sigma-
Aldrich, P6148) in PBS for 20 minutes. Brains were removed, then further 
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fixated in 4% PFA overnight and cryoprotected in 30% in sucrose-PBS 
solution. Next, brains were frozen in crushed dry ice. 
Coronal sections (30µm in thickness) were prepared using a Leica 
CM1900 cryostat. Sections, containing the striatum, were free-floated in 1× 
TBS (50 mM Tris-Cl (Sigma-Aldrich, 93352), pH 7.6; 150 mM NaCl) were 
rinsed twice in TBS for 1 minute each with gentle agitation, blocked in 5% 
normal goat serum (Vector Laboratories, S-1000) in 0.2% Triton X-100 TBS 
(TBS-Tx). The sections were then stained overnight at 4˚C in the Chicken 
Anti-GFP (1:10000) and Rabbit Anti-α2 (1:1000) antibodies in TBS-Tx. 
Sections were rinsed three times (five minutes each) with TBS to remove 
excess primary antibodies prior to secondary labelling with Donkey Anti-
Chicken 488 (1:500) and Goat Anti-Rabbit 568 (1:500) for 2 hours. This and 
the following steps were performed in the dark given the light sensitive 
nature of the fluorophores. Sections were then mounted onto Superfrost 
slides (Cole-Parmer, WZ-48512-00) with Fluoroshield. Images were captured 
using the Leica TCS SP8 confocal system attached to a DMI 6000 AFC 
Inverted Motorised Research Microscope at 20x magnification (zoom factor 
1), and analysed in Fiji. 
2.9.1.3. Quantitative reverse transcriptase PCR (qRT-PCR) 
mRNA analysis 
2.9.1.3.1. Preparation of tissue samples and phase separation 
Four weeks post-surgery, brains of three mice injected with shScr-
containing rAAVs and those of four mice injected with rAAV-EGFP-shα2 
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were dissected and tissue samples from the NAc were collected using a 
1.5mm biopsy punch (Kai Medical Inc., BP15F).  
Accumbal punches were homogenised in 600µl of Trizol (Invitrogen, 
15596026) and 200µl of RNAse-free H2O (Invitrogen, AM9932). Chloroform 
(160µl; Sigma-Aldrich, 528730) was then added to the homogenised sample 
and phase separated in a peqGOLD PhaseTrap A phase-lock tube (PEQLAB) 
by centrifugation for 15 minutes. 
2.9.1.3.2. RNA precipitation 
The nucleic acid-containing aqueous layer was decanted into a new 
1.5ml Eppendorf tube, then mixed with isopropanol (Fisher BioReagents, 
10284250), 50µl of sodium acetate (Invitrogen, AM9740) and 5µl of glycoblue 
(Invitrogen, AM9516). Each sample was then incubated at -80˚C overnight 
and thawed at room temperature before centrifugation (12,000g) at 4°C for 
20 minutes until a blue RNA pellet was formed. The supernatant was 
discarded and the RNA pellet was washed with 1ml of 75% EtOH (Fisher 
BioReagents, 10041814) for 5 minutes at 4°C. The wash was removed and 
the pellet was left to air dry for approximately 30 minutes before being 
resuspended in 87.5µl of RNase-free H2O. 
2.9.1.3.3. RNA cleanup 
RNA cleanup was performed using the RNeasy MinElute Cleanup Kit 
(Qiagen, 74204) according to the manufacturer’s instructions. The amount 
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and purity of RNA were measured using the Nanodrop 2000 
Spectrophotometer. 
2.9.1.3.4. cDNA synthesis 
The iScript cDNA Synthesis kit (Bio-Rad, 1708891) was used for 
cDNA synthesis with 100ng of each RNA sample according to the 
manufacturer’s protocol. The amount and purity of cDNA were measured 
using Nanodrop 2000 Spectrophotometer. 
2.9.1.3.5. qPCR 
The qPCR assays were performed using the QuantiTect SYBR Green 
PCR kit (Qiagen, 204145) according to the manufacturer’s instructions. 
Sample concentrations were determined based on the serial dilution 
concentration curves and each reaction was set up in triplicate. 1µl of each 
sample was used as the template cDNA (or 1µl of RNase-free H2O as the no 
template control), with 0.3µM of each of the forward and reverse primers 
(GAPDH (housekeeping gene), GFP, and GABAAR α2 subunit primer pairs; 
see Table 2.3). The total reaction volume of each reaction was 20µl. The 
qPCR assay was performed on the Mx4000 multiplex quantitative PCR 
sampler (Stratagene). Quantification of mRNA expression levels is described 
below in Section 2.12.2. Note that the α2 primer pairs were positioned 
upstream of the RNAi-mediated excision site for a more accurate measure of 
gene expression knockdown (Holmes, Williams, Chapman, & Cross, 2010). 
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Table 2.3  
Primer Forward (5’-3’) Reverse (5’-3’) 
GAPDH 
 
TGCCCCCATGTTTGTGA 
TG 
TGTGGTCATGAGCCCTT 
CC 
GABAAR α2 
subunit (Gabra2) 
 
TGGCTGAACAGAGAATCG 
GT  
TCCCAAGCCCATCCTCTT 
TT 
EGFP 
 
CGCACCATCTTCTTC 
AAGGACGAC 
GCGGATCTTGAAGTTCAC 
CTTGATGCC 
mCherry GAACGGCCACGAG 
TTCGAGA 
 
CTTGGAGCCGTACAT 
GAACTG 
 
Table 2.3. Primer sequences used for qRT-PCR assays of RNAi-mediated α2 
knockdown. 
2.9.2. Knockdown of α2 expression with rAAV-
EGFP_mCherry(DO_DIO)-shα2 
2.9.2.1. Confirmation of mouse genotype by in situ hybridisation 
(RNAscope) 
The presence of Cre in either D1R- or D2R-harbouring neurons in D1- 
(n = 3) or D2-Cre (n = 3) mice respectively was assessed by fluorescent in 
situ hybridisation, i.e. RNAscope Fluorescent Multiplex reagent kit 
(Advanced Cell Diagnostics, 320850). The probes used for this assay, 
designed by Advanced Cell Diagnostics, targeted Cre (GenBank accession 
number KC845567.1; Cat no. 312281-C2) and Drd1a (GenBank accession 
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number NM_010076.3; Cat no. 406491-C3) or Drd2 (GenBank accession 
number NM_010077.2; Cat no. 406501) transcripts.  
For this assay, mice were sacrificed by cervical dislocation and the 
brains were removed and rapidly frozen in isopentane (Sigma-Aldrich, 
270342) at -50˚C. Next 10µm striatal slices were prepared using a Leica 
CM1900 cryostat and RNAscope in situ hybridisation was performed as 
previously described (Rubio et al., 2015). The probes were incubated with 
the brain sections at 40˚C for 2 hours. The sections from each genotype (i.e. 
D1- or D2-Cre mice) were hybridised with probes against Cre recombinase, 
and Drd1a or Drd2 transcripts to visualise the presence (or absence) of Cre 
in a specific cell population. Next, they were incubated with the three-step 
preamplifier an amplifier probes prior to incubation with the fluorescently-
labelled probes (Atto 550 and Atto 647). Finally, the slides containing brain 
sections were coverslipped with VECTASHIELD HardSet Antifade 
Mounting Medium with DAPI (Vector Laboratories, H-1500) and imaging 
was performed on the Olympus BX53 microscope (at 20x magnification). 
Images were captured using the QI click camera (Qimaging) attached to the 
microscope, viewed using the iVision software (version 4.0.15, Biovision 
Technologies), and analysed in Fiji. 
2.9.2.2. Immunohistochemical analysis of the Cre-mediated 
fluorescent switch 
D2-Cre (n = 3) and WT (n = 3) male mice were injected with rAAV-
EGFP_mCherry(DO_DIO)-shα2 into the NAc core as previously described in 
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Section 2.8. Four weeks post-surgery, animals were perfused, brains were 
removed, cryopreserved and cut into 30µm sections using a cryostat. 
Sections were then subjected to immunohistochemical analyses as described 
in Section 2.9.1.2. Sections were stained with Rabbit Anti-GFP (1:10,000), 
Chicken Anti-mCherry (1:6000), and Mouse Anti-Cre (1: 2000) primary 
antibodies, followed by secondary labelling with Goat Anti-Rabbit 488 
(1:500), Goat Anti-Chicken 568 (1:500), and Goat Anti-Mouse 647 (1:500). 
2.9.2.3. qRT-PCR analysis 
Five D2-Cre mice, injected with Cre-dependent rAAVs harbouring 
shScr (n = 3) or shα2 (n = 2) were used. The qPCR assay was performed as 
described in Section 2.9.1.3 with GAPDH (housekeeping gene), mCherry, 
and GABAAR α2 subunit primer pairs (refer to Table 2.3).  
2.10. Conditioned Reinforcement  
2.10.1. Animals 
A total of 97 mice were used for the conditioned reinforcement (CRf) 
experiments in this thesis (refer to Table 2.4 for more details). Thirty-nine of 
these mice were obtained from Charles River Laboratories, while the rest 
were bred and maintained at the University of Sussex. All mice were 7-8 
weeks old at the start of the experiment (refer to Section 2.6 for 
maintenance conditions).  
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Table 2.4 
Genotype 
  
Number Breeding 
  Male Female 
Wild-type 39 0 Charles River 
Laboratories 
Wild-type 11 9 University of Sussex 
D1-Cre 11 8 University of Sussex 
D2-Cre 10 9 University of Sussex 
 
Table 2.4. The number and genotype of animals used in the conditioned 
reinforcement experiment (refer to Chapter 4, Figure 4.2 for details on viral 
manipulations). 
2.10.2. Apparatus 
Eight operant chambers (Med Associates Inc.), enclosed in sound-
attenuating boxes, were used to assess conditioned reinforcement. Each 
animal was placed in a single unit, equipped with a food magazine 
delivering sweetened pellets (5TUL; Test Diets, 1811142), two nose-poke 
modules, a tone generator above the food magazine and two LED stimulus 
lights located opposite the nose-poke modules, and a ventilation fan. Head 
entries into the food magazine were detected using an infrared 
photodetector. The number of head entries and/or nose-poke inputs in both 
training and testing phases was recorded using the Med-PC IV software. 
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2.10.3. Drugs 
Cocaine Hydrochloride (Macfarlan Smith, UK) was dissolved in 0.9% 
saline solution to a reach a final concentration of 0, 3, or 10 mg/kg and 
injected into the peritoneal cavity at a volume of 10 ml/kg. 
2.10.4. Stereotaxic viral injection 
Animals were bilaterally injected with the rAAV-EGFP-shRNA 
(Chapter 4) or with the rAAV-EGFP_mCherry(DO_DIO)-shRNA (Chapter 5) 
into the NAc core. The procedure for stereotaxic viral injection surgery and 
coordinates were detailed in Section 2.8. 
2.10.5. Pavlovian Conditioning 
Three weeks post-surgery, all animals received at least one week of 
acclimatisation to food restriction to maintain 85-90% of free-feeding body 
weight, which continued throughout the experiment. Mice then underwent 
10 daily 60-minute Pavlovian training sessions (with no house light 
illumination) in the operant chambers. In each session, two stimuli were 
presented; 16 presentations of 10-second flashing lights and 16 
presentations of 10-second tone. One (CS+) always served to predict food 
delivery, i.e. stimulus commenced five seconds prior to food delivery and 
continued for five seconds after, whereas presentations of the other (CS-) 
yielded no outcome (counterbalanced across animals). The order of stimulus 
presentation was randomly mixed and each stimulus presentation was 
separated by variable inter-trial intervals (i.e. 80-120s between trials). The 
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percentage of magazine entries during the presentations of CS+ or CS- was 
then calculated to provide a measure of Pavlovian conditioning. To ensure 
stable levels of performance, we established a learning criterion (≥80% 
magazine entries during CS+ presentations over the 60-minute session). 
2.10.6. Conditioned Reinforcement  
Following the completion of Pavlovian training, two nosepoke 
modules were introduced in each operant chamber. Mice were trained to 
nosepoke into the ‘active’ module to yield CS+ presentation. Nosepoking into 
the ‘inactive’ module led to CS- presentation (counterbalanced across 
animals). Rates of nosepoke responses for CS+ and CS- were measured 
following i.p. cocaine, ie. 0, 3, and 10mg/kg, in a Latin square arrangement. 
2.10.7. Immunohistochemical analyses of rAAV placement 
2.10.7.1. α2 knockdown in wild-type mice with rAAV-EGFP-shα2 
Immunohistochemical analyses were performed as described in 
Section 2.9.1.2 
2.10.7.2. α2 knockdown in D1-or D2-Cre mice with rAAV-
EGFP_mCherry(DO_DIO)-shα2 
Immunohistochemical analyses were performed as described in 
Section 2.9.1.2. Sections were incubated with Rabbit Anti-GFP (1:10,000) 
and Chicken Anti-mCherry (1:6000) primary antibodies, followed by 
secondary labelling with Goat Anti-Rabbit Alexa Fluor 488 (1:500) and Goat 
Anti-Chicken Alexa Fluor 568 (1:500).  
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2.11. Cocaine-induced locomotor sensitisation 
2.11.1. Animals 
A total of 34 wild-type C57BL/6 mice, bred at Sussex University, were 
used in the sensitisation experiments (males = 16, females = 18) (refer to 
Figure 4.2 in Chapter 4 for more details). All animals were 7-8 weeks of age 
at the start of the experiment (refer to Section 2.6 for details on housing 
conditions).  
2.11.2. Apparatus 
Locomotor activity was measured in 16 annular black Perspex 
runways, with a diameter of 24cm and annulate width of 6.5cm. These were 
placed in a clouded Perspex sheet on an elevated frame. A digital camera, 
positioned underneath the sheet, was used to capture the silhouettes of the 
boxes’ edges and the mice within them. The MatLab (MathWorks, UK) video 
analysis programme and Microsoft Excel macro were used to transform 
video data into a quantitative measure of distance travelled (in meters).  
2.11.3. Drugs 
Cocaine Hydrochloride (Macfarlan Smith, UK) was dissolved in 0.9% 
saline solution to a reach a final concentration of 10 mg/kg and injected into 
the peritoneal cavity at a volume of 10 ml/kg. 
  
134 
 
2.11.4. Stereotaxic viral injection 
Mice in the sensitisation experiments were bilaterally injected with 
shα2- or shScr-containing rAAV-EGFP-shRNA vectors into the NAc core or 
shell (refer to specific experiments in Chapter 4). The stereotaxic viral 
injection surgery is detailed in Section 2.8. 
2.11.5. Locomotor sensitisation to cocaine 
Prior to the sensitisation experiment, all mice underwent two 
habituation sessions on two consecutive days. On the first day, mice were 
habituated to the runway for 60 minutes before being returned to the 
homecages and on the second day, they were habituated to the equipment 
for 30 minutes, then received sham i.p. injections followed by a 60-minute 
habituation session. Subsequently, all mice received repeated treatment of 
10 mg/kg cocaine for 10 consecutive daily sessions. Their locomotor activity 
was recorded for 60 minutes in each session.  
2.11.6. Conditioned activity 
Seven days following the completion of the sensitisation experiment 
described above, all mice received 10 ml/kg saline injections and their 
activity within the runway was recorded for 60 minutes.  
2.11.7. Immunohistochemical analyses of rAAV placement 
Immunohistochemical analyses were performed as described in 
Section 2.9.1.2 
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2.12. Statistical analyses 
2.12.1. Immunocytochemistry/immunohistochemistry 
All fluorescent images from the immunocytochemical and 
immunohistochemical experiments were analysed using Fiji. The potency of 
the shα2 constructs designed in the present research was quantified by 
measuring differences in the average fluorescence intensity (integrated 
density value; IDV) of α2, normalised to the corresponding IDV of GFP or 
mCherry (for the Cre-dependent rAAVs) to control for variations in 
transfection/transduction efficiency in the shα2 condition(s) relative to that 
in the shScr group. Data are presented as the mean fold change ± SEM. 
All statistical analyses described here and in subsequent sections 
were performed using SPSS Statistics 24 (IBM), and data were plotted using 
GraphPad Prism (GraphPad Software). First, a one-way analysis of variance 
(ANOVA) was performed to analyse differences in α2 expression upon 
transfection of HEK293 cells with pAAV-EGFP-shRNA constructs 
harbouring either shScr, shα2 (A), or shα2 (B) with group as the 
independent variable and the normalised α2 IDV as the dependent variable. 
Independent-sample t-tests were also carried out to compare the IDV of α2 
expression (normalised to that of GFP) in accumbal neurons of mice 
transduced with rAAV-EGFP-shα2 and those transduced with rAAV-EGFP-
shScr, as well as to compare the IDV of α2 expression (normalised to that of 
mCherry) in HEK293 cells transfected with shScr- or shα2-harbouring Cre-
dependent pAAVs.  
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2.12.2. qRT-PCR 
Data on the RNA expression level were collected using the Mx4000 
data analysis software (Stratagene, CA, USA), then exported to an Excel 
worksheet. Averaged α2 reaction triplicates were normalised against GFP 
(or mCherry for the Cre-dependent rAAVs) to provide a measure of the delta 
CT. Normalising the CT value of α2 against that of GFP or mCherry would 
account for variations in transduction efficiency of the virus. The delta CT 
value of the accumbal samples obtained from mice injected with the shα2-
containing rAAVs was then normalised against those of mice injected with 
the shScr-containing rAAVs to give a measure of the delta delta CT. Lastly, 
a mathematical model was used to calculate the fold change based on the 
delta-delta CT value (Pfaffl, 2001).Independent t-tests were then performed 
to analyse differences in α2 mRNA levels in the NAc of mice injected with 
the shα2-containing rAAVs relative to those injected with shScr-containing 
rAAVs, with group as an independent variable and delta CT as the 
dependent variable.  
2.12.3. In situ hybridisation (RNAscope) 
Colocalisation of the Cre signal with that of Drd1a or Drd2 visualised 
using the in situ hybridisation technique was quantified by first defining the 
region of interest (i.e. cell nuclei via DAPI staining), then, measuring 
bivariate Pearson’s correlation cefficient of fluorescence intensity (i.e. IDV) 
of Cre and that of Drd1a or Drd2,  given that the expression of Cre is 
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controlled by Drd1a or Drd2 promoters in D1- or D2-Cre mice respectively 
(Gong et al., 2007). 
2.12.4. Conditioned Reinforcement 
2.12.4.1. Pavlovian Conditioning 
Pavlovian conditioning data presented in Chapters 4 and 5 were 
assessed using three-way mixed ANOVAs with groups as the between-
subjects factor, conditioned stimulus (CS; CS+ and CS-) and session as the 
within-subjects factors, and magazine entries as the dependent variable. 
The latency to approach food magazine following CS+ onset was also 
analysed using two-way mixed ANOVAs, with group as the between-
subjects factor and session (1 vs. 10) as the within-subjects factor with the 
latency (in seconds) as the dependent variable. 
Importantly, note that for all ANOVAs described here and throughout this 
thesis, assumptions of normality (Kolmogorov-Smirnov’s test) and 
homogeneity of variance (Levene’s test) were checked. If violated, log-
transformed data were used. The assumption of sphericity was also checked 
and violation of this assumption led to the use of Greenhouse-Geisser’s 
corrected value. 
2.12.4.2. Conditioned Reinforcement  
The baseline rates of nosepoke responses for the conditioned 
reinforcer (CR) and the non-conditioned reinforcer (NCR) presentations 
were analysed using two-way mixed ANOVAs, with stimulus-associated 
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nosepoke modules (i.e. nosepokes) as the within-subject factor, group as the 
between subject factor and the nosepoke responses for the CR vs. NCR as 
the dependent variable.  
The pattern of CR-maintained responding over the 60 minute session, 
broken down in 10 minute time bins, was further analysed using two-way 
mixed ANOVAs with time as the within-subjects factor and group as the 
between-subjects factor, with the number of nosepoke responses in each 10 
minute timebin as the dependent variable. 
2.12.4.3. Cocaine effects on Conditioned Reinforcement 
To assess cocaine effects on responding for CRf, three-way mixed 
ANOVAs were performed with group as the between-subjects factor, and 
cocaine dose and stimulus-associated nosepoke modules (i.e. nosepokes) as 
the within-subject factors. To aid interpretation of the three-way 
interaction, post-hoc two-way repeated measures ANOVAs (with Bonferroni 
correction for multiple comparisons), with nosepokes and cocaine dose as the 
within-subject factors were performed, with the number of nosepoke 
responses as the dependent variable. 
2.12.5. Cocaine-induced Sensitisation 
2.12.5.1. Locomotor response to acute cocaine 
Locomotor response to cocaine was measured by statistical 
comparison of the average distance travelled post sham injection prior to the 
sensitisation procedure and that following the first cocaine injection (i.e. 
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sensitisation day 1). Two-way mixed ANOVAs were performed with group 
as the between-subjects factor and cocaine dose as the within-subjects 
factor, with the distance travelled in meters as the dependent variable. 
2.12.5.2. Sensitisation 
Locomotor sensitisation to cocaine in mice injected with rAAV-EGFP-
shα2 or rAAV-EGFP-shScr, in the NAc core or shell, was analysed using 
two-way mixed ANOVAs with group as the between-subjects factor and 
session (either Session 1 to Session 10, or Sessions 1 and 10) as the within-
subjects factor. The distance travelled in meters was the dependent 
variable. 
2.12.5.3. Conditioned activity 
Conditioned activity following repeated cocaine exposure was 
analysed using two-way mixed ANOVAs with group as the between-subjects 
factor and sham injection (pre- vs. post-sensitisation) as the within-subjects 
factor, and meters travelled in the locomotor runway as the dependent 
variable. 
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Chapter 3  
 
Design and construction of mouse 
Gabra2-targeting RNAi vectors 
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3.1. Introduction 
 
Polymorphic variation of the GABAA receptor α2 subunit-encoding 
gene, GABRA2 (or Gabra2 in the mouse), is a well-established genetic 
marker of alcohol dependence in various populations (Edenberg, Dick, Xuei, 
& Tian, 2004; Enoch, 2008; Matthews, Hoffman, Zezza, Stiffler, & Hill, 
2007; Philibert et al., 2009) and is more recently linked to cocaine addiction 
(Dixon et al., 2010; Enoch et al., 2010). The intronic GABRA2 single-
nucleotide polymorphism (SNP) rs11503014, located within the 5’ 
untranslated region (UTR) of the alternative GABRA2 transcript and 
thought to be implicated in exon splicing, has been associated with cocaine 
addiction particularly in African-American individuals with a history of 
childhood adversity (Enoch et al., 2010). Haplotype analyses of subjects of 
Caucasian origin (with a mix of African and Native American ancestry) 
further indicated that the susceptibility to develop cocaine addiction is 
linked to the SNP rs894269, located in the promoter block approximately 
9kb away from the transcription start site, alongside other markers 
(rs279871, rs279845, and rs279836) within the GABRA2 transcript. A 
protective haplotype, i.e. rs894269 (T), rs2119767 (T), rs929128 (G) 
positioned within the promoter block, has also been identified. Individuals 
carrying this haplotype are approximately 30% less likely to develop cocaine 
addiction, relative to those carrying alternative ones (Dixon et al., 2010). 
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If rs11503014 (or other risk SNPs in the vicinity) is in fact implicated 
in exon splicing, it may influence GABRA2 expression, thus providing a 
potential molecular mechanism by which GABRA2 contributes to the 
development of cocaine addiction. Some support for this interpretation is 
derived from a recent study using the induced pluripotent stem cell (iPSC) 
model, demonstrating that neural cultures derived from GABRA2 
rs279858*C risk allele carriers, previously linked to alcohol dependence, 
displayed significantly lower GABRA2 mRNA expression (Lieberman et al., 
2015). 
Using mice devoid of the GABAAR α2 subunit, we have previously 
established that Gabra2 is not critical for the primary rewarding effects of 
cocaine, but is paramount for its “energising” effects on motivated 
behaviours. Namely, whole-brain deletion of Gabra2 blocked cocaine-
induced locomotor sensitisation and cocaine-potentiated CRf (Dixon, 
Halbout, King, & Stephens, 2014; Dixon et al., 2010). Some of these findings 
have recently been extended to another psychostimulant drug, i.e. 
methylphenidate (Duka et al., 2015). 
Central to mediating these behavioural effects is the 
psychostimulants’ ability to elevate extracellular dopamine concentration in 
the NAc (Kalivas & Duffy, 1993; Parkinson, Olmstead, Burns, Robbins, & 
Everitt, 1999; Williams & Steketee, 2005; Wolterink et al., 1993), where 
GABAAR α2 subunit is the predominant GABAAR (Chen et al., 2007; Dixon 
et al., 2010; Hörtnagl et al., 2013; Pirker, Schwarzer, Wieselthaler, Sieghart, 
& Sperk, 2000). It is thus conceivable that the phenotypic disparities 
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observed between Gabra2 null mutants and the wild-type (WT) counterparts 
might have been attributed to the loss of α2, specifically in the NAc. To 
address this hypothesis, this study sought to develop viral-based RNAi tools, 
which continue to be routinely used to study gene function in discrete brain 
regions (Hommel et al., 2003; Salahpour, Medvedev, Beaulieu, Gainetdinov, 
& Caron, 2007). These molecular tools would not only aid in providing 
further anatomical specificity to our previous knockout data presented in 
the Dixon et al. (2010) study, but would also be valuable for advancing our 
understanding of the functional significance of α2-GABAARs in the brain.  
In concept, the fundamental question that gene knockout- and RNAi-
based studies seek to answer are somewhat aligned, i.e. what is the 
phenotype when gene X is silenced? It is however important to note that 
RNAi downregulates, rather than completely ablates, gene expression to 
varying degrees depending on the efficacy of the silencing construct, i.e. 
si/shRNA, as well as on the proportion of transduced cells, thus yielding 
hypomorphic phenotypes that do not always mirror the loss-of-function 
phenotypes induced by genetic mutations. Thus, in many cases, its 
application serves to complement rather than fully substitute gene targeting 
approaches, e.g. gene knockout, for investigating gene function (Boettcher & 
McManus, 2015; Salahpour et al., 2007). 
As detailed in Chapter 1, the RNAi technology reduces gene 
expression through base-pair interactions between the siRNA and the target 
mRNA, thus inhibiting protein synthesis with an unprecedented degree of 
specificity (Elbashir, 2001; Fire et al., 1998). The high efficacy and success 
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rate of RNAi-induced gene expression silencing has been documented in the 
literature using various cell types, including neurons (Heitz et al., 2014; 
Hommel et al., 2003; Krichevsky & Kosik, 2002). However, a proper 
selection of functional siRNA remains to be one of the most challenging 
aspects of RNAi-based gene silencing and although there is no guarantee of 
a successful knockdown until empirically proven, numerous groups have 
developed siRNA design algorithms in the continuing effort to maximise the 
potentials of RNAi-based gene expression knockdown (for examples, see 
Huesken et al., 2005; Reynolds et al., 2004; Ui-Tei et al., 2004; Vert, Foveau, 
Lajaunie, & Vandenbrouck, 2006). 
Several lines of research to date have employed the Cre-regulated 
RNAi to exert greater temporal and spatial control over gene expression. 
Namely, transcription of shRNA is enabled by the presence of Cre 
recombinase (Cre), thus gene expression knockdown only occurs in Cre-
expressing cells (i.e. CRE-ON system) (Fritsch et al., 2004; Kasim, 
Miyagishi, & Taira, 2004; Ventura et al., 2004). In brief, Cre/Lox 
recombination involves Cre-mediated excision of specific DNA sequences 
flanked by a direct repeat of loxP sites (Sauer & Henderson, 1988). 
Alternatively, if the DNA sequence of interest is flanked by two pairs of 
inverted lox sites (e.g. loxP and lox511 pairs), a one way, Cre-dependent 
genetic inversion (FLEx switch) occurs. Both lox sites are recognised by Cre, 
however, an efficient recombination occurs only between pairs of identical 
lox sites. For instance, lox511 can only recombine with another lox511, 
albeit not with loxP (Schnütgen et al., 2003). To achieve the genetic switch, 
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Cre-mediated recombination may first induce the inversion mediated by 
either loxP or lox511 sites, producing a direct repeat of either loxP or lox511 
pairs. This is then followed by Cre-mediated excision of DNA sequence 
located between the two loxP/lox511 sites, leading to an irreversible switch 
(Figure 3.1). 
 
Figure 3.1. The FLEx switch system (adapted from Schnütgen et al., 2003) 
The α2-containing receptors are preferentially expressed on the 
striatal MSNs, i.e. D1- and D2-MSNs, thought to play somewhat distinct 
roles in motor control and motivated behaviours (Durieux, Schiffmann, & de 
Kerchove d’Exaerde, 2012; Natsubori et al., 2017; Smith, Lobo, Spencer, & 
Kalivas, 2013; Soares-Cunha et al., 2016). It is also therefore of interest to 
investigate cell-type-specific roles of mesoaccumbal α2 and one plausible 
method to address this is by utilising Cre-regulated RNAi tools in either D1- 
or D2-Cre transgenic mice. However, there currently exists no suitable Cre-
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dependent RNAi vector that also permits the visualisation of Cre activity, 
where shRNA activation occurs. This study thus further aimed to construct 
a novel Cre-dependent RNAi vector, which harbours: (i) two fluorescent 
markers (EGFP and mCherry) to enable the visualisation of Cre-positive 
and Cre-negative neurons using the FLEx switch system (A. Saunders, 
Johnson, & Sabatini, 2012; Schnütgen et al., 2003), and (ii) an α2-targeting 
shRNA construct (shα2) or its non-targeting scrambled control (shScr), 
placed under the control of the lox site-containing mutant mouse U6 
promoter  (Ventura et al., 2004). 
Finally, all shRNA vectors generated in the present research were 
packaged into recombinant AAV2 (rAAV2) vectors for targeted delivery into 
the region of interest (mainly the striatal subcompartments). This study 
specifically harnessed the restricted transduction efficiency or viral spread 
(Aschauer et al., 2013) and the preferential neuronal tropism of rAAV2 
(Hsueh et al., 1998) for highly specific targeting of neurons in NAc 
subcompartments, i.e. core and shell.  
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3.2. Experimental design 
In this chapter, we constructed and tested the efficacy of RNAi 
vectors targeting the mouse Gabra2 transcripts (with the non-targeting 
scrambled control). A brief summary of the experimental timeline, 
comprising the design, construction, and assays of the Gabra2-targeting 
RNAi vectors, is depicted in Figure 3.2. 
 
Figure 3.2. An experimental workflow of the rAAV-shRNA design and 
production.    
3.3. Results 
3.3.1. shRNA design 
Figure 3.3A demonstrates the stem-loop structure of the shRNA used 
in the present research (Hommel et al., 2003). The stem portion comprises a 
sense strand, comprising a 24-nt region of the α2 transcript or a scrambled 
control sequence and the corresponding antisense strand. A one-base 
mismatch was introduced in the former, positioned 5’ of the PolyT stretch, to 
aid antisense strand incorporation into the RISC (Hommel et al., 2003). The 
10-nucleotide loop consists of bases with low complementarity to avoid loop 
collapse and non-canonical cleavages (Gu et al., 2012; Li et al., 2007). Two 
shα2 constructs (i.e. shα2(A) and shα2(B)) were designed and tested in the 
present research. The stem portion of the shRNAs comprises 24-nt α2-
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targeting siRNA sequences (i.e. siα2(A) and siα2(B)), which were designed in 
compliance with the Reynolds’ siRNA design algorithm (Reynolds et al., 
2004). The siα2(A) and siα2(B) scored 6 and 7 points based on the algorithm 
respectively. 
Table 3.1 
Sequence  Sense (5'-3') Antisense (5'-3') 
shα2(A) GGA GAC AGT ATT ACT 
GAA GTC TTC 
 
GAA GAC TTC AGT AAT 
ACT GTC TCC 
shα2(B) GGA TGA TGG AAC ATT 
GCT ATA TAC 
 
GTA TAT AGC AAT GTT 
CCA TCA TCC 
shScr GGA TGC TAG AAC ATC 
CCT ATA TGC 
 
GCA TAT AGG GAT GTT 
CTA GCA TCC 
Table 3.1. Sense and antisense siRNA sequences of Gabra2-targeting and 
scrambled shRNA constructs. 
A scrambled hairpin construct (shScr) harbours a non-targeting siRNA 
sequence. A BLAST analysis against the mouse genome revealed that scr is 
unlikely to target α2 transcripts, either by siRNA-mRNA interaction or by a 
miRNA-like seed pairings (Carthew & Sontheimer, 2009; Ellwanger, 
Büttner, Mewes, & Stümpflen, 2011). The list of siRNA sequences used in 
the present research is vsummarised in Table 3.1. 
  
149 
 
3.3.2. Construction of the pAAV-EGFP-shRNA vector 
Each shRNA construct was ligated into the shRNA expression vector 
(i.e. pAAV-EGFP), kindly donated by Ralph DiLeone (Yale University; also 
used in Hommel et al., 2003). To facilitate ligation into the vector, SapI and 
XbaI recognition sites were added to the ends of the shRNA 
oligonucleotides, as illustrated in Figure 3.3B. The loss of SapI site 
represents successful ligation of the shRNA construct into the pAAV-EGFP 
vector. Sequence integrity was then confirmed by DNA sequencing (Eurofins 
Genomics) (Figure 3.3C).  
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Figure 3.3. Construction of pAAV-EGFP-shRNA vector (A) The shRNA 
stem-loop structure. (B) SapI and XbaI recognition sites were added to aid 
shRNA insertion into the pAAV-EGFP vector and (C) successful cloning of 
the construct was initially verified by restriction analysis (i.e. loss of SapI 
recognition site). 
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3.3.3. RNAi-mediated silencing of Gabra2 expression 
3.3.3.1. In vitro assays  
An in vitro assay of the shRNA silencing efficacy was performed prior 
to recombinant virus production. For this, human embryonic kidney 293 
(HEK293) cells were co-transfected with pCMV-Gabra2 (a plasmid that 
harbours the mouse Gabra2 cDNA under the control of the CMV promoter) 
and pAAV-EGFP-shRNA vector carrying either shα2(A), shα2(B) or shScr, 
at a 1:3 ratio respectively (Figure 3.4A). Note that each co-transfection 
condition was set up in triplicate. Forty-eight hours post-transfection, cells 
were fixed and immunocytochemical (ICC) analyses of EGFP and α2 
expression were performed to assess the silencing efficacy of the shα2 
constructs. 
The extent of α2 knockdown was quantified by measuring the 
integrated density value (IDV; intensity or mean gray value × area) of α2 
(normalised to the corresponding IDV of GFP to control for variations in 
transfection efficiency) in shα2(A), shα2(B) conditions relative to that in the 
shScr counterpart. Given that scr should not modulate the level of α2 
expression, it was therefore presumed that the normalised α2 IDV in the 
shScr condition was indicative of pCMV-Gabra2 transfection efficiency, thus 
yielding a fold change of 1. Figure 3.4B depicts the mean fold change ± SEM 
of normalised α2 IDV (n = 3) in shScr, shα2(A) and shα2(B) conditions. 
A one-way ANOVA, with Tukey’s correction for multiple comparisons, 
comparing relative α2 expression levels between the experimental 
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conditions revealed a significant main effect of group (F(2,8) = 11.41, p < 
.01). The post-hoc test further indicated that α2 expression in the shα2(A) 
condition was significantly lower (86.37%) than that in the shScr 
counterpart (p < .01), but the difference in α2 expression between the shScr 
and shα2(B) conditions was statistically non-significant (p = .240). Overall, 
these data suggest that shα2(A), but not shα2(B), effectively silenced α2 
expression in vitro and the former was therefore used for subsequent in vivo 
experiments.  
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Figure 3.4. In vitro analyses of shα2 silencing potency. (A) HEK293 cells co-
transfected with pCMV-Gabra2 and pAAV-EGFP-shRNA at a 1:3 ratio. (B) 
Cells transfected with shα2(A), but not shα2(B), displayed markedly less α2 
staining in the immunocytochemical assay relative to the shScr condition. 
Scale bar 100µm. ** p < .01. 
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3.3.3.2. In vivo assays 
For in vivo assays, shScr and shα2(A) (hereafter referred to as shα2) 
were individually packaged into AAV2 capsid proteins to generate 
recombinant AAV2 vectors (i.e. rAAV-shScr and rAAV-shα2) for targeted 
delivery into the brain, with respective viral titres of 1x109 and 5x108 
infectious units/ml. Titres were measured in HEK293 cells using methods 
previously described in the McClure, Cole, Wulff, Klugmann, & Murray, 
(2011) study. 
The functionality of the rAAVs was tested by injecting these viruses 
bilaterally into the NAc core (injection volume of 0.5µl per side) (see Figure 
3.5A for the injection site). Two groups of mice, receiving either rAAV-shScr 
or rAAV-shα2 injection into the NAc core, were used in this experiment. 
Twenty one days post viral infusion, reverse transcription qPCR (RT-qPCR) 
(n = 3-4 per group) and immunohistochemical (n = 4 per group) analyses 
were performed to visualise rAAV transduction profile and/or assess the 
silencing efficacy of shα2 in vivo. 
First, the RT-qPCR analysis was carried out to assess the extent of 
RNAi-induced α2 knockdown at the transcriptomic level. Relative 
expression levels of α2 mRNA (normalised to EGFP to control for 
transduction efficiency) in shScr and shα2 conditions are summarised in 
Figure 3.5B. Current data showed a ~57% shα2-induced downregulation in 
α2 mRNA expression and this difference reached statistical significance, t(5) 
= 2.52, p < .05, one-tailed t-test. 
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By contrast, data from the immunohistochemical (IHC) experiment 
corroborated the ICC data. Using the same method of quantification as the 
ICC experiment described above, the α2 expression was significantly lower 
in the shα2 group than that in the shScr group (70.41% decrease, t(6) = 8.83, 
p < .001) (Figure 3.5C). 
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Figure 3.5. (A) Histological examination of EGFP expression after virus 
infusion into the NAc core (area marked with the red box indicates the 
target injection site; Paxinos & Franklin, 2001) Scalebar 200µm. Analyses of 
α2 knockdown by (B) RT-qPCR and (C) double immunofluorescence (i.e. 
colocalisation of EGFP and α2). Scale bar 20µm *** p < .001. 
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3.3.4. Construction of the Cre-dependent pAAV-
EGFP_mCh(DO_DIO)-shRNA vector 
 
In efforts to study the role of Gabra2 in D1R- and D2R-expressing 
neurons selectively within the NAc, a Cre-dependent shRNA-harbouring 
vector (pAAV-EGFP_mCh(DO_DIO)-shRNA) was constructed from two 
plasmids, i.e. pSico and pAAV-Ef1a-DIO-mCherry-WPRE-pA, kindly 
donated by Tyler Jacks (Massachusetts Institute of Technology; Ventura et 
al., 2004; Addgene plasmid # 11578) and Bernardo Sabatini (Harvard 
University; Saunders et al., 2012; Addgene plasmid # 37083) respectively 
(Figure 3.6A). 
Figure 3.6B summarises the cloning steps for pAAV-
EGFP_mCh(DO_DIO)-shRNA construction in a chronological order. Firstly, 
PCR-based cloning was performed to insert an EGFP construct into pAAV-
Ef1a-DIO-mCherry-WPRE-pA. This would enable the labelling of Cre-
negative (EGFP-ON) and Cre-positive (mCherry-ON) cells in a population of 
transduced neurons. Next, the CMV + EGFP construct within pSico was 
substituted with the 80-bp STOP cassette containing a Poly(T) tail to 
prevent shRNA transcription in the absence of Cre recombinase. The 
shRNA was then inserted at the HpaI site and finally, the region within 
pSico spanning the mU6 promoter to the shRNA was then subcloned into 
the EGFP-harbouring pAAV-Ef1a-DIO-mCherry-WPRE-pA at the EcoRV 
site, yielding a 5092-bp rAAV genome. DNA sequencing was performed after 
each cloning step to check sequence integrity and the presence of mutations. 
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Figure 3.6. (A) Design of and (B) cloning procedures to generate pAAV-
EGFP_mCh(DO_DIO)-shRNA vector. 
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3.3.5. Cre-dependent RNAi-mediated silencing of Gabra2 
expression 
3.3.5.1. In vitro assays 
 
An in vitro analysis of Cre-driven α2 knockdown was performed by co-
transfecting HEK293 cells with pAAV-EGFP-mCherry(DO_DIO)-shRNA, 
harbouring shScr or shα2, pCMV-gabra2, and pAAV-EF1α-iCre (a gift from 
Karl Deisseroth, Stanford University; Addgene plasmid # 55636) at a 3:1:3 
ratio (see Figure 3.7). Cells were fixed 72 hours post-transfection and 
subsequently subjected to immunocytochemical analyses. Firstly, to probe 
whether the molecular switch of the fluorescent markers was successfully 
induced in the presence of Cre, cells were stained with antibodies against 
EGFP, mCherry, and Cre (n = 3 per condition). As illustrated in Figure 
3.8A, mCherry, but not EGFP, co-localises with Cre, suggesting a Cre-
mediated switch of the fluorescent constructs.  
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Figure 3.7. The functionality of the Cre-dependent pAAV was tested by co-
transfecting HEK293 cells with pAAV-EGFP-mCherry(DO_DIO)-shRNA, 
carrying either shScr or shα2, pCMV-gabra2, and pAAV-EF1α-iCre at a 
3:1:3 ratio. 
 
In the following immunocytochemical experiment, cells were stained 
with antibodies against mCherry and α2 (n = 3 per condition) to assess the 
extent of Cre-dependent α2 knockdown. To quantify this, the IDV of α2 was 
normalised to that of mCherry to control for variations in transfection 
efficiency of the Cre-expressing cells. Results are illustrated in Figure 3.8B. 
A t-test comparison between shScr and shα2 manipulations indicated that 
the α2 expression in the latter was significantly lower (82.03%) relative to 
that in the shScr condition, t(4) = 23.06, p < .001.  
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Figure 3.8. (A) A Cre-mediated switch of fluorescent constructs. The 
mCherry-, but not EGFP-positive cells co-express Cre recombinase, 
suggesting a Cre-dependent activation of mCherry. (B) Immunocytochemical 
analysis of Cre-dependent α2 knockdown demonstrated significantly lower 
α2 mRNA expression in cells treated with shα2 relative to those treated 
with shScr. Scale bar 100µm *** p < .001. 
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3.3.5.2. In vivo assays 
Next, the Cre-dependent rAAV harbouring shScr or shα2 (titre = 2-3 
× 108 infectious units/ml) was injected into the NAc core of D2-Cre and wild-
type (WT) mice (n = 3 in each group)to test its functionality in vivo (see 
Figure 3.9A for targeted injection site).  Results from the manual cell count 
revealed that in the NAc core of a D2-Cre mouse, for example, of 118 cells 
counted, 53 and 65 cells stained positive for EGFP and mCherry 
respectively (Figure 3.9B). Figures 3.9C&D depict the representative 
confocal images of EGFP, mCherry, and Cre expression in the transgenic 
and WT mice respectively. As anticipated, the mCherry expression was 
notably absent in the WT brain and thus, its expression only occurred in the 
presence of Cre.  
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Figure 3.9. Immunohistochemical analysis of the Cre-switch dual 
fluorescent system (A) Histological examination of EGFP and mCherry 
expression after virus infusion into the NAc core of a D2-Cre mouse (area 
marked with the red circle indicates the target injection site; Paxinos & 
Franklin, 2001). Scalebar 200µm. (B) Neurons expressing mCherry and 
EGFP are non-overlapping (i.e. no neurons stained positive for both 
fluorophores were detected). (C) The mCherry-, but not EGFP-positive 
neurons were found to colocalise with Cre in the D1- and D2-Cre mice, but 
(D) mCherry and Cre expressions were notably absent in the NAc core of a 
wildtype mouse injected with the Cre-dependent rAAV harbouring shα2, 
collectively suggesting that mCherry expression was dependent on Cre 
activity. Scale bar 50µm. 
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The RT-qPCR assays were then performed to assess Cre-dependent 
knockdown of α2 expression in vivo. Two groups were used in these 
experiments, i.e. D2-Cre mice injected with either shScr- or shα2-harbouring 
Cre-dependent rAAV into the NAc core. Firstly, the RT-qPCR assay 
revealed that the α2 mRNA level (normalised to mCherry) in the shα2 group 
(n = 2) was 35.26% lower relative to that in the shScr (n = 3) condition (t(3) 
= 2.74,  p < .05, one-tailed t-test; Figure 3.10). 
 
Figure 3.10. Quantification of Cre-dependent α2 mRNA knockdown in vivo 
by RT-qPCR.  
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3.4. Discussion 
Since its discovery, RNAi continues to be recognised as a powerful 
tool for inhibition of gene expression. Here we have demonstrated that a 
novel α2-targeting silencing construct effectively silenced α2 expression in 
WT and Cre-expressing cells, further extending RNAi applicability to study 
GABAAR function. While there already exists published data utilising α2-
targeting siRNA vector in the rat (Liu et al., 2011), to the best of our 
knowledge, this study is first to report the use of RNAi strategy to target 
Gabra2 expression in the adult mouse brain. These molecular tools would 
undoubtedly aid future investigations into the functional roles of α2-
GABAARs in various regions as well as in specific cell subpopulations 
through the use of the Cre-dependent RNAi vector developed here. 
3.4.1. The shα2 design and efficacy 
Two shRNA sequences were originally tested for their potency in 
vitro. The 24-nt stem sequences comprised α2-directed siRNAs designed in 
accordance with the Reynold’s algorithm (Reynolds et al., 2004). This 
algorithm was selected for the present research owing to the high reported 
potency of siRNAs generated with this algorithm (i.e. all beyond 50% gene 
expression knockdown, mostly 80% and above), as well as due to the high 
success rate, i.e. generating 29 out of 30 effective RNAi effectors (Reynolds 
et al., 2004). In line with these findings, shα2(A) induced >70% knockdown 
of α2 expression in WT or Cre-expressing cells when tested in vitro and in 
vivo, though our analysis of transcript abundance revealed less robust α2 
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mRNA knockdown in vivo. One potential reason for such discrepancy might 
be the incomplete degradation of target mRNA fragments that persisted 
following RNAi-mediated cleavage, compromising the RT-qPCR detection of 
knockdown. This is, however, unlikely given that the primer pair used to 
detect knockdown in the present research amplified the 5’ mRNA fragment, 
not the 3’ fragment that was reported to accumulate following RNAi 
cleavage possibly due to RNA-protein interactions, thereby acting as 
template for cDNA synthesis (Holmes et al., 2010). Instead, the differences 
in ICC/IHC and RT-qPCR findings might have been driven by the technical 
limitations discussed further below.  
By contrast, the shα2(B) reduced α2 expression only by ~33% relative 
to that in the shScr condition in vitro. This is somewhat surprising as 
siα2(B) exhibited perfect complementarity to the Gabra2 transcript and 
fulfilled more design criteria in the algorithm compared to the siα2(A), 
giving rise to a higher overall score. Firstly, although scr was designed by 
introducing five base mismatches to siα2(B) and previous evidence suggests 
that some mismatches can be tolerated (Du, Thonberg, Wang, Wahlestedt, 
& Liang, 2005), it is unlikely that the shScr induced silencing effects on α2 
mRNA levels, masking shα2(B)-induced knockdown, as the mismatches 
were introduced in the seed region of the siα2(B) to preclude not only 
siRNA-mRNA interaction, but also miRNA-like seed interaction with the α2 
transcripts (Carthew & Sontheimer, 2009; Ellwanger et al., 2011; Jackson, 
Burchard, Schelter, et al., 2006).  
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One potential reason for the low silencing efficacy of shα2(B) could be 
its target position within the α2 transcript. In fact, a large variation in the 
efficacy of siRNAs targeting different sites within the same transcript have 
been reported (Holen, Amarzguioui, Wiiger, Babaie, & Prydz, 2002), leading 
to continuously emerging rules for improvement of siRNA design. In 
addition to the design criteria used in the present study, the target sites for 
both siRNAs in the present research were within the recommended 
parameters defined by previous research (i.e. located at least 100 
nucleotides away from the AUG codon and not within 50-100 of the 
termination codon, also avoiding the UTR regions) (Mocellin & Provenzano, 
2004). However, there exist additional sequence-specific discriminants that 
have been reported to improve mRNA susceptibility to RNAi-induced 
perturbations. These include specific nucleotide preferences, thermodynamic 
characteristics and other sequence features proposed in other design 
algorithms (Huesken et al., 2005; Ui-Tei et al., 2004; Vert et al., 2006), as 
well as local target accessibility or secondary structure (Heale, Soifer, 
Bowers, & Rossi, 2005; Luo & Chang, 2004; Westerhout, Ooms, Vink, Das, 
& Berkhout, 2005). These parameters might have, in part, elucidated 
variations in the silencing efficacy of the α2-targeting shRNAs designed 
here. 
Alternatively, the answer may lie in the inherent variations between 
shRNA- and siRNA-based silencing. It was originally surmised that shRNA 
and siRNA were governed by the same mechanism, thus sequences that 
were effective siRNAs were often placed in the scaffold of shRNA. Recent 
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research however indicated that functional shRNA and siRNA exhibit 
similar, but not identical, target preferences. Namely, functional shRNAs 
display preferences for G/C and A/U at positions 11 and 9 respectively, 
whereas functional siRNAs strongly favour G/C at position 9 (Li et al., 
2007). Intriguingly, the functional shα2(A) and the non-functional shα2(B) 
harbour A and C bases at position 9 respectively, which might somewhat 
explain the low efficacy of shα2(B). Nonetheless, given the small shRNA 
samples used in the Li et al. (2007) study and the lack of existing evidence 
supporting these data, this interpretation should be treated with caution.  
3.4.2. Design and functionality of the Cre-dependent RNAi 
vector 
 
This study further constructed and tested the functionality of a Cre-
dependent RNAi vector to improve the spatial resolution of α2 knockdown, 
i.e. only in a defined cell population (Cre-expressing cells; CRE-ON system) 
within a specified region (Ventura et al., 2004). It also permits two 
fluorescent transgenes to be simultaneously expressed in spatially 
intermingled Cre-expressing and non-expressing cells (Saunders et al., 
2012). Note that mCherry was used in the present research, instead of the 
TdTomato in the Saunders’ Cre-switch vector due to the rAAV genome size 
constraints (Hermonat, Quirk, Bishop, & Han, 1997; Saunders et al., 2012; 
Srivastava et al., 1983). 
Findings from the ICC and IHC analyses consistently demonstrated 
that the FLEx genetic switch was induced only in the presence of Cre, as co-
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localisation between EGFP and Cre was not observed. The ICC data also 
revealed that the shα2 appeared to evoke potent knockdown of α2 expression 
in comparison to the shScr control, when placed under the control of a 
modified form of U6 promoter, which constitutes a TATA-containing 
bifunctional lox site. Such modification was reported to retain WT promoter 
activity, given that the critical elements within the promoter, i.e. proximal 
sequence element (PSE), the TATA box, as well as spacing between PSE and 
TATA (17bp) and TATA and transcription start site (25bp), were preserved 
(Paule & White, 2000; Ventura et al., 2004). Preliminary data generated in 
the present research further confirmed that the disparity in α2 expression 
between the shScr and shα2 co-transfection conditions was likely to be Cre-
dependent as the silencing effect of shα2 was abolished in the absence of 
Cre, i.e. in WT cells (Appendix A), further demonstrating the functionality of 
the STOP cassette to prevent shRNA transcription in the absence of Cre and 
substantiating previous evidence for the lack of effective recombination 
between the three pairs of distinct lox sites, i.e. loxP, lox2272, and lox511 
(Araki, Araki, & Yamamura, 2002; Lee & Saito, 1998; Saunders et al., 2012; 
Schnütgen et al., 2003).  
Nevertheless, comparison of relative mRNA expression by RT-qPCR 
revealed that shα2 appeared to induce marginal silencing effects (< 50%) on 
the α2 mRNA level in the NAc core of D2-Cre mice. This is not surprising as 
only ~50% of the striatal neurons express D2Rs (Gerfen et al., 1990; Gertler, 
Chan, & Surmeier, 2008; Saunders et al., 2012; also shown by the cell count 
data in the present research), thus the degree of α2 knockdown with the 
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Cre-dependent rAAVs should be approximately 50% lower than that 
achieved by rAAV-EGFP-shα2 (also refer to technical limitations outlined 
below). Additional characterisations of total and surface α2 expression 
knockdown in vivo also remain to be performed.  
3.4.3. Conclusions and technical considerations 
To conclude, findings from the present research showed that α2 
expression did not appear to be resilient to RNAi-induced perturbations. 
Nonetheless, the varying abilities of shα2(A) and shα2(B) to evoke 
translational repression may, in part, be explained by our limited 
understanding of RNA-target recognition, as well as the contribution of 
various contextual factors. To further improve the specificity of gene 
expression knockdown, this study also constructed a Cre-dependent RNAi 
vector, which not only harbours a silencing construct for RNAi application, 
but also permits visualisation of the full range of transduced cells (i.e. Cre-
positive and Cre-negative cells) to enable cell-type-specific analyses when 
appropriate.  
Nevertheless, some of the current findings should be interpreted with 
caution due to technical limitations and therefore warrant further 
investigation.  Firstly, using the current measures of α2 knockdown in the 
in-vitro analyses, this study cannot at present eliminate the possibility that 
differences in α2 expression levels might have been an artefactual result of 
variations in the transfection efficiency of the Gabra2-harbouring plasmid or 
the lack of co-localisation of both plasmids within the same host. One 
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plausible way of rectifying this issue would be to utilise a pCMV-Gabra2 
that carries a fluorescent marker, controlled by a separate promoter, to 
which α2 could be normalised as it would serve as a better indicator of its 
transfection efficiency. Though current in vivo assays of α2 knockdown 
should provide a more accurate indicator of shα2’s silencing potency due to 
endogenous α2 expression, a few technical limitations should be noted. 
Firstly, using the SYBR Green RT-qPCR method of assay, the presence of 
dsDNA contaminants in the samples, target abundance, and inaccurate 
targeting of the NAc core might result in overestimation of the target and 
thus, undermine the true suppressive capacity of shα2 (Arvey, Larsson, 
Sander, Leslie, & Marks, 2010; Smith & Osborn, 2009).  
Of equal importance, despite the ubiquitous use of viral vectors for 
delivery of genetic materials in the CNS, creating high viral titres remains 
to be a challenge in rAAV production and is often impeded by viral genome 
sizes (Dong, Fan, & Frizzell, 1996). Lower titres of the Cre-dependent 
rAAVs in the present research could thus be explained by the size of the 
viral transgene (slightly under 5.1 kb), which exceeded the small packaging 
capacity of AAV virions (4.7 kb) (Srivastava et al., 1983). Though there 
exists evidence that the rAAV particles are able to accommodate 900 extra 
nucleotides above the aforementioned wild-type packaging capacity, yielding 
a maximum packaging limit of 5.6 kb (Hermonat et al., 1997), rAAVs have 
been observed to exhibit reduced titres as the genome size increases (Dong 
et al., 1996). To circumvent this issue, one could resort to the use of other 
AAV capsids to generate AAV hybrids in efforts to improve viral spread or 
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transduction efficiency (Aschauer et al., 2013), or opt for the lentiviral vector 
system for the delivery of larger constructs (Kumar, Keller, Makalou, & 
Sutton, 2001). 
Finally, there remains a need for future experiments, such as 
electrophysiological or radioligand binding experiments, to probe whether 
the extent of α2 knockdown achieved in the present research would be 
sufficient to alter α2-GABAAR number. This is fuelled by previous evidence 
that oligomerisation of GABAAR subunits is highly inefficient with less than 
25% of subunits being assembled into pentameric receptors (Gorrie et al., 
1997; also reviewed extensively in Jacob, Moss, & Jurd, 2008).  
Over the past years, tremendous progress has been made to harness 
RNAi pathway as a method to decipher gene functions in various organisms. 
Recent years have also witnessed growing advances in the delivery method 
of RNAi effectors tailored for specific experimental or therapeutic purpose, 
thereby further expanding its utility (Capel et al., 2018; Kannan, 2018; 
Prakash, Malhotra, & Rengaswamy, 2010). Despite the aforementioned 
caveats, the superiority of this approach over the conventional reverse 
genetic approaches continues to make RNAi a method-of-choice in modern 
biology (Silva, Chang, Hannon, & Rivas, 2004). 
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Chapter 4  
 
Effects of GABAAR α2 subunit 
knockdown in the nucleus accumbens on 
cocaine-facilitated conditioned 
reinforcement and locomotor 
sensitisation 
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4.1. Introduction 
The original findings by (Olds & Milner, 1954) that rats would work 
for electrical stimulation to specific brain regions soon propelled the search 
for circuitry and interconnections between areas that underlie reward 
processing. Of these, the nucleus accumbens (NAc) has been demonstrated 
to be a key component of the neural pathway implicated in reinforcement 
and motivational processes (Carelli, 2002; Di Chiara et al., 2004; Mogenson, 
Jones, & Yim, 1980; also refer to Salamone, 2006).  
To date, the NAc continues to receive much attention in the field of 
reinforcement-related research given its unique role as a “limbic-motor 
interface” (Mogenson et al., 1980), integrating and filtering converging 
inputs from cortical and subcortical structures, including the prefrontal 
cortex (Christie, James, & Beart, 1985; Groenewegen, Room, Witter, & 
Lohman, 1982; Sesack & Pickel, 1992) and subcortical structures, including 
the amygdala (French & Totterdell, 2003; Robinson & Beart, 1988), 
hippocampus (Floresco et al., 2001; Kelley & Domesick, 1982), thalamus 
(Berendse & Groenewegen, 1990; Robinson & Beart, 1988), and the VTA 
(Brown et al., 2012; Fallon & Moore, 1978; Hasue & Shammah-Lagnado, 
2002; Van Bockstaele & Pickel, 1995), and subsequently, transmitting this 
information to downstream motor regions that ultimately govern behaviour 
(Mogenson et al., 1980). It is also noteworthy that the NAc core and shell 
subdivisions display functional heterogeneity, due to histochemical and 
input-output pathway disparities (Heimer, Zahm, Churchill, Kalivas, & 
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Wohltmann, 1991; Zahm, 1999; also refer to Chapter 1 for afferents and 
efferents to and from the NAc core and shell).  
Approximately 90-95% of neurons in the NAc are GABAergic, yet the 
role of GABA in mediating cocaine-induced responses remains overlooked. 
Cocaine evokes an array of behavioural effects, many of which are linked its 
ability to increase extracellular dopamine level in the NAc and some of 
these include cocaine-induced locomotor sensitisation (Brenhouse, Montalto, 
& Stellar, 2006; Filip & Siwanowicz, 2001; Kalivas & Duffy, 1990; Kalivas & 
Stewart, 1991; Nakagawa et al., 2011), and its ability to enhance 
conditioned behaviours (Chu & Kelley, 1992; Dixon et al., 2010; Rutsuko Ito, 
Robbins, & Everitt, 2004; Taylor & Robbins, 1986; Wolterink et al., 1993). 
Intriguingly, previous work in our laboratory using mice devoid of the 
GABAAR α2 subunit-encoding gene (Gabra2) established that whole-brain 
ablation of Gabra2 blocked cocaine’s ability to induce locomotor 
sensitisation, as well as to invigorate instrumental responding for CRf 
(Dixon et al., 2010). More recent data investigating the effect of 
methylphenidate further confirmed the latter (Duka et al., 2015), suggesting 
that intact GABAergic functioning at α2-GABAARs is a prerequisite for 
these dopamine-dependent conditioned behaviours.  
Given that the α2-GABAARs are densely expressed in the NAc (Dixon 
et al., 2010; Hörtnagl et al., 2013; Pirker, Schwarzer, & Wieselthaler, 2000), 
the experiments reported here sought to address the standing hypothesis 
that the loss of cocaine specifically in the NAc might have contributed to 
these phenotypes observed in the α2 knockout (α2-/-) mice. We thus 
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examined the effects of RNAi-induced silencing of α2 expression in the NAc 
core and shell on cocaine’s ability to induce locomotor sensitisation, and in 
the NAc core on cocaine’s ability to potentiate CRf. Note that the CRf data 
from the NAc shell manipulation were not presented here due to low sample 
size. 
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4.2. Experimental design 
4.2.1. Conditioned Reinforcement 
This experiment examined whether RNAi-induced silencing of 
GABAAR α2 subunit expression in the NAc core affected the acquisition of 
nosepoking for CRf and its modulation by cocaine. Two groups of mice, 
injected with the shα2- or shScr-harbouring vectors into the region of 
interest (i.e. the NAc core), were used (refer to Figure 4.2C for group 
details). Note that data from NAc shell manipulation were inconclusive and 
thus, not included in this thesis due to small sample size. 
A summary of the experimental procedure is depicted in Figure 4.1. 
In brief, all animals were trained to associate a stimulus, either flashing 
lights or tone (counterbalanced across animals), with food reward for 10 
consecutive days (Pavlovian conditioning, PC). Next, all animals were 
subjected to a conditioned reinforcement (CRf) test session, whereby the 
rates of nosepoking for the food-paired, conditioned reinforcer (CR) and the 
control, unpaired stimulus (non-conditioned reinforcer, NCR) were 
measured. The effects of cocaine (0, 3, and 10mg/kg) on CR- and NCR-
maintained responding were also measured in the present research. 
 
Figure 4.1. An overview of the conditioned reinforcement experiment.  
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4.2.2. Cocaine-induced locomotor sensitisation 
This experiment examined whether RNAi-induced silencing of 
GABAAR α2 subunit expression in the NAc core or shell affected the 
development of sensitisation to cocaine. Two groups of mice, injected with 
shα2- or shScr-containing rAAVs into the NAc core or shell, were used (see 
Figure 4.2C for group details). Sensitisation to cocaine was assessed by 
measuring locomotor activity following repeated, daily cocaine over the 
course of 10 days. Conditioned locomotor activity (with a sham injection) 
was then measured seven days post-sensitisation (refer to Figure 4.7A 
below).  
4.3. Results 
4.3.1. Histological assessments 
To examine the role of intra-accumbal α2-GABAARs in mediating 
cocaine potentiation of conditioned behaviours, viral vectors carrying shα2 
or shScr (rAAV-EGFP-shRNA) were injected in the NAc core or medial shell 
of adult C57BL/6J WT mice, three weeks prior to the start of the 
behavioural experiment. Figure 4.2 depicts the targeted injection sites for 
NAc core (coordinates AP 1.18; L+/-1.00; DV -4.20; Figure 4.2A) and shell 
(coordinates AP 1.18; L+/-0.50; DV -4.50; Figure 4.2B) (Paxinos & Franklin, 
2001). The transduction profile and silencing potency of the rAAV vectors 
used in this study were previously characterised, as detailed in Chapter 3. 
Behavioural results from mice without viral infection or those with 
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inaccurate targeting of intracerebral viral injection into one or the other 
hemisphere were excluded from the analyses (refer to Figure 4.2C) 
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Figure 4.2. Histological assessment of bilateral viral infusions into the NAc. 
Fluorescent immunostaining of EGFP shows rAAV-EGFP-shRNA-infected 
neurons within the (A) NAc core or (B) dorsomedial shell subdivision from 
adult mice, taken approximately 10 weeks after viral injection. Areas 
marked in red indicate the target injection sites. Scalebar 200µm. (C) A 
detailed summary of the experimental groups in the conditioned 
reinforcement and sensitisation experiments. Animals without viral 
infection or with inaccurate viral placement in one hemisphere or the other 
were excluded from the analyses (refer to Chapter 2 for the 
immunohistochemical methodology).  
  
aca 
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4.3.2. The effects of α2 knockdown in the NAc core on 
conditioned reinforcement and its facilitation by cocaine 
 
4.3.2.1. Pavlovian conditioning 
The effect of α2 knockdown in the NAc core on the Pavlovian 
discriminated approach is illustrated in Figure 4.3A, calculated as the 
percentage of magazine entries during the onset of a stimulus associated 
with food delivery (conditioned stimulus, CS+) or the unpaired, control 
stimulus (i.e. CS-). All animals reached the set criterion of 80% magazine 
entries during the CS+ presentations by session 10. On average, the shScr 
and shα2 groups reached 82.3 ±3.30% and 86.3 ±2.35% entries during the 
CS+ period respectively. A three-way mixed ANOVA, comparing the 
percentage of magazine entries during CS+ and CS- presentations between 
the experimental groups across 10 daily sessions yielded a significant three-
way (CS × session × group) interaction (F(9,162) = 2.15, p < .05). These data 
further showed that over time, both experimental groups were more likely 
to approach the food magazine upon CS+, than CS-, onset (i.e. significant 
main effect of CS (F(1,18) = 336.36, p < .001) and session × CS interaction 
(F(9,162) = 36.74, p <.001)). However, there were no differences between 
groups in this particular measure of discriminated approach, either through 
the main effect of group (F(1,18) = 0.49, p = .491), the session × group 
interaction (Greenhouse-Geisser corrected, F(2.51, 45.23) = 0.56, p = .611, ε 
= .279), or through the CS × group interaction (F(1,18) = 0, p = .986).  
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The expression of stimulus-reward learning was further probed by 
analysing changes in the latency to approach the food magazine following 
CS+ onset (CS+ latency) in both experimental groups on sessions 1 vs. 10 
(Figure 4.3B). A food pellet was delivered into the magazine 5 seconds into 
each CS+ presentation. On average, the CS+ latencies for the shScr group 
was 8.74 ±0.26 seconds (session 1) and 4.84 ±0.37 seconds (session 10), 
whereas the CS+ latencies for the shα2 group was 7.86 ±0.50 seconds and 
4.95 ±0.52 seconds on sessions 1 and 10 respectively. An ANOVA comparing 
CS+ latency on sessions 1 and 10 between shScr and shα2 groups indicated 
that the CS+ latency of both groups combined was significantly lower on 
session 10 (estimated marginal means = 4.90 ±0.31 seconds) relative to 
session 1 (estimated marginal means = 8.30 ±0.27 seconds) (F(1,18) = 65.22, 
p < .001). However, there were no differences between groups, either 
through session × group interaction (F(1,18) = 1.33, p = .263) or the main 
effect of group (F(1,18) = 0.93, p = .347). Overall, these data suggest that 
Pavlovian learning with food reward was unaffected by RNAi-induced 
silencing of α2 in the NAc core. 
4.3.2.2. Conditioned reinforcement 
The effect of α2 knockdown in the NAc core on the baseline rates of 
instrumental responding (i.e. nosepoking into a port) for the conditioned 
reinforcer (CR, previously CS+) and for the control stimulus (NCR, 
previously CS-) is depicted in Figure 4.3C. On average, the shScr group 
made 96 ±17.24 and 32 ±3.06 CR and NCR nosepokes respectively, whereas 
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the shα2 counterpart made 110 ±12.74 and 42 ±6.20 CR and NCR nosepokes 
respectively. Note that statistical analyses displayed below were performed 
with the log-transformed data to maintain homogeneity of variance. 
An ANOVA comparing the rates of nosepoking for CR and NCR in both 
groups demonstrated a statistically significant main effect of CS (F(1,18) = 
61.58, p < .001), though neither the main effect of group (F(1,18) = 2.46, p = 
.134) nor the group × CS interaction (F(1,18) = 0.02,  p = .896) was 
significant. These data therefore indicate that α2 knockdown in the NAc 
core had minimal effects on the average total rates of responding solely 
governed by a reward-associated stimulus. The pattern of CR-maintained 
responding across the 60-minute session, broken down in 10-minute time 
bins, also indicated no differences between the experimental groups (i.e. 
non-significant time × group interaction (F(5,90) = 0.35, p = .883). However, 
the main effect of time was statistically significant (F(5,90) = 10.31, p < 
.001), indicating marked time-dependent changes in CR-maintained 
responding, with responding for the CR decreasing over time (Figure 4.3D).  
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Figure 4.3. Effects of α2 knockdown in the NAc core on conditioned 
reinforcement. (A) Both shScr (n = 11) and shα2 (n = 9) groups of mice 
learned the Pavlovian stimulus-reward association to a similar degree, as 
indicated by the level of discriminated approach over the course of 10 daily 
sessions and (B) the amount of time taken (latency) to approach the food 
magazine upon CS+ onset on sessions 1 and 10. (C) The rates of reinforced 
and non-reinforced nosepoke responses during a conditioned reinforcement 
test. Both groups made more nosepoke responses into the reinforced, than in 
the non-reinforced module. Reducing α2 expression in the NAc core affected 
neither the total nor (D) the pattern of the reinforced response rates. Data 
are presented as mean ± SEM. ***p < .001  
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4.3.2.3. Cocaine enhancement of conditioned reinforcement 
The rates of nosepoking for CR and NCR with acute cocaine pre-
treatments, administered in a Latin-square arrangement, are summarised 
in Figure 4.4. Data were log-transformed to maintain homogeneity of 
variance. A three-way mixed ANOVA comparing CR vs. NCR nosepokes in 
different groups pre-treated with multiple doses of cocaine revealed 
statistical significance for the three-way interactions (nosepokes × group × 
dose) (F(2,36) = 4.57, p < .05), as well as for all of the two-way interactions, 
i.e.  dose × group (F (2,36) = 8.15, p = .001), nosepokes × dose (F(2,36) = 6.73, 
p < .01) and nosepokes × group (F(2,36) = 10.88, p < .01) interactions. These 
collectively suggest that the interaction between cocaine treatments and the 
rates of nosepoking for CR and NCR was likely to be affected by 
manipulation of α2 subunit expression in the NAc core. Given the complex 
nature of the three-way interaction, post-hoc analyses of simple main effects 
and interactions within each experimental group were performed. 
Firstly, shScr group made significantly more CR over NCR nosepokes 
regardless of the dose of cocaine administered (i.e. significant main effect of 
nosepokes F(1,10) = 62.76, p < .001) and the stimulant properties of cocaine 
were also evident through a significant main effect of dose (F(2,20) = 33.54, 
p < .001). Importantly, a significant nosepokes × dose interaction, F(2,20) = 
45.90, p = .001) further suggests that cocaine selectively increased 
nosepoking for CRf. Repeated measures ANOVAs (with Bonferroni 
correction for multiple comparisons), conducted to explore cocaine effects on 
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the rates of nosepoking for the CR and NCR separately, revealed significant 
main effects of dose on reinforced nosepokes (F(2,20) = 42.60, p < .001), as 
well as on non-reinforced nosepokes (F(2,16) = 6.58, p < .01), indicating 
dose-dependent increases and decreases in reinforced and non-reinforced 
nosepokes respectively in the shScr group (see Figure 4.4A).  
Similarly, suppressing α2 expression in the NAc core left 
instrumental responding for CRf intact (i.e. a significant main effect of 
nosepokes, F(1,8) = 113.14, p < .001). However, this manipulation 
completely abolished cocaine’s ability to selectively enhance CR-driven 
responding (i.e. a significant main effect of dose, F(2,16) = 7.54,  p < .01 and 
a non-significant nosepokes × dose interaction, F(2,16) = 0.15, p = .865) 
(Figure 4.4B) 
In summary, both experimental groups made more responses on the 
reinforced than the non-reinforced module, regardless of experimental 
manipulations (i.e. cocaine pre-treatment and/or RNAi-induced knockdown 
of α2 expression in the NAc core) introduced in the present research. 
Nevertheless, whilst responding on the CR-associated module was 
selectively enhanced by acute cocaine in the shScr group, it was not in the 
shα2 counterpart. 
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Figure 4.4. Cocaine facilitation of conditioned reinforcement in shScr and 
shα2 groups. (A) Cocaine markedly increased responding for the conditioned 
reinforcer and decreased responding for the non-conditioned reinforcer in 
the shScr group, but (B) yielded no marked effects in the shα2 counterpart.  
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4.3.3. The effects of α2 knockdown in the NAc core and shell on 
cocaine-induced locomotor sensitisation 
Next, two separate experiments (i.e. BS-CORE and BS-SHELL 
experiments) were conducted to probe whether α2 expression in the NAc 
core and/or shell was critical for cocaine-induced locomotor sensitisation (for 
group details. For each experiment, two experimental groups, i.e. shScrCore 
and shα2Core in the BS-CORE experiment, and shScrShell and shα2Shell in 
the BS-SHELL experiment, were used (for group details, see Figure 4.2C). A 
brief summary of the sensitisation experimental timeline is shown in Figure 
4.5A. 
Sensitisation to cocaine was assessed by measuring locomotor activity 
following repeated, daily cocaine over the course of 10 days (Day 3-12) and 
the conditioned activity to the cocaine-associated context was analysed by 
comparing locomotor activity following sham injections pre- and post-
cocaine sensitisation (i.e. Day 2 vs. Day 19). Acute locomotor effects of 
cocaine were analysed by comparing locomotor activity post-sham injection 
(Day 2) and following the first exposure to cocaine (Day 3).  
Locomotor activity in each session is presented as the average 
distance travelled (forward movement) in metres and each session lasted for 
60 minutes. Also, note that one animal from the shα2Core group (BS-CORE 
experiment), as well as four animals, two from shScrShell and two from 
shα2Shell groups, in the BS-SHELL experiment were excluded from the 
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experiment due to inaccurate targeting of either side of the NAc core or 
shell.  
4.3.3.1. Acute locomotor responses to cocaine: Effects of α2 
knockdown in the NAc core or shell  
All groups of mice regardless of α2 manipulation in the NAc displayed 
increases in locomotor activity to acute cocaine (i.e. significant main effect of 
dose in BS-CORE and BS-SHELL experiments, FCORE(1,17) = 19.08, p < 
.001; FSHELL(1,7) = 6.96, p < .05; Figures 4.5B&C). In fact, RNAi-induced 
perturbations of α2 levels in the NAc core or shell did not seem to affect 
acute responses to cocaine when compared to the respective shScr 
counterparts, indicated by statistically non-significant dose × group 
interaction (FCORE(1,17) = 0.02, p = .886; FSHELL(1,7) = 2.08, p = .192)  and 
main effect of group (FCORE(1,17) = 0.08, p = .777; FSHELL(1,7) = 2.22, p = 
.180). 
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Figure 4.5. (A) Timeline of the cocaine sensitisation experiment. (B) 
Reducing α2 expression in the NAc core or (C) in the shell subdivision failed 
to alter acute locomotor responses to cocaine. Data are presented as mean ± 
SEM. *** p < .001 *p < .05 
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4.3.3.2. Sensitisation to cocaine: Effects of α2 knockdown in the 
NAc core (BS-CORE) 
Figure 4.6A displays the effects of repeated, non-contingent cocaine 
administration (10 mg/kg i.p.) on locomotor activity in the shScrCore and 
shα2Core groups. An ANOVA comparing group differences in the locomotor 
responses to cocaine across 10 days revealed a significant main effect of 
session (Greenhouse-Geisser corrected, F(4.95,84.24) = 7.781, p < .001, ε = 
.551), but no significant main effect of group (F(1,17) = 0.74, p = .402) or 
group × session interaction (Greenhous-Geisser corrected, F(4.95,84.24) = 
0.38, p = .863, ε = .551), suggesting that both groups of mice sensitised to 
cocaine to a similar degree. Locomotor sensitisation to cocaine was further 
evidenced by a significant elevation in cocaine-induced responses on session 
10 relative to those on session 1, through a significant main effect of session 
with the estimated marginal means (± SEM) of the distance travelled of 
120.43 ±11.51 metres and 174.90 ±14.53 metres for sessions 1 and 10 
respectively (F(1,17) = 12.53, p < .01) (Figure 4.6C). Intriguingly, there was 
no evidence of conditioned activity in either group, as no differences in 
locomotor activity following sham injections pre- and seven days post-
sensitisation were observed (i.e. non-significant main effect of session 
(F(1,17) = 0.14, p = .716), group (F(1,17) = 0.24, p = .631) or session × group 
interaction (F(1,17) = 0.69, p = .419)) (Figure 4.6E). 
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4.3.3.3. Sensitisation to cocaine: Effects of α2 knockdown in the 
NAc shell (BS-SHELL) 
Figure 4.6B illustrates the effects of repeated, non-contingent cocaine 
administration (10 mg/kg; i.p.) on locomotor activity in the shScrShell and 
shα2Shell groups. The ANOVA comparison of acute locomotor responses to 
cocaine (over 10 sessions) between experimental groups yielded a significant 
main effect of session (F(9,63) = 15.57, p < .001), but the group × session 
interaction was statistically non-significant (F(9,63) = 0.67, p = .734), 
indicating that cocaine-induced sensitisation was evident in both groups. 
Importantly, α2 knockdown in the NAc shell also failed to disrupt cocaine-
induced sensitisation in contrast to observations in the constitutive 
knockout mice (Dixon et al., 2010). Instead, manipulating α2 levels 
specifically in the NAc medial shell appeared to enhance acute responses to 
cocaine, indicated by the significant main effect of group (F(1,7) = 10.95, p < 
.05). This was further confirmed by an ANOVA comparison of locomotor 
responses to cocaine on sessions 1 and 10, through a non-significant group × 
session interaction (F(1,7) = 0.90, p = .375), but significant main effects of 
group (F(1,7) = 9.92, p < .05) and session (F(1,7) = 41.09, p < .001), with 
estimated marginal means of 82.32 ±19.35 metres and 242.66 ±16.58 metres 
for sessions of 1 and 10 respectively (Figure 4.6D). 
In marked contrast to the BS-CORE data, both groups in the BS-
SHELL experiment displayed a significantly higher locomotor activity 
following sham injections post-, compared to pre-sensitisation, with the 
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estimated marginal means of 32.81 ±4.19 metres and 102.54 ±10.32 metres 
pre- and post-sensitisation respectively (i.e. significant main effect of session 
F(1,7) = 76.03, p < .001), thereby providing evidence for conditioned activity 
in the cocaine-associated locomotor chamber (Figure 4.6F). However, no 
group differences were observed, either via group × session interaction 
(F(1,7) = 2.19, p  = .183) or via the main effect of group (F(1,7) = 1.34, p = 
.285). Overall, the current data show that α2 knockdown in the NAc core or 
shell did not disrupt cocaine-induced locomotor sensitisation. Silencing α2 
expression specifically in the NAc shell, however, appeared to enhance the 
acute locomotor effects of cocaine without affecting its conditioned 
behavioural effects.  
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Figure 4.6. Effects of repeated intermittent cocaine (10mg/kg) on locomotor 
activity. (A&C) Knockdown of α2 expression in the NAc core or (B&D) shell 
did not abolish cocaine’s sensitising effects. The shα2Shell (n = 5) mice 
displayed higher acute locomotor responses to cocaine compared to the 
shScrShell (n = 4) group (p < .05). (E) Conditioned locomotor activity was 
notably absent in shScrCore (n = 10) and shα2Core (n = 10) groups in the 
BS-CORE experiment. (F) By contrast, cocaine-sensitised shScrShell and 
shα2Shell groups (BS-SHELL experiment) displayed conditioned activity (p 
< .001), though no between-group differences were observed. Data are 
presented as mean ± SEM. ***p < .001 
  
200 
 
4.4. Discussion 
This study offers an important insight into the interaction between 
dopaminergic and GABAergic systems by demonstrating the functional 
significance of the GABAAR α2 subunit in the NAc in the expression of 
cocaine-induced responses. Namely, RNAi-induced silencing of α2 
expression selectively in the NAc core abolished cocaine’s ability to 
invigorate the expression of a learned behaviour (i.e. nosepoking for CRf), 
though manipulation of α2 in the NAc core or shell failed to affect cocaine-
induced locomotor sensitisation. Instead, α2 knockdown specifically in the 
NAc shell enhanced acute locomotor, but not the conditioned, effects of 
cocaine.  These data thus question the initial hypothesis, also proposed in 
the Dixon et al. (2010) study, that both cocaine’s sensitising and CRf-
enhancing properties may share a common circuitry involving 
mesoaccumbal α2-containing receptors, downstream of the dopaminergic 
pathway.  
Although both of the behavioural models used in this thesis appear to 
engage an overlapping circuitry involving the mesolimbic dopamine system, 
there exists evidence for the mechanistic dissociation between 
psychostimulant-facilitated locomotor sensitisation and CRf. For example, 
the VTA and NAc (especially for cocaine) are key structures for the 
development of psychomotor sensitisation (reviewed in Vanderschuren & 
Kalivas, 2000), whereas psychostimulant enhancement of CRf has been 
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shown to implicate both the NAc and VP (Fletcher, Korth, Sabijan, & 
DeSousa, 1998; Figure 4.7) 
 
Figure 4.7. Dissociation between psychostimulant-facilitated locomotor 
sensitisation and CRf revealed by localised drug administration studies 
(Fletcher et al., 1998; Vanderschuren & Kalivas, 2000).  
 
4.4.1. The effects of α2 knockdown in the NAc core and shell on 
locomotor sensitisation to cocaine 
Emerging evidence to date has implicated the role of GABA in the 
expression of drug-induced locomotor sensitisation. Namely, reducing 
GABAAR-mediated inhibition via whole-brain ablation of Gabra2 and 
optogonetic activation of GABA-expressing neurons in the NAc have been 
shown to block cocaine-induced sensitisation respectively (Dixon et al., 2010; 
Wang et al., 2014). Similarly, decreasing inhibitory tone in the NAc by 
selectively silencing of parvalbumin-expressing FSIs blocked early ad later 
stages of amphetamine-induced locomotor sensitisation (Wang et al., 2017), 
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collectively pointing to mesoaccumbal GABAergic activity as a critical 
substrate underpinning psychostimulant-induced sensitisation. This is 
further substantiated by the Henry & White (1995) study, which detected a 
sensitised response of NAc neurons to iontophoretically applied GABA after 
one day of withdrawal in cocaine-sensitised rats. Nevertheless, it is 
important to note that the mechanism by which deletion of α2-GABAARs 
affects the net neuronal activity and output remains unclear, given the 
varying roles of phasic inhibitory systems depending on the receptor’s 
subcellular localisation (i.e. somatic vs. dendritic localisation) (extensively 
reviewed in Koos, Tepper, & Wilson, 2004; Tepper, Tecuapetla, Koós, & 
Ibáñez-Sandoval, 2010; Tepper, Wilson, & Koós, 2008). Due to the 
hyperpolarised RMP of striatal MSNs, which is more negative than the Cl- 
reversal potential (i.e. ~-60mV), GABA action at GABAARs can have 
excitatory effects on MSN activity. In the MSNs, this is likely to occur when 
GABAergic post-synaptic potentials (PSP) shortly precede glutamatergic 
inputs in a time window of 140ms (with maximum effect reached between 
50-60ms, limiting the influence of shunting effects) (Bracci & Panzeri, 2006; 
also discussed further in Chapter 1). Based on evidence available to date, it 
appears that the blockade of locomotor sensitisation to psychostimulants is 
associated with altered GABAergic control of the NAc neurons.  
Findings from the present research, however, demonstrated that 
reducing GABAAR α2 subunit expression in the NAc core or shell by RNAi, 
potentially dampening phasic inhibitory control of neuronal activity (Dixon 
et al., 2010), did not affect the development of cocaine-induced locomotor 
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sensitisation. This is in line with the widely-accepted notion that the NAc is 
primarily implicated in psychostimulant-induced locomotor hyperactivity, 
but not necessarily in the development of locomotor sensitisation per se (see 
Kalivas & Weber, 1988; Pijnenburg & Rossum, 1973), though note that this 
view was primarily built upon observations on dopaminergic activity. 
Moreover, based on the previous knockout data (Dixon et al., 2010), one 
could posit that suppressing α2 level in the NAc core or shell specifically 
might not be sufficient to induce marked effects on sensitisation. This seems 
unlikely as a study by Engin et al. (2014) demonstrated that targeted α2 
knockdown in the whole NAc using the site-specific Cre/Lox recombination 
technology also failed to produce marked effects on locomotor sensitisation 
to cocaine.  
Virtually all drugs of abuse decrease neuronal firing in the NAc 
(Bourdelais & Kalivas, 1990; reviewed in Wise, 1998) and such decreases in 
accumbal activity have been linked to drug-induced locomotor hyperactivity 
(Henry & White, 1995; Pennartz, Groenewegen, & Lopes da Silva, 1994). 
Slice electrophysiological data also identified decreased synaptic strength at 
excitatory synapses in the NAc shell of cocaine-sensitised mice (Thomas, 
Beurrier, Bonci, & Malenka, 2001). Increasing NAc neuronal activity by 
means described in previous studies might therefore block drug-induced 
sensitisation and mere downregulation, instead of complete ablation, of α2 
subunit in the NAc might not be sufficient to alter NAc activity to an extent 
that would adversely influence cocaine-induced effects that underlie the 
development of locomotor sensitisation. While this remains a plausible 
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speculation, note that in some cases, effects that are masked due to 
compensatory changes in the constitutive knockouts could be more easily 
observed in the knockdowns due to minimal or no compensations (Engin et 
al., 2014). Without electrophysiological evidence, this study cannot 
eliminate the possibility that α2 knockdown might, in fact, induce a larger 
effect on the mIPSC characteristics relative to the knockouts.  
Some of the key regions implicated in the development of 
sensitisation, including the PFC (Yong Li et al., 1999; Wolf et al., 1995) and 
the dorsal hippocampus (Degoulet et al., 2008) harbour high amounts of the 
GABAAR α2 subunit (Hörtnagl et al., 2013). The phenotypic discrepancy 
observed between the current data and those from the α2 constitutive 
knockouts (Dixon et al., 2010) might stem from the absence of α2 in 
region(s) other than the NAc (discussed further in Chapter 6). 
Developmental factors and the extended period α2 deletion are also among 
the variables that are likely to contribute to the loss of sensitisation in the 
α2 knockouts, which are not applicable to gene silencing by RNAi. Overall, 
findings from this study indicate that α2 expression in the NAc core or shell 
is not required for cocaine-induced sensitisation.  
 Conditioning has long been thought to be an important process in 
aiding the expression of sensitisation. In some cases, this form of learning is 
critical for the development of sensitisation (Crombag et al., 2001; Dykman, 
1976; Le Merrer & Stephens, 2006; Mattson et al., 2007). However, in the 
BS-CORE experiment, conditioned activity was not observed using the 
current measure, irrespective of the α2 manipulation, perhaps suggesting 
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that sensitisation might have occurred in a context-independent manner. It 
should be noted that given the lack of saline control groups in the 
sensitisation experiments, the measure of conditioned activity is distinct 
from those typically presented in previous research. Alternatively, one could 
argue that the damage resulting from viral injection into the NAc core 
might have somewhat disrupted context-dependent learning and/or other 
phenotypes that may influence the expression of conditioned activity, such 
as reactivity to novel environment. While the former explanation is unlikely 
given that such procedure induced no effect on other forms of conditioning 
observed in the present research (see CRf discussion below), the latter 
remains a possibility given that NAc lesioned-rats displayed significantly 
higher locomotor activity in a novel environment than the sham controls 
(Burns, Annett, Kelley, Everitt, & Robbins, 1996). The occurrence of such a 
behavioural effect might have masked conditioned activity in the present 
research and thus, elucidated the lack of conditioned locomotor activity in 
both groups. One way of addressing this would be to further habituate the 
mice to the locomotor runways prior to the first cocaine exposure. It is also 
worth noting that dopamine-depleting lesions in the NAc core have 
previously been found to impair conditioned locomotor response (Sellings & 
Clarke, 2006). 
Notably, α2 knockdown in the NAc shell, but not in the core, 
potentiated the acute locomotor effects of cocaine, whilst having no effects 
on cocaine-induced conditioned activity. Complementary to these findings, 
lesion to the dorsomedial shell of the NAc disrupted neither the baseline 
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locomotor activity nor locomotor responses to the initial (acute) exposure to 
cocaine (15mg/kg; i.p.). However, the lesion group exhibited significantly 
lower locomotor activity compared to the sham controls on the fifth (last) 
day of repeated cocaine regimen (Todtenkopf, Carreiras, Melloni, & Stellar, 
2002). Similar findings implicating the importance of NAc shell in 
psychostimulant-induced locomotor hyperactivity were also reported in the 
Parkinson et al. (1999) study. Interestingly, dampening GABAergic activity, 
via local injection of GABAAR antagonist picrotoxin in the NAc, also 
increased locomotor activity, mimicking the effect of intra-accumbal 
dopamine injection (Wachtel & Anden, 1978; Costall & Naylor, 1975; 
Pijnenburg & Rossum, 1973). It is thus conceivable that intact GABAergic 
activity, particularly in the NAc shell, may serve to attenuate 
psychostimulant-induced locomotor hyperactivity such that in a state of 
reduced inhibition, heightened locomotor responses to the drug were 
observed. 
Secondly, the lack of group differences in conditioned activity in the 
BS-SHELL experiment extends previous and current observations that α2-
GABAARs are not essential for mediating the unconditioned properties of 
food and psychostimulant rewards that facilitate conditioning, either in the 
sensitisation, CRf, or in the drug self-administration paradigm (Dixon, 
Halbout, King, & Stephens, 2014; Dixon et al., 2010; also see the CRf 
discussion below).  
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4.4.2. The effects of α2 knockdown in the NAc core on 
conditioned reinforcement and its facilitation by cocaine 
Despite having no effect on cocaine-induced sensitisation, α2 depletion 
specifically in the NAc core abolished cocaine’s ability to invigorate 
instrumental responding maintained by the CR, most likely through GABA 
× dopamine interactions. Corroborating this view is the findings from 
pharmacological and lesion studies, collectively yielding a conclusion that 
the mesolimbic dopamine system does not mediate CRf, but is critical for its 
potentiation by psychostimulant agents (Taylor & Robbins, 1986; Wolterink 
et al., 1993). 
Results from this study also extend existing evidence on cocaine’s 
ability to energise instrumental responding for CRf (Chu & Kelley, 1992; 
Dixon et al., 2010; Macpherson et al., 2016). Namely, the shScr group 
displayed markedly enhanced reinforced nosepoking with cocaine (10 mg/kg) 
pre-treatment. The magnitude of cocaine effect was, in fact, comparable to 
that observed in a separate group of mice receiving sham injection into the 
NAc core to control for both the surgical procedure and activation of the 
RNAi pathway (see Appendix B). 
Firstly, the loss of cocaine facilitation in the shα2 group did not arise 
from their lack of ability to learn stimulus-reward (Pavlovian) or action-
outcome (instrumental) association. Similar findings were also reported 
with the α2 knockouts, suggesting that GABA action α2-containing 
receptors is not required for basic reward-learning processes. In keeping, it 
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has been reported that GABAAR-mediated activity in the NAc, primarily in 
the shell, appears to subserve an inflexible behavioural component of 
feeding that is independent of its incentive motivational property via 
disinhibition of neurons within the lateral hypothalamus (Stratford & 
Kelley, 1997, 1999), as well as the VP (Stratford & Wirtshafter, 2012) that 
mediate motor programs specific to ingestion. This mechanistic pathway is 
thought to bypass inputs that are relevant to food-seeking behaviour, 
including appetitive conditioning. Further, deficits in the acquisition of CRf 
responding were observed only upon selective excitotoxic lesion of the BLA, 
but not in CeA-, NAc core-, or shell-lesioned rats, relative to the respective 
controls (Cador et al., 1989; Parkinson et al., 1999; Robledo, Robbins, & 
Everitt, 1996), implicating the significance of BLA integrity in the 
expression of CR-governed motivated behaviours.  
Importantly, providing anatomical specificity to published data with 
the α2 constitutive knockouts is the finding that intact functioning of α2-
GABAARs specifically in the NAc core is critical for cocaine facilitation of 
CRf. Firstly, note that cocaine enhancement of CRf is not a result of cocaine-
induced increases in general activity, thus eliminating the argument that 
the loss of cocaine’s facilitatory effect on CRf in the shα2 mice was simply 
attributed to insensitivity to cocaine’s motor stimulant effect. The locomotor 
data presented above lend further support to this argument. Alternatively, 
due to the predictive value of the CR (i.e. predicting food delivery), as well 
as the physiological state of the animals at the time of testing, one could 
posit that cocaine might have affected other aspects of food-seeking 
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behaviour in the shα2 group, e.g. increasing conditioned Pavlovian approach 
or goal-tracking responses (Holden & Peoples, 2010), thus masking its CRf-
potentiating effect. This is also unlikely as this study failed to observe 
cocaine-induced potentiation in the rates of magazine entries during the CRf 
sessions (Appendix C). Thirdly, a pilot CRf experiment, performed to 
investigate the effect of α2 knockdown in the DS further questioned the 
possibility that the phenotypes observed in the shα2 group were artefactual 
results of viral leakage in the DS (Appendix D).  
Instead, the answer may lie in the synergistic interaction between 
GABA and dopamine in the NAc, namely, how RNAi-induced 
downregulation of α2 expression affects dopamine action such that cocaine-
evoked increases in extracellular dopamine in the NAc core can no longer 
act as a ‘gain-amplifier’ controlling the vigour of the goal-directed response. 
To date, a few mechanisms by which GABAergic and dopaminergic systems 
interact have been proposed. Firstly, it is now well-established that 
dopamine favours the activation of D1-MSNs but dampens the excitability of 
those harbouring D2Rs (Gerfen & Surmeier, 2011; Harsing & Zigmond, 
1997). At the intercellular level, reducing α2-GABAAR expression may 
interfere with the synaptic communication, i.e. lateral and feedforward 
inhibition, both of which are deemed critical in the manifestation of cocaine-
induced responses, e.g. locomotor hyperactivity and self-administration, to 
name a few (Dobbs et al., 2016; Yu et al., 2017). Alternatively, a recent 
study indicated that midbrain dopamine neurons can inhibit striatal MSNs 
through a non-canonical release of GABA, i.e. via the membrane uptake, not 
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synthesis of GABA (Tritsch, Jun, Ding, & Sabatini, 2012; Tritsch, Oh, Gu, & 
Sabatini, 2014). Though the understanding of the functional relevance of 
GABA co-released with dopamine remains in its infancy, it may be of 
significance when considering the interaction between drug-induced 
elevation in extracellular dopamine and CR-induced firing of dopamine 
neurons, co-releasing GABA and dopamine (Schultz, 1998).  
At the intracellular level, the action of dopamine at D1Rs and D2Rs 
activate and inhibit protein kinase A (PKA) through Gs/Golf and Gi/o 
respectively (Stoof & Kebabian, 1984; also refer to Chapter 1 for more 
details). The GABAAR β1 and β3 subunits are subject to PKA-mediated 
phosphorylation, whereby phosphorylation of the former reduces, whereas 
β3 phosphorylation facilitates GABAergic currents (McDonald et al., 1998). 
D1R stimulation and/or internal PKA application were reported to facilitate 
α5- and δ-containing GABAAR-mediated tonic conductance in the D1-MSNs 
of juvenile and adult mice respectively, whereas D1R- or D2R-stimulation 
marginally prolonged the mIPSC decay kinetics in juvenile mice (Janssen, 
Ade, Fu, & Vicini, 2009; Maguire et al., 2014). It is yet to be determined 
whether dopamine effect on phasic GABA currents is somewhat distinct in 
adult mice and potentially possesses functional significance that may 
underlie some of cocaine’s reinforcing properties.  
Somewhat corroborating the current findings are those presented in 
the (Parkinson et al., 1999) study, which also implicated the NAc core as a 
critical structure for psychostimulant enhancement of CRf. The 
fundamental difference between the current and previous data however lies 
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in the type of manipulations, affecting neuronal activity in a seemingly 
antagonistic fashion. Namely, at a more cellular level, both reducing α2 
expression, thus presumably reducing inhibitory tone and increasing net 
activity (though also note the depolarising effects of GABA in striatal 
neurons discussed above), and the loss of NAc core activity via excitotoxic 
lesion (Parkinson et al., 1999) completely abolished psychostimulant’s 
ability to enhance responding for CRf. In fact, similar observations have 
been observed with agonism or antagonism at AMPA and NMDA receptors 
in the NAc (Burns et al., 1994). Adding to this complexity, lesioning the 
ventral subiculum of the hippocampus (Burns et al., 1993) or CeA (Robledo 
et al., 1996), which provides glutamatergic afferents to the NAc and 
midbrain dopamine neurons respectively also abolished psychostimulant 
potentiation of CRf. Taken together, intact functioning of glutamatergic, 
dopaminergic, and GABAergic transmission in the NAc core, as well as the 
interaction between these subsystems are vital for psychostimulant’s CRf-
potentiating effects. A CRf experiment investigating the consequence of α2 
knockdown in the shell was also carried out but yielded inconclusive results 
due to small sample sizes.  
4.4.3. Conclusions and technical considerations 
To date, our understanding of the exact mechanism underlying the 
relationship between GABA action at α2-GABAARs and the expression of 
cocaine-induced dopamine-mediated behaviours remains rudimentary. This 
study, to the best of our knowledge, is the first to employ viral-based RNAi 
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in efforts to investigate the functional role of α2-GABAARs in mouse models 
and using this method, the results indicated that wild-type expression level 
of GABAAR α2 subunit is critical for cocaine’s CRf-enhancing properties, 
albeit not for reward learning or for cocaine’s sensitising properties. Given 
that whole-brain deletion of Gabra2 also abolished methylphenidate 
potentiation of CRf (Duka et al., 2015), it is plausible to assume that the 
effects of intra-accumbal α2 knockdown could be extrapolated to other 
stimulants though this warrants future investigation.  
Of final note, there are several technical considerations that merit 
consideration in addition to those already mentioned above. Firstly, given 
the lack of evidence pertaining to RNAi-induced reduction in the total 
number of functional α2-containing receptors on the cell surface, caution 
should be exercised when interpreting these data, which assayed only the 
effects of manipulation on the total amount of the α2 subunit expression 
(refer to Chapter 3). This issue could be addressed by performing 
electrophysiological, ligand-binding, or immunohistochemical assays to 
provide a more accurate account of receptor function and/or density. 
Secondly, though one of the strengths of RNAi-induced knockdown is the 
lack of compensatory change, one should take into account the intrinsic 
homeostatic mechanism regulating phasic and tonic inhibition, whereby 
overexpression of extrasynaptic, α5- or α6-GABAARs was found to decrease 
synaptic GABAergic transmission regardless of extrasynaptic receptor 
activation (Wu et al., 2013). Thus, this study cannot at present eliminate 
such homeostatic competition, which might contribute to the observed 
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phenotypes. One plausible way to rectify this limitation would be to 
characterise both phasic activity and tonic conductance in neurons targeted 
by the shRNA-harbouring rAAVs. Overall, findings from the present 
research add to the field by providing a deeper understanding of the role of 
α2-containing GABAARs, specifically in the NAc subregions, in mediating 
some of cocaine-induced responses. 
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Chapter 5  
 
Effects of GABAAR α2 subunit 
knockdown in the nucleus accumbens D1 
or D2 receptor-containing neurons on 
cocaine-facilitated conditioned 
reinforcement  
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5.1. Introduction 
Although the vast majority of neurons within the NAc are 
GABAergic, dopaminergic projections to the accumbens play an important 
role in modulating their function. Dopaminergic activity within the NAc is 
paramount for learning processes related to reinforcement and the exertion 
of effort-related actions (Di Chiara, 1998; Di Chiara et al., 2004; Nowend, 
Arizzi, Carlson, & Salamone, 2001; Salamone, 2006; Salamone & Correa, 
2012; Saunders, Richard, Margolis, & Janak, 2017). Illustrating the former 
is the classic reward prediction error (RPE) model, built upon the 
observations that dopamine neurons fire not only when an animal received a 
reward but also when a previously neutral stimulus has been learned to 
predict its delivery (conditioned stimulus, CS). When a reward is fully 
predicted, the dopamine response to the reward itself disappears, but 
dopamine neurons continue to exhibit larger responses if more than the 
predicted reward occurs (Schultz, Dayan, & Montague, 1997; Schultz, 1998).  
Although the mesolimbic dopamine system has long been thought as 
the biological substrate for reward or hedonia, originally proposed by Roy 
Wise (Wise, 1978), there is a wealth of evidence in the literature challenging 
the traditional tenets of the dopamine hypothesis of reward, thus prompting 
further theoretical development in the field of dopamine research 
(extensively reviewed in Nutt, Lingford-Hughes, Erritzoe, & Stokes, 2015; 
Salamone & Correa, 2012). After decades of investigations, it is now widely 
accepted that the mesolimbic dopamine is, rather, involved in motivational 
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processes (e.g. see Herberg, Stephens, & Franklin, 1976). Behavioural 
measures that were originally thought to measure the hedonic function of 
mesolimbic dopamine, e.g. progressive ratio breakpoints, are now viewed as 
measures of effort-related decision making (Salamone, 2006; Salamone & 
Correa, 2012). It is therefore no surprise that lesions of, or any form of 
interference with the dopaminergic system in the NAc would, to varying 
degrees, affect the ability of psychostimulant drugs to augment the 
expression of motivated behaviours (for examples, see Fritz et al., 2011; 
Parkinson, Olmstead, Burns, Robbins, & Everitt, 1999; Todtenkopf, 
Carreiras, Melloni, & Stellar, 2002). 
Within the NAc, the modulatory action of dopamine is mediated by 
five dopamine receptors, classified into two major categories, i.e. D1-like and 
D2-like receptor classes (D1Rs and D2Rs), that are expressed by largely 
nonoverlapping subpopulations of MSNs (Gerfen et al., 1990; Gerfen & 
Surmeier, 2011). Note, however, that dopamine D2Rs are also found on 
cholinergic interneurons, thus often rendering interpretation of phenotypic 
changes linked to D2R manipulation difficult (Aubry, Schulz, Pagliusi, 
Schulz, & Kiss, 1993; Maurice et al., 2004). All dopamine receptors are G 
protein-coupled and regulate intracellular signalling cascades, serving to 
enhance or dampen neuronal outputs. D1Rs are coupled to Gs/olf proteins. 
The binding of dopamine to D1Rs typically enhances neuronal excitability 
and facilitates long-term potentiation by stimulating adenylyl cyclase 
activity, elevating cyclic adenosine monophosphate (cAMP) and 
subsequently, activating protein kinase A (PKA). PKA has a wide array of 
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targets, including various transcription factors, ion channels, and glutamate 
receptors. In contrast, activation of D2Rs, coupled to the Gi/o proteins, 
inhibits adenylyl cyclase, triggers the activation of K+ channels, and the 
modulation of numerous ion channels, collectively dampening cell 
excitability and the facilitation of long-term potentiation (Neve, Seamans, & 
Trantham-Davidson, 2004; Stoof & Kebabian, 1984). 
The conditioned reinforcement (CRf) paradigm has long been 
considered to provide a stringent measure of the reinforcing or motivational 
properties of Pavlovian conditioned stimuli (Kelleher, 1966). Akin to other 
psychostimulant drugs, cocaine has a capacity to energise instrumental 
actions to obtain the conditioned reinforcer (CR) and this cocaine effect is 
known to dopamine-dependent (Chu & Kelley, 1992; Dixon et al., 2010; 
Parkinson et al., 1999; Wolterink et al., 1993; refer to Chapter 1, Section 
1.7). Though there is evidence that co-activation of D1Rs and D2Rs is 
required to enhance responding for CRf (Chu & Kelley, 1992), others have 
shown that selective activation of either receptor subtype is sufficient to 
increase the rate of responses for CRf (Wolterink et al., 1993). Studies with 
dopamine receptor antagonists, however, have yielded more consistent 
results. Namely, intra-NAc infusion of a D1R antagonist (SCH23390) or a 
D2R antagonist (raclopride, pimozide, or metoclopramide) completely 
blocked the potentiating effects of psychostimulants (i.e. d-amphetamine, 
cocaine, or pipradrol) on responding for CRf (Chu & Kelley, 1992; Ranaldi & 
Beninger, 1993; Wolterink et al., 1993). At higher doses, intra-accumbal 
microinfusion of SCH23390 or raclopride were found to block CRf in the 
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absence of amphetamine (Wolterink et al., 1993). These data collectively 
suggest that dopamine signalling via D1Rs and/or D2Rs is a key mechanism 
underlying the ability of psychostimulant drugs to enhance instrumental 
responding for CRf.  
Nevertheless, it is ultimately the NAc activity, regardless of 
originating influences, that governs the behavioural output. The effect of 
dopamine is merely modulatory and it is glutamate that provides an 
excitatory drive to the NAc neurons. Consistent with this notion, 
pharmacological manipulations of the glutamatergic activity in the NAc 
have been reported to block amphetamine-facilitated CRf and 
amphetamine-induced locomotor hyperactivity (Burns, Everitt, Kelley, & 
Robbins, 1994). Similarly, alterations of GABAergic activity within the NAc 
have also been found to block cocaine-facilitated CRf (see Chapter 4), 
inhibited the expression of cocaine CPP, and attenuated the expression of 
cocaine-induced sensitisation (Wang et al., 2014). Together, these findings 
highlight the significance of intact functional interactions between the 
dopaminergic, glutamatergic, GABAergic subsystems for the manifestation 
of cocaine-induced behavioural effects.  
Traditionally, D1- and D2-MSNs in the ventral striatum are thought 
have antagonistic influences on behaviours due to distinct projection targets 
within the basal ganglia (BG). Namely, D1-MSNs project directly to VM 
whereas D2-MSNs form indirect projections to the VM via the VP (Kreitzer 
& Malenka, 2008). Using a combination of optogenetics and 
electrophysiology, recent data presented in the Kupchik et al. (2015) study 
219 
 
revealed that MSN projections, specifically from the NAc core (ventromedial 
striatum) of mice, do not display exclusive segregation of the direct and 
indirect pathways. Instead, there is some degree of anatomical overlap in 
their projection targets as nearly half of the VP neurons are innervated by 
D1-MSNs, thus calling into question whether the anatomical and 
behavioural disparities between D1- and D2-MSNs apply to efferents from 
the NAc in mice.  
Findings from progressive ratio tasks to test the level of effort exerted 
to obtain food reinforcers revealed that optogenetic inhibition of D1-MSNs 
or D2-MSNs reduced breakpoints, whereas optogenetic activation of 
mesoaccumbal D1R- or D2R-expressing neurons increased the number of 
cumulative presses and breakpoints, indicating an absence of accumbal D1-
D2 antagonism (Natsubori et al., 2017; Soares-Cunha et al., 2016; Tsutsui-
Kimura et al., 2017). In contrast, emerging literature supports the 
differential roles of D1- and D2-MSNs in regulating psychostimulant-
induced motivated actions. For instance, optogenetic activation of D1- and 
D2-MSNs was found to generate opposing effects on cocaine-induced 
conditioned place preference, with the former promoting and the latter 
reducing conditioned preference for the cocaine-paired chamber (Lobo et al., 
2010). Consistent with the Lobo et al. (2010) data, chemogenetic inhibition 
of D1-MSNs blocked cocaine-induced increases in D1-MSN activity and 
preference for the drug-paired chamber, leading to a premise that it is D1, 
albeit not D2, signalling that drives the motivation to enter the cocaine-
paired chamber (i.e. the expression of CPP) (Calipari et al., 2016). The 
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differential involvement of D1-/D2-MSNs pertaining to drug-induced 
reinforcement has also been observed in the sensitisation (Chandra et al., 
2013; Song et al., 2014). In contrast to the findings with food reinforcers, 
these data lend support to the behavioural distinction between D1- and D2-
MSN activity pertaining to motivation.  
Nearly all striatal neurons are GABAergic (Bolam et al., 1983; Tepper 
et al., 2010) and there is evidence that dopamine can modulate MSN activity 
(i.e. GABA release) in the striatum. Namely, D1R agonist enhances, 
whereas D2R agonist decreases, electrically-stimulated GABA release in the 
striatum (Harsing & Zigmond, 1997). These differential modulatory effects 
of dopamine, particularly on the lateral inhibitory network within the NAc, 
may be an important mechanism by which cocaine facilitates CRf, given 
that RNAi-induced knockdown of the α2 subunit expression in the NAc core 
was sufficient to block cocaine’s CRf-enhancing properties (refer to Chapter 
4). This study, therefore, postulated that the RNAi-induced translational 
repression of the α2 subunit in the NAc core D1R- or D2R-harbouring 
neurons, using the newly developed Cre-dependent RNAi vectors (refer to 
Chapter 3), would abolish or at least, attenuate cocaine facilitation of CRf.  
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5.2. Experimental design 
The present research examined the effects of α2 knockdown in D1R- 
or D2R-expressing neurons within the NAc core (i.e. D1 and D2 experiments 
respectively). In each experiment, three groups of mice, i.e. D1- or D2-Cre 
mice injected with Cre-dependent rAAVs carrying either the shScr or shα2, 
and WT mice injected with the Cre-dependent shα2-containing vectors (see 
Section 5.3.1 for more details). A brief summary of the experimental 
procedure is described in Chapter 4 (refer to Chapter 2, Section 2.10 for 
detailed methods). 
 
Figure 5.1. An overview of the conditioned reinforcement experiment. In the 
Pavlovian conditioning session, animals were trained to associate a 
stimulus, either flashing lights or tone (counterbalanced across animals), 
with food reward. The position of the reinforced and non-reinforced 
nosepoke modules during CRf test sessions was also counterbalanced across 
animals. 
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5.3. Results 
5.3.1. Histological assessment 
To probe the functional contributions of mesoaccumbal α2-GABAARs 
specifically in D1R- and D2R-expressing neurons in the expression of 
motivated behaviour (i.e. CRf) and its potentiation by cocaine using the Cre-
dependent rAAVs (harbouring shScr or shα2), D1- and D2-Cre transgenic 
mice were used. RNAscope validation of their genotypes is presented in 
Figure 5.2A. In the D1 Cre mouse, D1Rs was found to colocalise with Cre, 
indicated by a strong positive correlation between the integrated density 
values (IDVs) of Drd1a and Cre signals, r  = .869, p < .001 (n = 345 cells) 
and a weak, but significant negative correlation between the IDVs of Drd2 
and Cre signals, r = -.273, p < .001 (n = 278 cells). Similarly, D2Rs colocalise 
with Cre in the D2 Cre mouse, r = .759, p< .001 (n = 380 cells), and no 
correlation between the IDVs of Drd1a and Cre signals was observed in the 
D2-Cre mouse, r = .029, p = 0.630 (n = 280 cells). A separate group of WT 
mice, injected with shα2-carrying Cre-dependent rAAVs, was also used in 
each behavioural experiment to control for Cre integration within the 
genome and to ensure that any observed phenotypic effect of shα2 was 
dependent on Cre-mediated recombination.  
Figure 5.2B illustrates the target viral injection site (i.e. the NAc 
core; coordinates AP 1.18; L+/-1.00; DV -4.20; Paxinos & Franklin, 2001). 
When injected into the NAc core of D1- or D2-Cre mice, a mixed population 
of mCherry- and EGFP-expressing cells was observed, but only EGFP-
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expressing cells were detected in the WT brain, indicating the absence of 
Cre in the latter (refer to Chapter 3 for characterisations of these viruses). 
Three groups of mice were used in each experiment, i.e. D1 Cre/shScr 
(n = 7; males = 4, females = 3), D1 Cre/shα2 (n = 12, males = 7, females = 5) 
and WT/shα2 (n = 10, males = 5, females = 5) in the D1 experiment, and D2 
Cre/shScr (n = 10 males = 5, females = 5), D2 Cre/shα2 (n = 9, males = 5, 
females = 4) and WT/shα2 (n = 10, males = 6, females = 4) in the D2 
experiment. Eight animals from each experiment (i.e. D1 and D2 
experiments) were removed from the analysis due to inaccurate placement 
of the rAAVs (see below for the number of animals in each group used for 
analysis).  
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Figure 5.2. (A) RNAscope verification of Cre expression patterns in the NAc 
core of D1- and D2-Cre transgenic mice. Positive correlation between Cre 
and Drd1a or Drd2 signals was observed in D1-Cre or D2-Cre mice 
respectively (B) Histological assessment of bilateral viral infusions into the 
NAc core. Fluorescent immunostaining of EGFP (Cre-negative cells) and 
mCherry (Cre-positive cells) in D1- and D2-Cre mice, or of EGFP only in the 
wildtype mice, shows the Cre-dependent rAAV-infected neurons, taken 
approximately 10 weeks after viral injection (refer to Chapter 3 for details 
on the construct design). Areas marked in red indicate the target injection 
sites. Scalebar 100µm. 
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5.3.2. The effects of α2 knockdown in NAc core D1R- and D2R-
expressing neurons in CRf and its facilitation by cocaine 
5.3.2.1. Pavlovian Conditioning 
Figure 5.3 illustrates the effect of α2 knockdown in the NAc core D1R- 
and D2R-expressing neurons on Pavlovian discriminated approach, 
displayed as the percentage of magazine entries during CS+ and CS- 
presentations over the course of 10 daily sessions.  
By session 10, D1 Cre/shScr (n = 6, males = 4, females = 2), D1 
Cre/shα2 (n = 7, males = 5, females = 2), and WT/shα2 (n = 8, males = 3, 
females = 5) mice reached 87.82 ±4.61%, 74.50 ±12.13% and 84.23 ±3.08% 
magazine entries during CS+ presentations respectively. A three-way mixed 
ANOVA comparing the percentage of magazine entries revealed a non-
significant session × CS × group interaction (Greenhouse-Geisser corrected, 
F(10.56, 95.08) = 1.13, p = .349, ε = .587). However, significant session × CS 
interaction (Greenhouse-Geisser corrected, F(5.28, 95.08) = 32.32, p < .001, ε 
= .587), as well as significant main effects of session (Greenhouse-Geisser 
corrected, F(3.59, 64.59) = 29.57, p < .001, ε = .399) and CS (F(1,18) = 
404.57, p < .001) collectively suggest that all groups of mice regardless of 
virus manipulation and genotype acquired the stimulus-reward association 
by displaying higher proportions of magazine entries during CS+ onset. 
Interestingly, there appears to be significant group differences in Pavlovian 
learning, through the CS × group interaction, F(2,18) = 6.40, p < .01) and 
the main effect of group (F(2,18) = 3.78, p < .05)). The Bonferroni’s post-hoc 
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test further revealed that the D1 Cre/shα2 mice displayed significantly 
reduced level of discriminated approach relative to the D1 Cre/shScr 
counterpart (p < .05) (Figure 5.3A).  
Next, in the D2 experiment, the D2 Cre/shScr (n = 7, males = 4, 
females = 3), D2 Cre/shα2 (n = 7, males = 5, females = 2), and WT/shα2 (n=7, 
males = 3, females = 4) groups reached 80.88 ±4.82%, 83.20 ±2.62% and 
81.83 ±3.71% magazine entries during CS+ presentations on session 10 
respectively. An ANOVA comparison of between-group differences in 
magazine entries during CS+ vs. CS- presentations over the course of 10 
sessions revealed non-significant session × CS × group (Greenhouse-Geisser 
corrected, F(8.59, 77.26) = 0.55, p = .830, ε = .477), CS × group (F(2,18) = 
0.04), and session × group (Greenhouse-Geisser corrected, F(8.79, 79.19) = 
0.70, p = .701, ε = .489) interactions. However, CS × session interaction 
(Greenhouse-Geisser corrected, F(4.29, 77.26) = 27.15, p < .001), as well as 
the main effects of CS (F(1,18) = 179.93, p < .001) and session (Greenhouse-
Geisser corrected, F(4.40, 79.19) = 42.19, p < .001, ε = .489) were 
statistically significant. These data indicate that all animals, regardless of 
genotype or virus manipulation, exhibited Pavlovian learning to a similar 
degree (Figure 5.3C).  
Pavlovian learning was further assessed by measuring changes in the 
latency to approach the food magazine following CS+ onset (CS+ latency) on 
sessions 1 and 10. In the D1 experiment, the average CS+ latencies were 
8.31 ±0.47, 8.42 ±0.30 and 8.66 ±0.34 seconds on session 1 and 4.19 ±0.22, 
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4.02 ±0.36 and 3.71 ±0.20 seconds on session 10 for D1 Cre/shScr, D1 
Cre/shα2, and WT/shα2 groups respectively. Though the CS+ latency on 
session 1 was significantly higher than that on session 10 (i.e. estimated 
marginal means of 8.46 ±0.21 (session 1) and 3.97 ±0.16 (session 10); 
significant main effect of session (F(1,18) = 203.97, p  <.001)), differences 
between groups were statistically non-significant, either via session × group 
interaction (F(2,18) = 0.61, p = .554) or the main effect of group (F(2,18) = 
0.03, p = .971) (Figure 5.3B).  
The average CS+ latencies in the D2 experiment were 8.69 ±0.27, 8.63 
±0.48 and 7.98 ±0.45 on session 1, and 4.24 ±0.40, 4.07 ±0.74 and 3.84 ±0.43 
on session 10 for D2 Cre/shScr, D2 Cre/shα2, and WT/shα2 groups 
respectively. Akin to the D1 experiment, all groups of mice displayed 
markedly lower CS+ latency on session 10 (F(1,18) = 203.97, p < .001), but 
there were no marked differences in the CS+ latency between groups (i.e. 
non-significant session × group interaction, F(2,18) = 0.61, p = .554) (Figure 
5.3D). Collectively these findings demonstrated that translational 
repression of α2 either in the D1- or D2-expressing neurons in the NAc core 
did not impair appetitive Pavlovian learning, though the former appeared to 
reduce the level of discriminated approach.  
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Figure 5.3. Appetitive Pavlovian learning in the D1 and D2 experiments. (A) 
All groups of mice in the D1 experiment acquired the food-stimulus 
association, indicated by the levels of discriminated approach over the 
course of 10 daily conditioning sessions and (B) the latency to approach the 
food magazine during CS+ presentation. The D1 Cre/shα2 mice, however, 
displayed a reduced level of discriminated approach relative to the shScr 
counterparts (p < .05). (C) The α2 knockdown in the D2-expressing NAc core 
neurons, however, had minimal effects on the Pavlovian discriminated 
approach and (D) CS+ latency. Data are presented as mean ± SEM. ***p < 
.001 
  
231 
 
5.3.2.2. Conditioned reinforcement 
  
The effects of α2 knockdown in the NAc core D1R- and D2R-
expressing neurons on the baseline rates of responding for CRf are 
summarised in Figure 5.4.  
Firstly, in the D1 experiment, the D1 Cre/shScr, D1 Cre/shα2, and 
WT/shα2 groups made, on average (±SEM), 107.83 ±18.68, 86.29 ±14.01 and 
81.63 ±19.50 CR and 41.17 ±7.12, 30.14 ±3.72 and 34.63 ±6.33 NCR 
nosepokes respectively. As depicted in Figure 5.4A, all groups of mice 
displayed markedly higher rates of nosepoking for the CR than the NCR (F 
(1,18) = 34.56, p < .001). However, manipulations introduced in the present 
research appeared to have only marginal effects on responding for CRf (i.e. 
non-significant nosepokes × group interaction, F(2,18) = 0.35, p = .712). 
Further analysis of the pattern of reinforced nosepoking rates over the 60-
minute session, broken down into six 10-minute timebins, revealed no 
significant time × group interaction (Greenhouse-Geisser corrected, F(6.54, 
58.83) = 0.95, p = .474, ε = .654) though the main effect of time was 
significant (Greenhouse-Geisser corrected, F(3.27, 58.83) = 4.35, p < .01, ε = 
.654), indicating time-dependent decreases in CR-maintained responding 
(Figure 5.4B). 
Statistical analyses for the D2 experiment were performed with log-
transformed data to maintain homogeneity of variance. The D2 Cre/shScr, 
D2 Cre/shα2, and WT/shα2 groups made 234.86 ±43.82, 194.57 ±39.15 and 
130 ±13.15 CR, and 46.71 ±7.15, 47.43 ±9.16 and 27.14 ±3.65 NCR 
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nosepokes respectively. Akin to the findings from the D1 experiment, all 
groups of mice displayed preferential responding for the CR over the NCR 
(i.e. a significant main effect of nosepokes, F(1,18) = 339.74, p < .001 and 
though D2 Cre, irrespective of the virus manipulation, appeared to display 
higher CR-reinforced nosepoking, the nosepokes × group interaction was 
found to be statistically non-significant (F(2,18) = 0.63, p = .546) (Figure 
5.4C). Analyses of the timebin data further demonstrated the lack of 
between-group differences in the pattern of reinforced nosepoking 
(Greenhouse-Geisser corrected, F(5.20, 46.81) = 1.41, p = .241, ε = .520) 
(Figure 5.4D). In summary, reducing α2 expression selectively in the NAc 
core D1R- or D2R-expressing neurons did not markedly affect the 
acquisition of instrumental responding for CRf.  
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Figure 5.4. The acquisition of an instrumental action (i.e. nosepoking into a 
port) for conditioned reinforcement in the D1 and D2 experiments. (A) All 
groups of mice in the D1 experiment displayed preferential nosepoking into 
the CR-associated module. (B) Time-dependent decreases in the rates of 
reinforced nosepoking (60-minute session) were observed in all groups. (C) 
All groups in the D2 experiment also exhibited higher rates of CR-driven 
nosepoking and (D) the rates of reinforced nosepoking appeared to decrease 
over time. Data are presented as mean ± SEM. ***p < .001 
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5.3.2.3. Cocaine enhancement of conditioned reinforcement 
 
Next, this study investigated the effects of α2 expression knockdown 
in the NAc core on cocaine (0, 3 & 10 mg/kg i.p.) facilitation of CRf, in an 
attempt to provide pathway specificity to the findings presented in Chapter 
4. The rates of nosepoke responses for the CR and NCR with different doses 
of cocaine administered in a Latin square design are summarised in Figure 
5.5.  
A three-way mixed ANOVA comparing between-group variations in 
CR- vs. NCR-maintained nosepoking with different doses of cocaine in the 
D1 experiment revealed that the nosepokes × dose × group interaction 
(Greenhouse-Geisser corrected, F(2.93, 26.33) = 0.81, p = .499, ε = .731), all 
of the two-way interactions, and main effects of dose and group were 
statistically non-significant (p > .05). However, there was a significant main 
effect of nosepokes (F(1,18) = 29.82, p < .001), suggesting that preferential 
responding for CRf appeared to be intact in all groups, but cocaine’s CRf 
enhancing properties were not evident in this experiment. This was further 
confirmed by post-hoc two-way ANOVAs of the experimental groups (i.e. 
significant main effect of CS in each group; FWT/shα2(1,7) = 15.67, p < .01; FD1 
Cre/shScr(1,5) = 7.44, p < .05; FD1 Cre/shα2(1,6) = 8.49, p < .05; Figure 5.5A, 5.5C 
& 5.5E). 
By contrast, the ANOVA comparison in the D2 experiment yielded a 
significant three-way interaction (F(4,36) = 5.96, p < .01), as well as 
significant dose × group (F(4,36) = 6.91, p < .001), CS × group (F(2,18) = 
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3.83, p < .05), and dose × nosepokes (F(2,36) = 26.95, p < .01) interactions. 
The main effects of dose and nosepokes were also statistically significant 
(Fdose(2,36) = 14.62, p < .001; Fnosepokes (1,18) = 112.62, p <.001). Collectively, 
these data suggest that cocaine differentially altered nosepoke responding 
for CR and/or NCR presentations in different experimental groups. Post-hoc 
analyses of simple interactions and main effects within each group were 
performed to aid data interpretation.  
Firstly, all experimental groups exhibited higher rates of responding 
for CR, than for the NCR, regardless of cocaine pre-treatments (main effects 
of CS, FWT/shα2(1,6) = 241.61, p < .001; FD2 Cre/shScr(1,6) = 36.29, p < .01; FD2 
Cre/shα2(1,6) = 22.51, p < .01). The stimulant properties of cocaine remained 
intact in both of the control groups, WT/shα2 and D2 Cre/shScr, indicated by 
the significant main effect of dose (FWT/shα2(2,12) = 13.97, p < .01; FD2 
Cre/shScr(2,12) = 12.90, p < .01), but were notably absent in the D2 Cre/shα2 
group (Greenhouse-Geisser corrected, F(1.15, 6.92) = 0.52, p = .522, ε = 
.576). Importantly, cocaine was found to differentially alter CR- and NCR-
maintained responding in both of the control groups (FWT/shα2(2,12) = 25.52, 
p < .001; FD2 Cre/shScr(2,12) = 12.82, p < .01; Figure 5.5B & 5.5D), but induced 
no significant effects on responding for CRf in the D2 Cre/shα2 counterpart 
(F(2,12) = 0.65, p = .539) (Figure 5.5F).  
Repeated measures ANOVAs (with Bonferroni correction for multiple 
comparisons), performed to probe cocaine effects specifically on the rates of 
CR- and NCR-maintained nosepoking in the WT/shα2 and D2 Cre/shScr 
groups, showed that cocaine selectively enhanced reinforced nosepoking in 
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both groups (FWT/shα2(2,12) = 19.25, p < .001; FD2 Cre/shScr (2,12) = 13.42, p < 
.01), whilst having no marked effects on responses for the NCR 
(FWT/shα2(2,12) = 2.02, p  = .176; FD2 Cre/shScr (2,12) = 2.34, p = .139. Overall, 
these findings suggest that reducing the total amounts of α2 in D2R-
expressing neurons within the NAc core completely blocked cocaine’s CRf-
potentiating properties.  
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Figure 5.5. The effects of cocaine pre-treatments on responding for 
conditioned reinforcement in the D1 and D2 experiments. In the D1 
experiment, cocaine (3 or 10mg/kg i.p.) failed to potentiate nosepoking for 
conditioned reinforcement in the (A) WT/shα2, (C) D1 Cre/shScr and (E) D1 
Cre/shα2 groups. In the D2 experiment, cocaine (10mg/kg) selectively 
enhanced CR-driven nosepoking in the (B) WT/shα2 and (D) D2 Cre/shScr 
groups, but not in the (F) D2 Cre/shα2 counterpart. Data are presented as 
mean ± SEM. **p < .01 
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5.4. Discussion 
To probe the possibly dissociable functions of α2 in D1R- and D2R-
expressing neurons, the Cre-dependent rAAVs, carrying either an α2-
targeting silencing construct (shα2) or a non-targeting construct (shScr), 
were injected into the NAc core of D1 Cre, D2 Cre, and WT mice. The effects 
of the cell-type-specific α2 knockdown on appetitive Pavlovian behaviour, 
CRf, and its facilitation by cocaine were subsequently investigated.  
Results from the current study showed that reducing α2 expression 
levels in the NAc core D1R- or D2R-expressing neurons did not impair 
Pavlovian or instrumental learning, though α2 knockdown in the D1R-
expressing cells reduced the level of discriminated approach when compared 
to the D1 Cre/shScr counterparts, indicating the dissociable roles of α2-
GABAARs in D1R- or D2R-expressing neurons in appetitive Pavlovian 
learning. Further, we also demonstrated the functional significance of the 
GABAAR α2 subunit expression, particularly in the NAc core D2R-
expressing neurons, in mediating cocaine facilitation of CRf. Namely, 
silencing α2 expression in this subpopulation of accumbal neurons 
completely abolished cocaine’s ability to selectively enhance responding for 
CRf, thus providing pathway specificity to the previous findings described in 
Chapter 4. Though α2 knockdown in the D1R-expressing neurons also 
appeared to block cocaine’s CRf-enhancing properties, current results from 
the D1 experiment remain inconclusive, due to the lack of significant 
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cocaine enhancement in both control groups for potential reasons discussed 
below. 
5.4.1. Effects of α2 knockdown in NAc core D1R- and D2R-
expressing neurons on associative learning  
The mesolimbic dopamine system is involved in the expression of 
learned behaviours, though the exact nature of its role remains unclear to 
date. Evidence derived from microdialysis and fast-scan cyclic voltammetry 
studies has implicated the mesoaccumbal dopaminergic system in appetitive 
associative learning (Bassareo, Musio, & Di Chiara, 2011; Cheng, de Bruin, 
& Feenstra, 2003; Flagel et al., 2011; Kiyatkin, 1995; Schultz et al., 1997). 
This study demonstrated that silencing α2 expression specifically in the 
D1R- or D2R-expressing neurons in the NAc core of the mouse failed to 
impair appetitive associative learning, in that over the course of 10 
Pavlovian conditioning sessions, all groups of mice in each experiment were 
progressively more likely to approach the food magazine during the CS+ 
onset and exhibited shorter latency to approach the magazine upon the CS+ 
presentation (prior to food delivery). However, α2 knockdown in D1R-
containing neurons appeared to reduce the level of discriminated approach. 
Intriguingly, disruptions in appetitive Pavlovian conditioned responses were 
also observed upon pharmacological blockade of the D1Rs, suggesting their 
functional importance in mediating incentive learning (reviewed in 
Beninger & Miller, 1998). For instance, the D1R antagonist SCH23390 dose-
dependently reduced magazine entries during the food-paired stimulus 
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presentations in a conditioning paradigm (Eyny & Horvitz, 2003) or reduced 
CS+ consumption in rats trained to associate flavoured saccharin solution 
with intragastric sucrose infusion (Azzara, Bodnar, Delamater, & Sclafani, 
2001). Studies with D2R antagonists, however, yielded mixed results. 
Namely, D2R antagonist (raclopride) has been shown to have positive effects 
on learning, i.e. increasing head entries during CS+ presentations compared 
to the vehicle controls (Eyny & Horvitz, 2003), though, the Azzara et al. 
(2001) study failed to observe marked effects of raclopride on flavour-
intragastric carbohydrate infusion conditioning. Such discrepancy could be 
explained by mounting evidence supporting the role of D2Rs in motor 
responding during learning (extensively reviewed in Beninger & Miller, 
1998). 
Furthermore, the present study showed that RNAi-induced 
downregulation of α2 expression in either of the neuronal subpopulations 
failed to disrupt the acquisition of instrumental responding for CRf, as 
indicated by the total number and the pattern of reinforced response rates. 
In particular, despite the reduced level of discriminated approach and the 
failure to meet the Pavlovian learning criterion (i.e. ≥80% magazine entries 
during CS+ presentations during the 60-minute conditioning session), mice 
with lower levels of α2 in the mesoaccumbal D1R neurons exhibited similar 
rates of CS+ - reinforced and non-reinforced nosepoking, relative to those in 
the control groups, suggesting that the CS+ acquired the capacity to 
function as reinforcer to a similar extent in all groups of mice in the D1 
experiment. Overall, this is not surprising given that lesion of the BLA, but 
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not of the NAc core or shell, abolished CR-induced control over behaviour, 
suggesting the importance of BLA integrity in responding for CRf (Burns, 
Everitt, & Robbins, 1999; Burns, Robbins, & Everitt, 1993; Parkinson, et al., 
1999). In keeping, there is evidence that disruptions in Pavlovian 
associative learning did not necessarily yield deficits in the acquisition of 
CRf (Olmstead, Robbins, & Everitt, 1998; though also see Beninger & 
Phillips, 1980).  
The NAc is enriched with post-synaptic and extra-synaptic GABAARs 
that mediate phasic and tonic GABAergic activity respectively (Dixon et al., 
2010; Farrant & Nusser, 2005; Hörtnagl et al., 2013; Maguire et al., 2014; 
Pirker, Schwarzer, & Wieselthaler, 2000). Intriguingly, previous research 
using mice lacking α4-GABAARs in D1R-expressing neurons (α4D1KO) 
found no genotypic differences in appetitive conditioning; in contrast, mice 
lacking α4-GABAARs in D2R-expressing neurons (α4D2KO) exhibited 
enhanced nosepoking for CRf (Macpherson et al., 2016). However, note that 
we identified higher CRf-maintained responding in the D2 Cre mice, 
irrespective of virus manipulation, thus potentially  challenging the 
previous α4D2KO findings, though further investigations remain to be 
performed. These findings not only extend previous findings pertaining to 
the role of dopamine signalling via D2Rs in motivation (Natsubori et al., 
2017; Soares-Cunha et al., 2016; Tsutsui-Kimura et al., 2017), but together 
with current data, also show that GABA action at α2- and α4-containing 
receptors in D1R- or D2R-containing neurons play different roles in distinct 
aspects of reward learning. Nonetheless, this interpretation should be 
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treated with caution as the knockout approach lacks regional specificity and 
the knockout models often display compensatory alterations, which may 
ultimately affect their phenotypes (Gingrich & Hen, 2000). Overall, current 
findings suggest that the GABAAR α2 subunit expression, either in the NAc 
core D1R- and D2R-expressing neurons, is not a pre-requisite for Pavlovian 
learning and the acquisition of a novel response maintained by Pavlovian-
conditioned stimuli. 
5.4.2. Effects of α2 knockdown in NAc core D1R- and D2R-
expressing neurons on cocaine enhancement of conditioned 
reinforcement 
Importantly, α2 knockdown in the D2R-containing neurons blocked 
cocaine’s ability to further invigorate motivated behaviours directed towards 
CRf. Though results from the D1 experiment appeared to yield similar 
findings as those observed in the D2 experiment (also refer to Chapter 6 for 
discussion on D1/D2 antagonism), cocaine effects in both D1R- control 
groups failed to reach statistical significance, most likely due to technical 
reasons discussed further below. Evidence exists that D1-MSN activity is 
important for the expression of cocaine-induced motivated behaviours. For 
instance, increased D1-MSN activity was detected immediately prior to 
entry into a cocaine-paired chamber in a CPP paradigm and the peak 
amplitude correlated well with the time spent in the drug-paired 
compartment, suggesting that D1 signalling drives the expression of place 
preference (Calipari et al., 2016). Consistent with that observation, 
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chemogenetic inhibition of D1-MSNs abolished preference for the drug-
paired chamber (Calipari et al., 2016). For these reasons, follow-up 
investigations should be carried out to confirm the effects of α2 knockdown 
in D1R-expressing neurons in the NAc core on cocaine facilitation of CRf.  
In line with current data, the CRf-potentiating effects of d-
amphetamine (Wolterink et al., 1993) and cocaine (Chu & Kelley, 1992) 
were completely abolished by pharmacological blockade of either D1Rs or 
D2Rs with SCH23390 or raclopride respectively, suggesting that reducing 
GABAergic activity via α2-containing receptors primarily in D2R- and 
possibly, in D1R-harbouring neurons blocked the downstream consequences 
of dopamine action in the NAc such that it could no longer energise 
responding for CRf (discussed below). Similarly, intra-NAc infusions of low 
doses of D2R antagonist were found to impair motivation – i.e. shifting 
behaviour away from food-reinforced tasks which required a considerable 
amount of effort and towards low-effort tasks with less reinforcement 
(Salamone, Correa, Farrar, & Mingote, 2007).  
It is, however, noteworthy that motivation, in itself, is a complex 
process, which involves various behavioural functions underpinned by a vast 
array of interacting circuits. There are quite distinct facets of motivation, for 
example, the activational (speed, vigour and persistence) and directional 
(away from or towards a stimulus) components (Salamone, Yohn, López-
Cruz, San Miguel, & Correa, 2016; Salamone & Correa, 2012). This also 
leads to an important question as to what aspect of motivation is, in fact, 
mediated by dopamine transmission via D2Rs. Using the random ratio 
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paradigm to measure effort in instrumental responding, a study by Trifilieff 
and colleagues (2013) further demonstrated that postsynaptic D2R 
overexpression in the NAc increased the willingness to work for food 
reinforcers without affecting consummatory behaviour. Taken together, 
these data suggest that dopamine transmission via D2Rs enhances 
motivation by influencing decision making based upon effort expenditure 
(i.e. the activational aspect of motivation, as described by Salamone & 
Correa, 2012), rather than by altering the representation of the value of the 
reinforcer per se. For this reason, we hypothesised that RNAi-induced 
downregulation of α2 expression in D2R-containing neurons blocked cocaine 
facilitation of CRf by reducing the willingness to work for CR presentations, 
without necessarily affecting its reinforcing value.  
5.4.3. GABA × Dopamine: Evidence for D1R-D2R interactions 
As discussed in the previous chapter, the interaction between 
dopamine and GABA in the NAc is crucial for cocaine-facilitated CRf to 
occur, but the form of interaction between these subsystems that specifically 
underlies this cocaine effect remains elusive.  
Firstly, dopamine can exert modulatory effects on GABA release in 
the striatum. Pharmacological data presented in the Harsing and Zigmond 
(1997) study have demonstrated that whilst dopamine action at D1Rs 
increased GABA overflow, evoked by electrical field stimulation, activation 
of D2Rs induced an opposite effect. Further, more recent studies 
demonstrated that the striatal MSNs form complex and highly 
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asymmetrical connectivity, forming a lateral inhibitory network. Namely, 
while the D1-MSNs have been shown to almost exclusively innervate 
neighbouring D1-MSNs, the D2-MSNs project to both subpopulations 
(Dobbs et al., 2016; Taverna et al., 2008; Tecuapetla, Koos, Tepper, Kabbani, 
& Yeckel, 2009). Thus, there is a possibility that RNAi-induced silencing of 
α2 expression in the D2R neurons might have induced a robust effect on 
cocaine-facilitated CRf via the targeting of D2R-, as well as D1R-expressing 
neuronal activity within the NAc microcircuitry.  
Further, existing data suggest that dopamine × glutamate interaction 
is implicated in the psychostimulant’s CRf-enhancing properties (Burns et 
al., 1993; 1994). An elegant series of experiments by Levine et al. (1996) 
demonstrated that mechanistically, the action of dopamine at D1Rs and 
D2Rs differentially modulates glutamatergic transmission in striatal 
neurons. Namely, D1R activation enhances NMDA-mediated responses only 
when the neurons are in a more depolarised, or “up” state, whereas D2R 
activation may effectively attenuate glutamatergic responses via AMPA 
receptors during the down state. Though note that tonic D1R or D2R 
activation was found to increase or decrease striatal neuron excitability 
respectively, regardless of the membrane potentials (West & Grace, 2002).  
To date, it remains unclear how phasic GABAergic action precisely 
modulates striatal MSN activity in behaving animals (refer to inhibitory 
and facilitatory accounts of striatal GABAergic function documented in 
Bracci & Panzeri, 2006; Kiyatkin & Rebec, 1999). Intriguingly, previous 
research demonstrated that GABAAR antagonist, bicuculline and picrotoxin, 
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blocked D2R inhibitory effects on NMDA receptors in the rat PFC (Tseng & 
O’Donnell, 2004). A similar triadic interaction between the dopaminergic, 
glutamatergic, and GABAergic systems has also been reported in accumbal 
MSNs. Recordings from the NAc neurons of adult rats indicated that D2R 
activation enhanced cortico-accumbal responses to cortical stimulation, but 
markedly attenuated synaptic responses to cortical stimulation in the 
presence of GABAAR antagonist, suggesting D2R recruitment of 
depolarising GABA responses to collectively modulate cortical inputs into 
the NAc. It was further proposed that D2R activation may have a dual effect 
within the NAc circuitry, i.e. attenuating corticoaccumbal EPSPs and 
enhancing feedforward mechanism through the activation of local GABA 
interneurons, which may exert a depolarising effect onto the hyperpolarised 
MSNs, but may shunt excitatory responses when neurons are at a more 
depolarised state (Benoit-Marand & O’Donnell, 2008). Based on these 
findings, we posit that reducing the α2-GABAARs in D2R-expressing 
neurons might have attenuated D2R-mediated facilitation of excitatory 
afferents onto the accumbal MSNs, primarily from the cortex (potentially 
mimicking the effects of D2R antagonism), which serves as a key 
mechanism underlying psychostimulant enhancement of CRf.  
Adding to this complexity, dopaminergic modulation of GABAergic 
signalling in the NAc has been reported to vary according to the type of the 
GABAergic connections. Namely, in the NAc shell, quinpirole (a D2R 
agonist) reliably reduced the amplitude of lateral inhibition (i.e. MSN-MSN 
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inhibition), but had divergent effects on FSI-MSN connections (Kohnomi, 
Koshikawa, & Kobayashi, 2012).  
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5.4.4 Conclusions and technical considerations 
To conclude, data generated in the present research provide valuable 
insights into the role of Gabra2 specifically in D1R- and D2R-containing 
neurons within the NAc core subregion using a newly developed Cre-
dependent RNAi vector (refer to Chapter 3 for vector design). Firstly, this 
research has unravelled the facilitatory role of Gabra2, specifically in D1R-
containing mesoaccumbal neurons, in appetitive learning, which was not 
revealed in the α2 constitutive knockouts (Dixon et al., 2010) or in the 
region-specific knockdowns (Chapter 4). Importantly, this study further 
provided cell-type specificity to the findings presented in Chapter 4. 
Namely, intact GABAergic activity via the α2-GABAARs, specifically in the 
NAc core D2R-expressing neurons, is a pre-requisite for cocaine facilitation 
of CRf.  
There are, nonetheless, several technical limitations that need to be 
considered when interpreting these data. Firstly, the differences in 
behavioural phenotypes revealed through the RNAi-induced regulation of α2 
in specific cell subpopulations provide strong evidence for the efficacy of the 
Cre-dependent rAAV tools used in the present research. However, further 
characterisations, including electrophysiological, immunohistochemical, 
and/or ligand-binding assays, are warranted to assess RNAi-induced 
silencing effects on the total amount of subunit expression, as well as on the 
membrane receptor number. Moreover, the lack of cocaine enhancement of 
CRf observed across all groups in the D1 experiment was unlikely to be 
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attributable to the non-specific damage in the NAc core caused by the viral 
injections, given that targeting the NAc core D2-MSNs with the same 
amount of shScr-harbouring Cre-dependent rAAVs did not disrupt cocaine’s 
CRf-potentiating effects. Instead, other experiment-specific confounding 
variables, presumably the physiological state of the animals at the time of 
testing (i.e. state of hunger) or potential variabilities in the experimental 
procedures, might have attenuated the magnitude of cocaine effect. A repeat 
experiment should, thus, be conducted to investigate the effects of α2 
knockdown in the NAc core D1R-expressing cells on CRf and its potentiation 
by cocaine. 
Of final note, it is important to highlight that up to 80% of cholinergic 
interneurons in the NAc also express D2Rs and selective activation of these 
receptors have been demonstrated to enhance phasic dopamine release in 
the NAc, thus influencing incentive learning (Alcantara, Chen, Herring, 
Mendenhall, & Berlanga, 2003; Aubry et al., 1993; Cachope et al., 2012). 
There is evidence that the α2-containing GABAAR isoform is preferentially 
enriched on striatal MSNs, thus leading to a hypothesis that the lack of 
cocaine enhancement seen in the D2 Cre/shα2 mice was likely to be 
attributed to reduced levels of α2 in D2-MSNs (Boyes & Bolam, 2007; 
Schwarzer et al., 2001). However, due to the lack of data in the literature 
pertaining to α2-GABAAR cellular and subcellular localisation in the 
striatum, this study cannot at present eliminate the possibility that this 
receptor subtype is expressed in the interneurons, including the cholinergic 
interneurons (CINs), akin to the α4-GABAARs (Maguire et al., 2014). To 
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rectify this issue, the Cre-dependent rAAVs designed in this thesis can be 
injected into the NAc core of the ChAT-Cre (Bloem et al., 2014) or Adora2a-
Cre mice (Durieux et al., 2009) to further probe whether the loss of cocaine 
facilitation of CRf was specifically attributed to reduced levels of α2 in the 
NAc core D2-MSNs or the CINs respectively. Overall, these findings not 
only improve current understanding of the role of the GABAAR α2 subunit 
in incentive learning and motivation, but also pave the way for future 
investigations into the functional roles of the accumbal function in the 
expression of motivated behaviour.  
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Chapter 6  
 
General Discussion 
 
 
Data presented in this thesis have demonstrated the role of the 
mesoaccumbal α2-containing GABAARs in mediating cocaine-facilitated 
conditioned behaviours, i.e. locomotor sensitisation and CRf (see Table 6.1 
for the summary of findings). Namely, the RNAi-induced suppression of the 
α2 subunit expression in the NAc shell was found to affect the locomotor 
stimulant effects of cocaine without altering its sensitising properties. 
Additionally, manipulating the level of α2 expression in the NAc core 
neither affected cocaine-induced hyperlocomotion nor sensitisation, but 
modulated cocaine’s ability to invigorate instrumental responding for CRf. 
Further discussions of how the present findings fit into the context of 
ongoing addiction research to date and their wider implications will be 
presented here.  
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6.1. Summary of findings 
6.1.1. Developing RNAi tools to target the mouse Gabra2 
expression in a site- and/or cell-type-specific manner 
Findings presented in Chapter 3 demonstrated the silencing potency 
of the α2-targeting RNAi effector used for the behavioural experiments in 
this thesis. Both in vitro and in vivo immunofluorescent analyses indicated 
>70% shα2-induced knockdown in the α2 subunit expression, when 
compared to the amount of the α2 subunit expression in cells transfected or 
transduced with a non-targeting scrambled control (shScr). A Cre-dependent 
RNAi (Cre-ON) vector was also developed in this thesis for region- and cell-
type-specific silencing of Gabra2 expression. The presence of Cre 
recombinase in the transfected/transduced cells promoted the mCherry 
expression and shRNA transcription, whereas transfected/transduced Cre-
negative (wild-type) cells expressed EGFP and the shRNA transcription was 
hindered by the STOP cassette in these cells. Using these tools, we were 
able to study the functional roles of intra-accumbal GABAergic signalling 
via α2-GABAARs in mediating cocaine-facilitated conditioned behaviours.  
6.1.2. The role of mesoaccumbal α2-GABAARs in cocaine-
facilitated conditioned reinforcement 
The CRf experiments presented in this thesis (Chapters 4&5) showed 
that intact GABAergic transmission via α2-GABAARs, specifically in the 
NAc core subdivision, is not required for CRf, but plays a critical role in 
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cocaine facilitation of CRf. Namely, reducing α2 expression in the NAc core 
completely abolished cocaine’s potentiating effect without disrupting the 
CR’s ability to act as a reinforcer and bias action selection, consistent with 
previous findings that CRf largely depends on the BLA, rather than the 
NAc, integrity (Burns et al., 1993; Parkinson et al., 1999). The current 
findings, together with previous work, further reveal the differential 
involvement of mesoaccumbal α2- and α4-GABAAR-mediated GABAergic 
activity in mediating CRf and its modulation by cocaine. Namely, RNAi-
mediated silencing of α4 subunit expression in the NAc or whole-brain 
ablation of the α4 subunit expression increased rates of CRf-maintained 
responding, but had no marked effects on cocaine-potentiated CRf 
(Macpherson et al., 2016; also refer to Section 6.4 for further discussion).   
Furthermore, reducing the expression level of α2 subunit in the D1R-
expressing neurons within the NAc core reduced the level of Pavlovian 
discriminated approach, whereas RNAi manipulation of α2 expression in the 
D2R-expressing neurons robustly abolished cocaine’s CRf-enhancing 
properties.  
6.1.3. The role of mesoaccumbal α2-GABAARs in cocaine-induced 
locomotor hyperactivity and sensitisation 
The RNAi-induced knockdown of the α2 expression in the NAc shell, 
but not in the core, markedly heightened cocaine-induced hyperlocomotion 
without altering conditioned activity. Intriguingly, this phenotype is not 
always observed in the constitutive knockouts, potentially due to Gabra2 
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deletion in other region(s) or compensations, which might nullified the effect 
(Dixon et al., 2010; Mitchell et al., 2018).  
Findings from this thesis are consistent with ample evidence 
implicating the NAc shell dopamine in locomotor behaviour. To name a few, 
microinjections of a mixture of D1R- and D2R-agonists in the medial shell of 
the NAc markedly increased locomotion, whereas pharmacological 
manipulations in the NAc core induced little or no effects on locomotion 
(Ikemoto, 2002). Even in a study that reported increases in locomotor 
activity upon psychostimulant microinfusion into the NAc core, the potency 
of the drug-induced enhancement in locomotion was reported to be 
significantly higher when administered in the shell than in the core 
(Heidbreder & Feldon, 1998). 
  Nevertheless, neither α2 knockdown in the NAc core nor in the shell 
induced significant effects on the development of locomotor sensitisation to 
cocaine or conditioned locomotor activity.  Collectively, the current findings 
revealed a dissociation between cocaine’s locomotor-enhancing and positive 
reinforcing effects that are often considered homologous (Wise & Bozarth, 
1987), and that the wild-type expression level of α2, primarily in the NAc 
shell, appears to play a role in dampening the reactivity towards cocaine’s 
locomotor-enhancing effects.
256 
 
 Table 6.1. 
Behaviour α2 
constitutive 
knockout 
 
α2 
knockdown 
(NAc shell) 
α2 
knockdown 
(NAc core) 
α2 knockdown 
(NAc core/D1-
expressing 
neurons) 
α2 knockdown 
(NAc core/D2-
expressing 
neurons) 
Appetitive Pavlovian learning Normal 
(Dixon et al., 
2010) 
? Normal Reduced 
discriminated 
approach 
Normal 
Conditioned Reinforcement Normal 
(Dixon et al., 
2010) 
? Normal Normal Normal 
Cocaine-facilitated 
Conditioned reinforcement 
Blocked 
(Dixon et al., 
2010) 
? Blocked ? Blocked 
Cocaine-potentiated locomotor 
activity 
Normal 
(Dixon et al., 
2010); 
Enhanced 
(Mitchell et 
al., 2018) 
Enhanced Normal ? ? 
Locomotor sensitisation to 
cocaine 
Blocked 
(Dixon et al. 
2010) 
Normal Normal ? ? 
Cocaine-induced conditioned 
locomotor activity 
Normal 
(Dixon et al., 
2010 
Normal ? ? ? 
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Table 6.1. Summary of the behavioural consequences of whole-brain α2 knockout (Dixon et al., 2010; Mitchell et al., 2018), as 
well as those of the RNAi-mediated α2 knockdown in the NAc shell and core (including in D1R- and D2R-expressing neurons 
(data presented in this thesis).
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6.2. Behavioural relationships between cocaine-induced 
sensitisation and potentiation of conditioned 
reinforcement 
Repeated, intermittent exposure to cocaine and other 
psychostimulant drugs can lead to hypersensitivity (sensitisation) to the 
drug-induced motor-enhancing and incentive-motivational effects (Kalivas 
& Stewart, 1991; Robinson & Berridge, 1993). According to the sensitisation 
theory of addiction, repeated drug exposure strengthens the ability of drug-
associated stimuli to control behaviour, as the underlying neural system 
also becomes progressively sensitised, thereby increasing the risk of 
addiction. Through the CRf paradigm, we have also learned that cocaine, 
among other psychostimulant drugs, can strengthen stimulus-driven 
conditioned behaviours. This is of particular importance, especially when 
considering the phenomenon of polysubstance abuse, whereby the effect of 
one type of drug may lead to stimulus-driven intensified craving for another 
drug and therefore, drug-seeking behaviours. To date, there is compelling 
evidence from animal (Crombag & Shaham, 2002; Grimm, Hope, Wise, & 
Shaham, 2001; Lu, Grimm, Dempsey, & Shaham, 2004) and human 
(Childress, McLellan, & O’Brien, 1986; Childress et al., 1999; Drummond, 
2000; Foltin & Haney, 2000) studies that drug-associated environmental 
stimuli are powerful triggers of “craving” (i.e. cue reactivity) both in animal 
and human studies, thus leading to persistent drug-seeking and drug-taking 
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behaviours, as well as increasing the propensity of relapse (refer to Perry, 
Zbukvic, Kim, & Lawrence, 2014 for a comprehensive review).  
A drug challenge, following a period of withdrawal, is often reported 
to induce a more sizeable effect on locomotor activity in psychostimulant-
sensitised WT mice than those receiving repeated, intermittent sham 
injections in a classic behavioural sensitisation experiment (for example, see 
Cornish & Kalivas, 2001; Jung, Lee, Sim, & Baik, 2013). The differences in 
the locomotor response to the psychostimulant drug could be, at least partly, 
explained by its ability to facilitate conditioned activity, which is somewhat 
reminiscent of the psychostimulant enhancement of CRf. This motivation-
enhancing effect of the drug is often difficult to isolate in the traditional 
sensitisation paradigm, given that the drug itself also serves as the US that 
promotes conditioning. However, in the study by LeMerrer and Stephens 
(2006), the effect of acute cocaine exposure on conditioned locomotion was 
significantly larger in the food-sensitised mice compared to the controls (i.e. 
cross-sensitisation). These findings suggest that: (1) locomotor sensitisation 
reflects a conditioned association between the reinforcing properties of food 
and its associated environment, and (2) cocaine can boost the expression of 
this conditioned behaviour. Further corroborating this notion is the findings 
documented in the Morris et al. (2008) study, which demonstrated enhanced 
conditioned activity upon acute cocaine challenge in Ro15-4513-sensitised 
α2(H101R) mutant mice. However, Ro15-4513 failed to enhance conditioned 
activity in cocaine-sensitised α2(H101R) mutants. From this line of 
reasoning, it thus seems plausible that cocaine facilitation of CRf and 
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locomotor sensitisation reflect an interaction between psychostimulant 
action and conditioned behaviours, and such a phenomenon may contribute 
to the development of drug addiction by facilitating cue-driven motivated 
behaviours. 
Neurobiologically, cocaine-induced increases in mesoaccumbal 
dopamine concentrations are heavily implicated in mediating both of these 
behavioural phenomena. The functional importance of dopamine in 
mediating psychostimulant enhancement of CRf has been revealed through 
lesion and pharmacological studies, extensively discussed in Chapters 4&5 
(Burns, Everitt, Kelley, & Robbins, 1994; Parkinson et al., 1999; Pierce & 
Kalivas, 1997; Wolterink et al., 1993). Further, a systemic cocaine challenge, 
following repeated cocaine exposure, was paralleled by a “sensitised 
response” of the mesoaccumbal dopamine (Cadoni, Solinas, & Di Chiara, 
2000; Chen, Marmur, Paredes, Pulles, & Gardner, 1996; Parsons & Justice, 
1993) and similarly, cocaine microinfusion into the NAc was found to induce 
a sensitised behavioural response in amphetamine-sensitised rats (Cador, 
Bjijou, & Stinus, 1995). 
There are, however, mechanistic differences between 
psychostimulant-induced sensitisation and psychostimulant-potentiated 
CRf. In the CRf literature, dopamine signalling via D2Rs is deemed critical 
for psychostimulant-potentiated CRf. Both systemic and intra-NAc 
raclopride treatment markedly attenuated stimulant-potentiated reinforced 
responding (Chu & Kelley, 1992; Wolterink et al., 1993). However, data from 
the sensitisation experiments yielded somewhat contradictory results. 
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Systemic raclopride markedly attenuated the expression of 
methylphenidate-induced enhancement in locomotor activity following 11 
days of methylphenidate exposure (Claussen, Witte, & Dafny, 2015). Similar 
effects were observed with systemic haloperidol in cocaine pre-exposed rats 
(Mattingly, Rowlett, Ellison, & Rase, 1996). In contrast, intra-NAc core 
raclopride infusion, RNAi-mediated D2R knockdown, or D2R-expressing cell 
inactivation failed to induce marked effects on locomotor sensitisation to 
cocaine (15mg/kg; i.p.) (Hikida, Kimura, Wada, Funabiki, & Nakanishi, 
2010; Jung et al., 2013; Sim et al., 2013). Thus, dopamine signalling via 
D2Rs in the NAc appears to be critical for psychostimulant enhancement of 
CRf, but not for that of conditioned locomotion.  
 It should also be noted that, despite the lack of evidence for 
conditioned activity in both groups in the BS-CORE experiment (potentially 
due to methodological factors discussed in Chapter 4), it is unlikely that α2 
knockdown specifically in the NAc core would have affected associative 
learning, given the marginal effects of α2 manipulations in the NAc core on 
Pavlovian appetitive learning. However, this remains to be investigated 
further due to the nature of the stimuli, i.e. contextual vs. discrete, which 
are known to be processed differently (Crombag, Badiani, Maren, & 
Robinson, 2000; Holland & Bouton, 1999; Selden, Everitt, Jarrard, & 
Robbins, 1991). 
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6.3. Conditioned reinforcement and its facilitation by cocaine: 
Role of the mesoaccumbal dopamine 
Cocaine’s ability to elevate dopamine concentration in the NAc 
underlies its ability to facilitate CRf  (Chu & Kelley, 1992; Taylor & 
Robbins, 1986), but a question remains as to whether the CR-induced 
activation of dopamine neurons plays a prominent role in the acquisition 
and expression of CRf-maintained instrumental actions, given that 
dopamine neurons are activated upon the presentation of the CS, not the 
primary reinforcer (Schultz, Dayan, & Montague, 1997). This phenomenon 
has also received a considerable amount of empirical support from other 
microdialysis (Ostlund et al., 2014), voltammetry (Cacciapaglia, Saddoris, 
Wightman, & Carelli, 2012), and electrophysiological studies (Kosobud, 
Harris, & Chapin, 1994).  
Firstly, it is crucial to highlight the distinction between the 
performance during the first CRf session (for baseline measurements) and 
during subsequent CRf tests with drug pre-treatments. Namely, the first 
session, during which animals were exposed to the nosepoke modules for the 
first time, without drug exposure, primarily assessed the acquisition of an 
instrumental action (i.e. instrumental learning) maintained by the CR, 
whereas subsequent CRf sessions assayed the expression (or performance) 
of learned actions solely motivated by the CR. Thus, it is likely that in the 
current study, cocaine facilitated the expression of CR-driven learned 
actions, rather than instrumental learning per se.  
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There currently exists compelling evidence implicating the 
involvement of the accumbal dopaminergic system in mediating some 
aspects of motivation (i.e. motor function or instrumental behaviour). To 
illustrate this, a study by Baldo, and colleagues (2002) demonstrated that 
pharmacological blockade of D1Rs or D2Rs in the NAc core or shell failed to 
suppress food intake, but impaired motor activity. In keeping, Adamantidis 
and colleagues (2011) reported that optogenetic stimulation of VTA 
dopamine neurons did not affect food intake per se, but enhanced food-
reinforced lever pressing, collectively suggesting that mesoaccumbal 
dopamine is not critical for the primary motivation to eat, but is involved in 
energising the activational aspect of motivation (Salamone & Correa, 2012). 
Dopamine is also heavily implicated in Pavlovian approach behaviours and 
Pavlovian to Instrumental Transfer (PIT), providing a mechanism by which 
CS exerts control over behaviour (Lex & Hauber, 2010; Parkinson et al., 
2002; Wyvell & Berridge, 2000).   
However, excitotoxic lesion of the NAc core or shell (Parkinson et al., 
1999) or dopamine depletion in the NAc (J. Taylor & Robbins, 1986) merely 
abolished d-amphetamine potentiation of CRf, without affecting the 
acquisition and expression of preferential responding for the CRf. Instead, it 
is lesion to the BLA that reduced the CR’s control over behaviour (Burns et 
al., 1993). Moreover, dopamine depletion in the NAc failed to disrupt 
sensitivity to reinforcer devaluation, thus, mesoaccumbal dopamine does not 
appear to be essential for encoding action-outcome association that is 
critical during instrumental learning (Lex & Hauber, 2010; Yin, Ostlund, & 
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Balleine, 2008). Also note that although intra-NAc infusion of high doses of 
dopamine antagonists (i.e. raclopride or SCH23390) has been reported to 
abolish preferential responding for the CR over the NCR, the authors 
believed that this might be a result of the overall decrease in locomotor 
activity (Wolterink et al., 1993). Based on existing data, it is conceivable 
that the mesoaccumbal dopamine may contribute towards, but is not critical 
for CRf-governed responding, most likely by affecting the motor output. This 
also suggests that CR-governed responding is a multifaceted phenomenon, 
which engages a complex network of activity involving the accumbal 
dopamine (Burns et al., 1994, 1993; Wolterink et al., 1993).  
So, how does psychostimulant-induced increase in dopamine levels 
enhances the rates of responding for CRf? The answer might lie in the 
interactions between the different time scales of dopamine transmission 
evoked by the CR presentation (brief pulses of dopamine) and cocaine 
(longer-term increases in extracellular dopamine) in the NAc (Hernandez & 
Hoebel, 1988; Schultz et al., 1997; Venton et al., 2006). Whilst phasic 
dopamine has been linked to its ‘teaching signal’ function, tonic dopamine 
release has been suggested to energise goal-directed actions (Hamid et al., 
2015). It is, perhaps, the prolonged response of target neurons to the high 
levels of extracellular dopamine, resulting from bursts of dopamine release 
evoked by the CR and cocaine-induced blockade in dopamine reuptake that 
enhanced instrumental responding selectively for CRf.  
Of equal importance, it also remains to be determined whether the 
CR-induced brief increases in dopamine are sustained throughout the CRf 
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sessions, especially when the animals have learned that the CR 
presentation did not predict food reward delivery. We posit that the time-
dependent decreases in the rates of reinforced nosepoking observed in the 
present research might have reflected the lack of dopamine response 
associated with the CR towards the end of each CRf session.  
 
6.4. Conditioned reinforcement and its facilitation by cocaine: 
Distinct roles of GABAergic signalling via α2- and α4-
GABAARs 
Phenotypic differences resulting from RNAi-induced α2 and α4 
knockdown in the NAc in the CRf experiments are likely to be linked to 
distinct forms of GABAergic signalling mediated by the α2- and α4-
harbouring receptors. Whilst the former is likely to participate in synaptic 
(phasic) GABAergic activity, α4 is largely involved in extrasynaptic (tonic) 
GABAergic transmission mediated by GABA spillover, affecting α4βδ 
receptors that are highly abundant in the NAc MSNs of adult mice (Dixon et 
al., 2010; Farrant & Nusser, 2005; Maguire et al., 2014). These findings 
further add to growing evidence pertaining to the mechanistic dissociation 
between baseline responding for CRf and its potentiation by cocaine (e.g. 
Burns et al., 1993; Parkinson et al., 1999).  
At rest, the MSNs exhibit a highly negative membrane potential (-85 
to 90 mV) (Jiang & North, 1991; Wilson & Kawaguchi, 1996) that is below 
the reversal potential for Cl- ions (-60 mV). This means that the opening of 
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GABAARs would trigger outward movement of the Cl- ions and thus, 
depolarise the neuron (Mercuri, Calabresi, Stefani, Stratta, & Bernardi, 
1991). As a result, the effect of GABA may be excitatory if temporally 
coupled with a glutamatergic signal (Bracci & Panzeri, 2006). Phasic 
GABAergic transmission may be best suited to serve such an excitatory 
effect, whereas sustained opening of the extrasynaptic GABAARs yields a 
shunting inhibitory effect, narrowing the magnitude of excitatory signals 
(Farrant & Nusser, 2005; Stephens et al., 2017). Differences in the outcome 
of α2 and α4 manipulations in CRf, presented in this thesis and in the 
Macpherson et al. (2016) study, might reflect the distinct physiological roles 
of GABAergic activity via α2- and α4-GABAARs in influencing the net MSN 
output. 
As previously discussed in Chapters 4 and 5, there exists a multitude 
of complex ways by which GABA interacts with dopamine in the NAc that 
may underlie cocaine-facilitated responding for CRf. Of particular interest, 
in the accumbal MSNs of adult rats, D2R activation with quinpirole 
increased the amplitude and frequency of evoked synaptic responses from 
the cortex. However, these effects were abolished upon treatment with 
GABAAR antagonist, picrotoxin, thus revealing the D2R’s “inhibitory” 
action, suggesting a triadic interaction between cortical glutamatergic 
input, dopamine action at D2Rs, and GABAergic signalling via the 
GABAARs. This was further corroborated by the finding that quinpirole 
increased glutamate-independent depolarising events that were AMPAR 
antagonist-resistant and GABAAR antagonist-sensitive (Benoit-Marand & 
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O’Donnell, 2008). Given the findings presented in Chapter 5, RNAi-induced 
downregulation of the mesoaccumbal α2-GABAARs in the NAc core D2R-
expressing neurons might have attenuated the “depolarising/excitatory” 
GABAergic responses, recruited by the D2Rs to modulate glutamatergic 
inputs.  
With the assumption that the presentation of a CR alone can evoke 
bursts of dopamine, one may posit that GABA, co-released with dopamine, 
by the dopaminergic neurons innervating the NAc (Tritsch, Jun, Ding, & 
Sabatini, 2012; Tritsch, Oh, Gu, & Sabatini, 2014) might serve to control 
goal-directed actions, perhaps primarily through its action at α4-containing 
receptors. Reducing the number of α4-containing receptors selectively in the 
NAc would reduce this and/or other (i.e. lateral inhibition and/or feed-
forward inhibition) forms of GABAergic control, leading to an overall 
increase in neuronal excitability within the NAc (Maguire et al., 2014) and 
allowing excitatory inputs to exert more powerful influence upon behaviours 
(i.e. increased CRf responding) (Burns et al., 1993). Intriguingly, α4 deletion 
in D2R-, but not D1R-expressing neurons, also mimicked the phenotype of 
α4 constitutive knockout or intra-accumbal α4 knockdown mice 
(Macpherson et al., 2016). Though further experiments to probe the role of 
α4-GABAARs in D1- or D2-expressing NAc MSNs is yet to be determined, 
current data together with findings from this thesis (refer to Chapter 5), 
suggest that intact D2 pathway from the NAc appears to be critical for the 
expression of CRf (Chu & Kelley, 1992; Macpherson et al., 2016; Wolterink 
et al., 1993). 
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The loss of cocaine facilitation of CRf was also observed upon intra-
accumbal activation of δ-containing GABAARs with THIP (4,5,6,7-
tetrahydroisoxazolo[5,4-c]pyridin-3-ol). The THIP-induced effect, however, 
was notably absent in the Gabra4 knockout mice, suggesting that the 
increase in the α4βδ GABAAR-mediated tonic conductance was responsible 
for the loss of cocaine-facilitated CRf (Macpherson et al., 2016). However, 
note that electrophysiological recordings from the accumbal MSN also 
revealed that the administration of THIP reduced mIPSC and sIPSC 
frequency (Maguire et al., 2014), thus raising an important question as to 
whether the loss of cocaine-facilitated CRf with THIP is directly attributable 
to α4βδ GABAAR agonism, or to the secondary effects (i.e changes in phasic 
GABAergic activity). 
6.5. α2-GABAARs and cocaine-facilitated CRf: Implicating the 
accumbal-pallidal connectivity 
 The long-standing view of CRf posits that following Pavlovian 
associations, the CR can serve as an incentive to allow motivated behaviours 
in its own right (Mackintosh, 1974). Alternatively, others posit that stimuli 
predictive of primary reinforcers merely function as a signal that serve to 
guide, rather than strengthen, behaviour to obtain the primary reinforcers 
(Davison & Baum, 2006). According to this “signpost” account of CRf, a 
response would occur not because the learned stimulus strengthens the 
response in a reinforcement-like manner, but because its presentation is 
useful for accessing the primary reinforcer (Shahan, 2010), thus providing a 
269 
 
plausible explanation for the time-dependent decline in the rates of 
responding during CRf tests, documented in Chapters 4 and 5. It would, 
nonetheless, be remiss not to consider the possibility that once learned, the 
CR may acquire both the reinforcing and predictive properties, collectively 
facilitating the instrumental learning and subsequently, the expression of 
the learned actions.  
It is a popular belief that psychostimulant-induced increases in 
extracellular dopamine amplify the incentive salience of the CR, rendering 
it a more potent “motivational magnet” (Berridge, 2012). However, owing to 
the fact that the mesoaccumbal dopamine could serve several independent 
functions, it is plausible that the predictive power of the CR (Schultz, 1998) 
and/or the willingness to work for a reinforcer (Salamone, Correa, Farrar, & 
Mingote, 2007; Salamone, 1998) may also be susceptible to psychostimulant 
manipulations, thus contributing to the overall increase in CR-maintained 
responding.  
The mesoaccumbal dopamine system is the neurobiological substrate 
underpinning cocaine’s ability to enhance responding for CRf (Taylor & 
Robbins, 1984; Taylor & Robbins, 1986). This thesis further showed that 
intact GABAergic transmission via the α2-containing receptors in the D2R-
expressing neurons of the NAc core, is a prerequisite for this cocaine effect 
to occur. Recent anatomical evidence demonstrated that D2-MSNs in the 
NAc core of the mouse innervate the VP, but not the VTA (Kupchik et al., 
2015), highlighting the importance of accumbal-pallidal connectivity in 
mediating cocaine-facilitated CRf. 
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As a major output region for limbic signals, the VP has been directly 
implicated in reinforcement learning and motivation associated with drug 
and food reinforcers in operant and place preference conditioning studies 
(Hiroi & White, 1993; McAlonan, Robbins, & Everitt, 1993; Robledo & Koob, 
1993). For instance, decreasing inhibitory transmission to the VP, achieved 
by selective upregulation of D2Rs or chemogenetic inhibition of D2-MSNs in 
the NAc core, was found to enhance the willingness to work for food (Gallo 
et al., 2018; Trifilieff et al., 2013) and augmented cocaine-seeking behaviour 
in mice (Heinsbroek et al., 2017). Consistently, optogenetic activation of NAc 
core D2-MSNs, thus facilitating their outputs to the VP, reduced 
conditioned preference for a cocaine-paired chamber (Lobo et al., 2010).  
The VP also receives dopaminergic innervation from VTA neurons 
(Klitenick, Deutch, Churchill, & Kalivas, 1992; Stout et al., 2016). 
Intriguingly, bilateral microinfusions of d-amphetamine in the NAc or VP 
enhanced CR-maintained responding, whereas picrotoxin microinfusions in 
the VP abolished preferential responding for CRf, implicating NAc-VP 
GABAergic transmission in psychostimulant enhancement of CRf (Fletcher, 
Korth, Sabijan, & DeSousa, 1998). The exact contributions of 
psychostimulant-elevated dopamine levels in the VP and NAc in boosting 
the rates of CRf-maintained responding remain elusive. However, we posit 
that the RNAi-induced knockdown of the mesoaccumbal GABAAR α2 
subunit expression, particularly in D2R-harbouring MSNs, might have 
interfered not only with dopamine action at the intra-accumbal level, but 
the resulting alterations in the net MSN output could also have modulated 
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dopamine action in the VP, leading to a complete loss of cocaine-facilitated 
CRf observed in the present research. Given that the D1-MSNs also provide 
afferents to the VP neurons (Kupchik et al., 2015), it is likely that α2 
knockdown in D1R-expressing NAc neurons would alter cocaine-facilitated 
CRf. Moreover, the effects of α2 knockdown in the NAc shell on cocaine 
enhancement of CRf are yet to be explored.  
 
Figure 6.1. The involvement in VTA-accumbal-pallidal and VTA-pallidal 
connectivity in cocaine-facilitated CRf. Dopamine projections to the NAc 
(Taylor & Robbins, 1986) and to the VP (Fletcher et al. 1998) have been 
implicated in cocaine’s ability to potentiate CRf. The loss of cocaine-
facilitated CRf in the mesoaccumbal α2 knockdown mice might be due to 
alterations at the accumbal and therefore, perhaps, the pallidal levels.  
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6.6. α2-GABAARs and cocaine-facilitated CRf: Challenging 
D1/D2 antagonism 
Mounting evidence to date suggests that D1- and D2-MSN activation 
in the NAc exerts opposing influences on cocaine-induced responses (refer to 
Chapter 5 for examples). Though further investigations are yet to be carried 
out, findings from the present research somewhat suggest a synergistic 
relationship between these two populations, particularly in mediating 
cocaine-facilitated CRf. Namely, reducing GABAergic signalling via α2-
GABAARs in the NAc core, or specifically in the D1- or D2-MSN 
subpopulations within this region appeared to be sufficient to block cocaine 
CRf.  
Intriguingly, the Chu and Kelley (1992) study concluded that the 
action of dopamine at both D1R and D2Rs are crucial for psychostimulant 
enhancement of CRf. It is commonly assumed that dopamine action at D1Rs 
and D2Rs are largely excitatory and inhibitory respectively (though also see 
Benoit-Marand & O’Donnell, 2008 for D2R activation and GABA in the 
NAc). Here, however, we showed that reducing inhibitory control on 
(potentially enhancing the activity of) both D1R- and D2R-expressing 
neurons blocked cocaine-facilitated CRf. So, how do our data fit in the 
current literature? The answer may lie in the complex interactions between 
dopamine and GABA (Table 6.2). Of particular interest, Benoit-Marand and 
O’Donnell (2008) demonstrated that D2R activation enhanced cortico-
accumbal synapses by recruiting GABA component in the adult rat brain, 
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revealed by picrotoxin treatment. It is currently not clear whether the D2R 
recruits both phasic and tonic GABAergic inhibitory systems to achieve such 
facilitatory effects on cortico-accumbal synapses, given that picrotoxin 
serves as an antagonist on both synaptic and extrasynaptic receptors 
(Farrant & Nusser, 2005). However, we speculate that the accumbal D2Rs 
may interact with the phasic, instead of the tonic, GABAergic system given 
that its facilitatory effect on MSN activity has been revealed in previous 
research (Bracci & Panzeri, 2006). Further, recent data from our laboratory 
showed that agonism at D2Rs had minimal effects on tonic GABAergic 
currents. For these reasons, we hypothesised that the decrease in GABAAR 
number as a result of α2 knockdown might have altered the modulatory 
action of dopamine on glutamatergic afferents into the NAc neurons, leading 
to the loss of cocaine-potentiated CRf. Moreover, α2 manipulations 
specifically in D2R-expressing neurons would similarly affect the net output 
of the NAc core, leading to the loss of cocaine’s CRf enhancing effects.  
Table 6.2. 
 
Table 6.2. Speculated modulatory effects of dopamine on D1R- or D2R-
expressing neuron excitability in the NAc core of wildtype and α2 
knockdown mice (Benoit-Marand & O’Donnell, 2008).  
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6.7. α2-GABAARs and cocaine-induced locomotor sensitisation: 
Mechanism beyond the NAc? 
Dopaminergic neuron activity within the VTA has long been thought 
to be the neurobiological correlate of the development of sensitisation 
(Kalivas & Stewart, 1991). The VTA is enriched with the α1-containing 
GABAARs, but the α2 subunit is sparsely expressed in this region (Hörtnagl 
et al., 2013; Schwarzer et al., 2001). This thesis, therefore, initially 
hypothesised that the loss of Gabra2 specifically in the NAc could have 
altered signalling within the VTA, leading to a loss of sensitisation to 
cocaine observed in the α2 constitutive knockouts (Dixon et al., 2010; Xia et 
al., 2011). In support of this notion, altering the inhibitory control of the 
NAc neurons via optogenetic activation of parvalbumin-expressing 
GABAergic interneurons in the NAc blocked locomotor sensitisation to 
amphetamine (Wang et al., 2017). 
Mounting behavioural and neurobiological evidence to date 
corroborates the view that psychostimulant-induced sensitisation is not a 
unitary phenomenon (Wise & Leeb, 1993) and mechanistically, sensitisation 
has been shown to engage a complex network of subsystems involving the 
NAc, VTA, amygdala, mPFC, laterodorsal tegmentum, and the subthalamic 
PVN (Beyer & Steketee, 2002; Kalivas & Alesdatter, 1993; Kalivas & 
Stewart, 1991; Nelson, Wetter, Milovanovic, & Wolf, 2007; Ujike, Onoue, 
Akiyama, Hamamura, & Otsuki, 1989; Wolf, Dahlin, Hu, Xue, & White, 
1995; Young & Deutch, 1998). As the α2 subunit is densely expressed in 
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some of these regions (Hörtnagl et al., 2013; Schwarzer et al., 2001), it is 
plausible that the blockade of sensitisation in the constitutive knockouts 
might have resulted from the loss of Gabra2 expression in multiple regions, 
perhaps including the NAc. In keeping, previous research has identified 
alterations in the GABAAR expression and function across different regions 
following repeated methamphetamine exposure. For instance, a radio-ligand 
binding assay reported decreases in [3H]flunitrazepam binding in the motor 
and cingulate cortices, caudate putamen, and the NAc in 
methamphetamine-sensitised mice. These changes were reversed by the 5‐
HT3 receptor antagonist, MDL72222, which attenuated locomotor 
sensitisation to methamphetamine (Yoo, Lee, Kim, Lee, & Jang, 2010).  
6.8. Considerations 
6.8.1. The RNAi strategy to study α2-GABAAR function 
At present, there are limited methods to study the functional roles of 
α2-GABAARs selectively. Existing pharmacological tools, such as 
benzodiazepines and their derivatives, lack receptor specificity (Atack et al., 
2006; Lüddens & Wisden, 1991; Tan et al., 2011). In this thesis, we have 
exploited advances in RNAi technology to enable investigations into the 
functional contributions of the α2-GABAARs in a site- and cell-type-specific 
manner. There are, however several issues that merit consideration. 
Firstly, the off-target effects, either of a sequence specific or a non-
sequence specific nature, comprise one of the major impediments of 
sh/siRNA-induced gene expression silencing. In the present research, the 
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occurrence of non-sequence specific off-target effects, i.e. the activation of 
the antiviral immune response pathway (Reynolds et al., 2006), was 
unlikely given the short length of the double-stranded RNAi effectors 
(Elbashir, 2001). Additionally, though off-target silencing of other genes, 
either by siRNA- or miRNA-like interaction might have occurred, we 
postulate that the effect was likely to be minimal, in part due to the high 
knockdown potency of shα2, as indicated by the immunocytochemical and 
immunohistochemical analyses presented in Chapter 3. 
Furthermore, current data demonstrated that α2 subunit expression 
did not appear to be resilient to our RNAi manipulations. However, it 
remains unclear whether the α2 expression knockdown achieved using this 
approach would sufficiently reduce the level of α2-containing receptor 
surface expression, as in vitro findings documented in the Gorrie et al. 
(1997) study showed that only a small proportion (<25%) of the GABAAR 
subunits underwent oligomerisation to form functional receptors. On the 
other hand, published data from the Liu et al. (2011) study found that 80% 
knockdown of Gabra2 expression in the rat significantly reduced radioligand 
([3H]flunitrazepam) binding in the CeA. This was thought to be solely 
triggered by the downregulation of the α2-containing receptors, as no 
changes in the expression level of the GABAAR α1 subunit, which is also 
highly expressed in the CeA, were observed. Though future investigations 
(i.e. electrophysiological or ligand-binding assays) are warranted, based on 
existing data, we argued that the extent of α2 knockdown achieved by the 
shα2 (>70%) used in the present research was likely to downregulate the 
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receptor number, thus leading to the aforementioned phenotypic differences 
observed in the present experiments. 
Alternatively, the inducible, site-specific gene knockout using the Cre-
lox strategy is also a suitable method for targeting specific GABAAR 
subunits as it permits site-specific gene knockout and this strategy has been 
utilised in previous research to study the functional roles of the 
mesoaccumbal Gabra2 in the mouse (Engin et al., 2014). Recent years have 
also witnessed growing interests in the use of CRISPR interference 
(CRISPRi) and Transcription Activator-Like Effector (TALE)-based 
transcriptional repression techniques as reverse genetic strategies 
(Boettcher & McManus, 2015). In a direct comparison with the RNAi, 
CRISPRi appeared to yield more consistent, potent knockdown (>75%) and 
greater loss-of-function phenotypes (Gilbert et al., 2013, 2014).  
Finally, one of the renowned strengths of post-transcriptional gene 
expression silencing with RNAi is the lack of compensations, commonly 
associated with gene targeting approaches (Rossi et al., 2015). However, it 
has been reported that phasic and tonic inhibitions, via synaptic and 
extrasynaptic GABAARs respectively, appear to regulate each other to 
maintain homeostasis. Namely, overexpression of α6β3δ receptors in 
cultured pyramidal neurons produced a substantial reduction in mIPSC 
frequency and such homeostatic plasticity occurred independent of the 
receptor activation. Nevertheless, the overexpression of α2β3γ2 receptors 
failed to alter THIP-sensitive currents when tested in vitro (Wu et al., 2013). 
Further electrophysiological characterisations of both tonic conductance and 
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mIPSC characteristics upon RNAi-induced α2 knockdown should, thus, be 
performed in continuing efforts to understand the functional interactions 
between these inhibitory systems that may work synergistically in 
mediating the expression of dopamine-dependent motivated behaviours. 
6.8.2. Behavioural paradigms 
It is also of importance to consider the caveats of the behavioural 
paradigms used in this thesis. Incentive motivation theory posits that 
repeated drug exposure can lead to greater salience of some of the drug-
induced effects, leading to a sensitised response (Robinson & Berridge, 
1993). Many drugs of abuse share a similarity in that some of their effects 
sensitise, e.g. locomotor effects  (Vanderschuren & Kalivas, 2000). It has 
been postulated that they may share a common mechanism by which they 
evoke locomotor sensitisation, given that cross-sensitisation between drugs 
has been reported, despite drug-specific differences in the mechanisms of 
action (Bonate, Swann, & Silverman, 1997; Cadoni et al., 2000; 
Cunningham, Finn, & Kelley, 1997). Though this phenomenon has been 
reported in a plethora of pre-clinical studies to date, the occurrence of 
sensitisation does not appear to extend to the human case and therefore, 
sensitisation as a mechanism of drug abuse is considered of somewhat 
limited explanatory value. In the animal literature, locomotor  sensitisation, 
in specific, is paralleled by a sensitised dopamine neuron reactivity (Vezina, 
Lorrain, Arnold, Austin, & Suto, 2002). Challenging the notion of 
sensitisation in humans is the imaging data documented in the Volkow et 
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al. (1997) study, which identified blunted dopamine responses to a 
methylphenidate challenge in the striatum of cocaine addicts, though others 
have modelled sensitisation (i.e. increased dopamine release) in healthy 
individuals treated with amphetamine (Boileau et al., 2006). The lack of 
changes in dopamine response upon the methylphenidate challenge in the 
Volkow et al. (1997) study could have been due to the fact that 
measurements were taken in the dorsal striatum, rather than in the NAc. 
Nevertheless, psychostimulant-induced sensitising effects have also been 
difficult to demonstrate in humans (refer to Leyton & Vezina, 2013 for 
review of sensitisation studies in humans). The apparent discrepancy 
between the animal and human literature is likely to be driven by drug 
administration regimens, withdrawal periods, surrounding cues (contextual 
and discrete cues), as well as contingent vs. non-contingent drug exposure 
(Caprioli, Celentano, Paolone, & Badiani, 2007; Leyton, 2007).  
Of final note, though paradigms that require noncontingent 
(experimenter-administered) drug administration have yielded a wealth of 
evidence on how acute or repeated drug exposure alters neural function, 
note that the neuroplasticity occurring in response to contingent drug 
administration may differ (for example, see Miguéns et al., 2008).  
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6.9. Future work 
 
6.9.1. Further investigations of the role of α2-GABAARs in 
locomotor sensitisation to cocaine 
Findings from Chapter 4 have demonstrated that Gabra2 expression 
in the NAc core or shell is not critical for the development of cocaine-induced 
locomotor sensitisation. As discussed above, though it is a possibility the 
loss of the GABAAR α2 subunit in multiple regions might have accounted for 
the blockade of the development of cocaine-induced sensitisation in the α2 
constitutive knockouts, a recent optogenetic study has shown that 
optogenetic activation of NAc GABAergic neurons was sufficient to abolish 
the expression of locomotor sensitisation during a cocaine challenge (Wang 
et al., 2014). This investigation could therefore be extended by examining 
the effects of α2 knockdown in the NAc core or shell on the long-term 
expression of sensitisation.  
6.9.2. Further investigations of the role of α2-GABAARs in 
cocaine-facilitated CRf 
The NAc core and shell subdivisions have been shown to be involved in 
mediating different aspects of psychostimulant-facilitated CRf. Namely, the 
NAc core was found to be a critical site for the interaction between the CR’s 
control over behaviour and its potentiation by d-amphetamine, whereas the 
shell subdivision primarily mediates the stimulant effects of d-amphetamine 
(Parkinson et al., 1999). Based on current findings, this study hypothesised 
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that the lack of mesoaccumbal Gabra2 expression might have specifically 
disrupted cocaine-induced enhancement in the willingness to work for the 
CR, as the loss of the cocaine facilitation of CRf was observed upon RNAi-
induced silencing of α2 expression in D2R-harbouring neurons. There is 
strong evidence in the literature implicating D2R-mediated dopamine 
transmission in tasks requiring high effort (Gallo et al., 2018; Soares-Cunha 
et al., 2016; Trifilieff et al., 2013). At the neurobiological level, we posit that 
reducing the level of α2 expression in the NAc core might have somewhat 
dampened the consequences of cocaine-induced D2R-, and possibly D1R-, 
mediated dopamine signalling, thus leading to enhanced inhibitory 
transmission to the pallidum and the loss of its CRf-potentiating effects.  
Mechanistically, as depicted in Figure 6.2, we further speculated that 
reducing the number of α2-harbouring receptors in the NAc would enhance 
MSN outputs to the VP, which in turn, might result in attenuated inhibitory 
afferents to the VTA dopamine and non-dopamine neurons. Note that in the 
rat, inhibition from the VP was more prominent in the non-dopamine 
neurons than in the dopamine counterparts (Hjelmstad, Xia, Margolis, & 
Fields, 2013). Given that the primary inhibitory control of dopamine 
neurons originate from the local GABAergic interneurons (Tan et al., 2012), 
we posit that the increase in GABAergic input from the interneurons may 
lead to a net decrease in the activity of dopamine neurons, leading to the 
loss of cocaine-induced effects 
Alternately, according to the RPE model, the presentation of a CR 
should trigger dopamine neuron activation (Schultz et al., 1997). Cocaine-
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induced blockade of dopamine transporters might prolong the availability of 
high dopamine level in the extracellular space triggered by CR presentation, 
leading to increased CR-maintained responding in the wildtype mice. 
However, it remains a possibility that in the α2 knockout or knockdown 
mice, CRs no longer evoked bursts of dopamine during the CRf tests, hence 
the absence of cocaine’s enhancing effect. 
Taken together, psychostimulant enhancement of CRf appears to 
involve dopamine action at the NAc and VP (Fletcher et al., 1998) though 
detailed mechanisms underlying this behavioural response remains to be 
fully elucidated. To probe whether cocaine-facilitated CRf requires the 
functional interaction between the dopaminergic action and GABAergic 
signalling via the α2-containing receptors strictly at the accumbal level, or 
at the level of NAc-VP synapses, future experiments should also address the 
effects of mesoaccumbal α2 knockdown on intra-NAc or intra-VP cocaine-
enhanced CRf.  
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Figure 6.2. Speculated influence of mesoaccumbal GABAAR α2 subunit 
knockdown in the D1- or D2-MSNs on the NAc-VP-VM-NAc circuitry. 
Reduced inhibitory control by GABA through α2-GABAARs may enhance 
MSN output to the VP, resulting in dampened inhibitory input to dopamine 
and non-dopamine neurons in the VM (Hjelmstad, Xia, Margolis, & Fields, 
2013). Such alterations are likely to elucidate the loss of cocaine-facilitated 
CRf in the α2 knockouts (Dixon et al., 2010) or in the mesoaccumbal α2 
knockdowns. 
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Whilst the current research has provided robust evidence for 
importance of α2-GABAARs in the NAc core in mediating cocaine 
enhancement of CRf, the contribution of α2 in the NAc shell remains 
elusive, warranting future investigations. We postulate that α2 knockdown 
in the NAc shell, would also affect cocaine facilitation of CRf as dopamine 
depletion in the NAc shell has also been demonstrated to abolish d-
amphetamine potentiation of CRf (Parkinson et al., 1999). We further posit 
that the heightened cocaine-induced hyperlocomotion resulting from α2 
knockdown in the NAc shell (refer to Chapter 4: BS-SHELL experiment) 
might enhance responding on both the CR- and NCR-associated modules 
(Parkinson et al., 1999). 
Furthermore, considering that α4-GABAAR activation with THIP, 
leading to an overall reduction in mIPSC frequency, also blocked cocaine-
facilitated CRf (Macpherson et al., 2016; Maguire et al., 2014), further 
investigations should be carried out to probe whether the loss of cocaine-
potentiated CRf upon RNAi-induced downregulation of α2 expression was 
attributable to the downregulation of the α2-containing receptors or simply 
resulted from a general decrease in phasic GABAergic activity in the NAc, 
mediated by the α2- and potentially, α1-containing receptors (Hörtnagl et 
al., 2013; Mitchell et al., 2018). Electrophysiological recordings from the 
NAc core neurons of the Gabra2 knockout mice indicated no genotypic 
differences in the mIPSC frequency, but revealed a ~33% decrease in the 
mIPSC amplitude, indicating the presence of other synaptic GABAAR 
isoform(s) (Dixon et al., 2010). Future studies could probe the effects of 
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RNAi-induced mesoaccumbal Gabra1 expression knockdown on cocaine’s 
CRf-potentiating properties. 
 It remains elusive whether the α1- and α2-GABAARs display 
subcellular colocalisation within the accumbal neurons (see Figure 6.3), thus 
gating the same excitatory inputs. Some argue that the α1-GABAARs are 
preferentially enriched in the GABAergic interneurons, whereas the α2-
harbouring receptors are densely expressed in the MSNs (Boyes & Bolam, 
2007; Schwarzer et al., 2001). However, more recent in vivo data suggest 
that both the α1- and α2-containing GABAARs are present on the MSN 
dendrites (Gross et al., 2011) and others have identified mixed α1/α2 
postsynaptic clusters in the developing MSNs (Arama et al., 2015). Based on 
the anatomical and THIP data described above, it is tempting to speculate 
that knocking down Gabra1 expression, thus reducing overall phasic 
GABAergic activity, would also block cocaine-facilitated CRf. However, note 
that α1- and α2-GABAARs have distinct kinetic properties, i.e. α1-GABAARs 
exhibit fast deactivation and desensitisation (Freund & Buzsáki, 1996), 
whereas  α2-GABAARs are often characterised by fast activation, slow 
deactivation, and higher GABA affinity (Lavoie, Tingey, Harrison, Pritchett, 
& Twyman, 1997; Levitan et al., 1988). 
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Figure 6.3. Subcellular localisation of α2-GABAARs within the NAc. It 
remains to be determined whether α2-GABAARs are localised on the 
dendritic and/or the somatic membrane of accumbal medium spiny neurons, 
which are involved in distinct forms of inhibition (i.e. lateral vs. feedforward 
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inhibition; also refer to Chapter 1 Section 1.3.3.3) (adapted from Stephens et 
al., 2017).  
The findings from Chapter 5 have yielded further insights into the 
cell-type-specific roles of the intra-accumbal α2 subunit, particularly in 
Pavlovian learning and cocaine-facilitated responding for CRf. However, 
given the inconclusive results, it remains unknown whether intact 
GABAergic signalling via the α2-containing receptors in the NAc core D1R-
expressing neurons are also crucial for dopamine’s ability to boost CRf. A 
repeat experiment should therefore be carried out to investigate this 
further. Additionally, to extend the D1/D2 pathway-specific investigations, 
future research could utilise optogenetic approaches to further establish 
causal relationships between the accumbal MSN activity and cocaine 
enhancement of CRf.  
Finally, akin to CRf, PIT also measures how reward-associated 
stimuli can alter motivation and ultimately, instrumental actions. Lesion 
studies have implicated activities within the CeA and NAc core, specifically 
in outcome-specific PIT (Corbit & Balleine, 2005; 2011). Intriguingly, 
psychostimulant drugs can potentiate the expression of PIT through 
augmented phasic dopamine signalling (Ostlund et al., 2014; Saddoris, 
Stamatakis, & Carelli, 2011). Future research could therefore probe 
whether the mesoaccumbal α2-containing receptors also play crucial roles in 
the expression of PIT and its potentiation by psychostimulant agents. 
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6.10. Conclusions 
To conclude, studies to date have yielded converging evidence for high 
genetic influences on dopamine-dependent behavioural responses to cocaine 
(Dixon et al., 2010; Duka et al., 2015; Mitchell et al., 2018). Using the RNAi 
technology in mouse models, findings presented in this thesis have 
demonstrated that reducing the expression level of the GABAAR α2 subunit, 
specifically in D2R-harbouring neurons of the NAc core, abolished cocaine’s 
ability to boost the expression of a learned instrumental action. Further, 
though manipulations of α2 expression in the NAc core or shell did not 
induce marked effects on the development of cocaine-induced locomotor 
sensitisation, the latter markedly amplified cocaine-induced locomotor 
hyperactivity. Collectively, this thesis has coalesced current data into a 
working hypothesis that the mesoaccumbal α2 expression is critical for 
cocaine’s CRf-enhancing properties, but not for its sensitisation-inducing 
effects. It remains to be determined whether the present findings with 
cocaine can be extrapolated to other psychostimulant drugs. 
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Appendix A - An in vitro  assay of the Cre-dependent pAAV-shα2 
 
 
 
The amount of α2 expression (signal), normalised to either mCherry or 
EGFP did not vary significantly between cells co-transfected with Cre- and Cre-
dependent shScr-harbouring plasmids and those transfected with pcDNA (No Cre 
control) and Cre-dependent pAAV-shα2 (experiments were set up in triplicates; 
scalebar 100µm), t(4) = 0.29, p = .784. Thus, the α2 knockdown by pAAV-
EGFP_mCherry(DO_DIO)-shα2, presented in Chapter 3, occurred only in the 
presence of Cre.  
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Appendix B - Investigating the effects of shScr injections into the 
NAc core on cocaine-facilitated conditioned reinforcement 
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Here, we showed that rAAV-EGFP-shScr injections into the NAc core 
(n = 11) did not affect baseline responding of conditioned reinforcement and 
cocaine-facilitated conditioned reinforcement through potential off-target 
effects when compared to a group of mice receiving sham injections (saline) 
into the NAc core (n = 14) (i.e. a non-significant three-way interaction 
between groups, dose, and nosepokes; F(2,46) = 1.14, p = .328). 
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Appendix C - Investigating the effects of cocaine on magazine 
entries during conditioned reinforcement sessions 
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 Different doses of cocaine failed to affect magazine entries during CRf 
sessions in both groups, indicated by statistically non-significant group x 
dose interaction (F(2,36) = 2.96, p = .065) and main effect of dose (F(2,36) = 
3.16, p = .055). 
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Appendix D - Investigating the effects of α2 knockdown in the 
dorsal striatum on cocaine-facilitated conditioned reinforcement  
 
 
 
An additional pilot experiment was conducted to examine whether 
the loss of cocaine’s CRf-enhancing effect seen in the shα2 group above could 
have been an artefact of viral spread and therefore, α2 knockdown in the 
dorsal striatum (DS). The target injection sites within the DS (coordinates 
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AP+1.18, L+/- 1.00, DV -3.30) are shown in Figure 4.5 (Paxinos & Franklin, 
2001). Two groups of mice, shScrDS (n = 4, all males) and shα2DS (n = 4, all 
males) were initially used in this experiment. Suppressing the expression of 
α2 in the DS did not affect Pavlovian learning with food rewards (i.e. a non-
significant three-way (CS × session × group) interaction (F(11,44) = 0.53, p  
= .875) and conditioned reinforcement (i.e. a non-significant nosepokes × 
group interaction (F(1,4) = 6.13, p = .069)). Further, α2 knockdown in the DS 
failed to abolish cocaine enhancement of CRf (FCR(2,4) = 14.81, p < .05; 
FNCR(2,4) = 2.00, p = .251). 
 
